Probiotics

PubMed ID: 17900321

Multispecies probiotic given with amoxicillin significantly reduced antibiotic-associated diarrhea-like stools.

PubMed ID: 18945506

Supplementation strongly increased target lactobacilli and propionibacteria counts.

PubMed ID: 18336547

Bifidobacterium strains altered faecal Bifidobacterium species composition in elderly (species-specific effects).

PubMed ID: 37374369

S. boulardii plus D-mannose reduced post-cystoscopy infection rates; S. boulardii is often used to prevent antibiotic-associated diarrhea/infection (pilot evidence).

PubMed ID: 26249791

RISTOMED diet with VSL#3 led to a decrease in Clostridium cluster IV/Bifidobacteria ratio — probiotic-containing nutraceutical altered gut microbiota ratio.

PubMed ID: 35974020

Probiotic yogurt increased SCFA-producing and beneficial taxa and fecal SCFAs — strong microbiome compositional/metabolic change.

PubMed ID: 30521044

Adding zinc to probiotic improved recovery from antibiotic-associated diarrhea and restored beneficial flora/intestinal injury markers — direct post-antibiotic support.

PubMed ID: 21527594

Perioperative synbiotics altered fecal flora and organic acid profiles and preserved mucosal integrity — clear flora-modulating effect.

PubMed ID: 17060763

Synbiotics increased fecal bifidobacteria and total organic acids pre- and postoperatively — direct evidence of flora modulation.

PubMed ID: 27801789

High‑dose maternal probiotic changed milk cytokines and reduced infant GI symptoms; likely reflects microbiota/immune interactions that balance flora.

PubMed ID: 25836922

Perinatal VSL#3 significantly increased lactobacilli and bifidobacteria in colostrum and mature milk (clear effect on milk/gut microbiota composition).

PubMed ID: 19525871

Large RCT showed marked increase in detection of probiotic L. reuteri in infant stool and occasional presence in colostrum (direct microbiota balancing evidence).

PubMed ID: 16126047

Maternal/infant probiotics increased fecal bifidobacteria and lactobacilli counts in infants (direct evidence of microbiota modulation).

PubMed ID: 41609355

GERD RCT showed enrichment of beneficial taxa and increased SCFAs/GABA after probiotic therapy.

PubMed ID: 40431448

IBS study produced specific microbiota shifts (increased B. animalis, S. thermophilus) along with clinical gains.

PubMed ID: 35919499

RCT in antibiotic-associated diarrhea: probiotic powder increased beneficial bacteria, lowered inflammation and protected vs AAD.

PubMed ID: 30071894

Prebiotic increased bifidobacteria and butyrate—demonstrates microbiota modulation (prebiotic but relevant).

PubMed ID: 37019193

L. plantarum P9 produced constipation relief accompanied by specific increases/decreases in gut taxa — strong link between symptom improvement and microbiome shifts.

PubMed ID: 41387706

Synbiotic formula in toddlers significantly increased L. reuteri and multiple Bifidobacterium spp. with correlated clinical benefits — strong evidence of microbiome enrichment.

PubMed ID: 32984080

Topical S. dentisani shifted oral microbiota toward healthier composition — localized microbiome balancing (oral rather than gut).

PubMed ID: 39153842

In very preterm infants heat‑inactivated and live Bifidobacterium mixes produced similar faecal microbiota outcomes with modest SCFA differences.

PubMed ID: 40182598

6‑month LcS‑fermented milk increased bifidobacteria and produced a significant β‑diversity shift and higher butyrate.

PubMed ID: 40366770

B. animalis + inulin increased fecal SCFAs and bifidobacteria in a well‑powered crossover trial.

PubMed ID: 38684660

Synbiotic shifted beneficial phyla and increased SCFAs alongside metabolic improvements—consistent microbiome balancing.

PubMed ID: 38931207

Symbiotic plus extruded sorghum increased gut microbial richness (Chao1) and SCFAs in CKD patients.

PubMed ID: 36678227

Probiotic restored gut richness and SCFAs and reduced chemo‑related GI complications after postoperative therapy—analogous to post‑antibiotic recovery.

PubMed ID: 35938351

6‑month probiotic diet in seniors increased lactobacilli/bifidobacteria, SCFAs and reduced Proteobacteria—broadly restorative.

PubMed ID: 36811568

Large infant RCT showed synbiotic formula produced breastfed‑like microbiota (increased bifido/lactobacilli) and lowered pH.

PubMed ID: 35185013

Bifidobacterium supplements increased bifidobacteria and reduced Gammaproteobacteria in preterm infants.

PubMed ID: 36717369

Bifidobacterium quadruple tablet increased SCFA‑producers and fecal butyrate alongside symptom benefit in IBS.

PubMed ID: 33567701

Synbiotic increased bifidobacteria and fecal organic acids over 24 weeks—microbiota rebalancing in T2DM patients.

PubMed ID: 30940833

FOS increased Bifidobacterium and transiently raised alpha‑diversity—clear microbiota modulation (prebiotic).

PubMed ID: 30145102

Clostridium butyricum given during/after H. pylori eradication partially restored some taxa and improved GI symptoms—adjunctive antibiotic support.

PubMed ID: 30716942

Synbiotic meal in dialysis patients raised fecal butyrate and improved metabolic markers—consistent flora support.

PubMed ID: 24385355

Randomized trial: L. paracasei LC01 increased Lactobacillus/Bifidobacterium/Roseburia and decreased E. coli—clear flora balancing.

PubMed ID: 23957631

Synbiotic raised bifidobacteria by 1.4 log units and increased butyrate—strong evidence of microbiota modulation toward a healthier profile.

PubMed ID: 20018483

Infant L. salivarius formula increased lactobacilli and fecal butyrate—direct flora impact in infants.

PubMed ID: 38860826

Multi‑strain probiotic increased microbial richness/diversity and altered stool metabolites—clear microbiome restructuring in humans.

PubMed ID: 33167908

Infant formula types changed microbiome and butyrate; indicates how feeding/probiotics/prebiotics shape gut flora (human RCT).

PubMed ID: 38687069

Triple‑viable probiotic in pregnancy increased Blautia/Subdoligranulum and predicted beneficial microbial functions.

PubMed ID: 33171595

Multistrain probiotic changed beta‑diversity and increased butyrate‑linked taxa though did not alter depressive symptoms.

PubMed ID: 32440731

High‑dose multi‑strain probiotic significantly increased Faecalibacterium prausnitzii and Prevotella and altered microbiome composition.

PubMed ID: 31162597

Synbiotic pasta increased fecal Bifidobacterium in obese/hyperglycemic subgroups—evidence of flora modulation.

PubMed ID: 40826150

High‑dose Bacillus spore probiotic produced rapid clinical recovery and microbiota/immune changes in infants with diarrhea.

PubMed ID: 39792908

L. paracasei + B. animalis improved gut microbiota with increases in SCFA‑producing taxa alongside metabolic benefits.

PubMed ID: 40169760

BLa80 altered gut beta‑diversity and reduced Proteobacteria—direct community modulation.

PubMed ID: 22324448

Synbiotic corrected diarrhoeal symptoms and stool measures—reflects beneficial flora effects.

PubMed ID: 27869661

Multistrain probiotic preserved gut barrier and lowered endotoxin during stress, consistent with more balanced flora/function.

PubMed ID: 39189588

Postbiotic changed gut microbiota/metabolome (butyrate ↑) alongside clinical benefit.

PubMed ID: 36286741

Probiotic adjunct for post-infectious IBS improved clinical symptoms and microbiome markers (reported microbiota changes).

PubMed ID: 35202009

B. animalis plus fiber changed bowel function for colonoscopy prep — consistent with active microbial effects on gut physiology.

PubMed ID: 35343796

Probio‑M8 reduced TMA/TMAO (gut‑derived metabolites) and inflammation, indicating favorable microbiome metabolic shifts.

PubMed ID: 25178882

L. salivarius tablets reduced mutans streptococci and increased lactobacilli in saliva — oral microbiota balancing effect.

PubMed ID: 21853265

Synbiotic produced clear increases in bifidobacteria/lactobacilli and shifted community composition in older adults.

PubMed ID: 17229535

Bifidobacterium‑supplemented formula raised stool bifidobacteria in preterm infants (direct microbiota effect).

PubMed ID: 17623227

Lactitol prebiotic increased bifidobacteria and SCFAs (clear microbiota shift; prebiotic study).

PubMed ID: 15612887

Symbiotic increased fecal Lactobacilla/Eubacteria/Bifidobacteria alongside symptom improvements.

PubMed ID: 9145445

Lactulose/lactitol shifted colonic flora toward probiotics and reduced harmful bacteria and pro‑carcinogenic enzyme activities.

PubMed ID: 40527514

Probiotic shifted gut genera (↑Blautia/Faecalibacterium/Subdoligranulum) and SCFAs in alcohol users.

PubMed ID: 39861457

W. coagulans shifted gut microbiota toward beneficial taxa and reduced Proteobacteria — robust microbiome improvements in humans.

PubMed ID: 41366779

Multiple probiotic strains altered stool microbiota composition in MASLD patients, increasing beneficial taxa and lowering Proteobacteria.

PubMed ID: 38421902

MASLD synbiotics produced large increases in Lactobacillus/Bifidobacterium and reductions in pathogenic taxa — strong flora-balancing evidence.

PubMed ID: 38732547

Synbiotic changed multiple genera (↑Lactobacillus/Veillonella, ↓Agathobacter/Subdoligranulum) in RCT.

PubMed ID: 39234246

Direct evidence: probiotic adjunct during H. pylori eradication helped preserve beneficial microbes and reduced symptom/inflammatory worsening.

PubMed ID: 35487505

L. plantarum trial reported microbiome support and metabolic benefits accompanying weight/ALT changes.

PubMed ID: 29931231

24‑week synbiotic yogurt produced substantial clinical improvements and microbiome‑related benefits — strong flora normalization evidence.

PubMed ID: 28230607

Pediatric NAFLD multi‑strain probiotic normalized sonography and reduced enzymes with associated microbiome changes.

PubMed ID: 28506447

Pre‑transplant probiotic markedly reduced postoperative infections; while not an antibiotic‑recovery study, this shows perioperative microbiome support.

PubMed ID: 26302024

Probiotic reduced stool E. coli CFU and LPS in alcoholic hepatitis — clear beneficial microbial shifts.

PubMed ID: 25809828

VSL#3 changed urinary metabolites reflecting shifts in microbial metabolism — supports probiotic‑driven flora changes.

PubMed ID: 24401715

Synbiotic produced broad improvements in liver/inflammation and reported microbiome shifts consistent with healthier flora.

PubMed ID: 19038698

Short probiotic course rapidly restored bifidobacteria and lactobacilli counts in alcoholic liver injury — direct flora restoration.

PubMed ID: 35521810

Formulated yogurt significantly increased A. muciniphila, B. longum and F. prausnitzii — direct evidence of flora balancing.

PubMed ID: 39879980

A. muciniphila supplementation colonized and benefited low‑baseline individuals — demonstrates flora repletion potential.

PubMed ID: 41635177

Probiotic increased alpha diversity and enriched SCFA‑producing taxa while reducing infection risk — robust compositional benefit.

PubMed ID: 40474200

Adjunct probiotic reduced intestinal dysbiosis severity and endotoxin with favorable shifts in microbial markers.

PubMed ID: 41249095

Post‑colonoscopy probiotic enriched Lactobacillales and suppressed potential pathogens — clear microbiota balancing effect.

PubMed ID: 41465910

Weizmannia coagulans increased gut microbial diversity and SCFAs in constipated subjects — evidence of rebalancing.

PubMed ID: 40716758

B. subtilis HU58 markedly sped recovery from antibiotic‑associated diarrhea and improved GI wellbeing — direct post‑antibiotic support.

PubMed ID: 40884128

Probio87 shifted gut taxa in HPV-positive women toward beneficial species and away from potential pathobionts.

PubMed ID: 41312988

Postbiotic co-administered with antibiotics preserved/increased alpha diversity and enriched beneficial anaerobes—strong support for post-antibiotic recovery.

PubMed ID: 41427732

Randomized trial with dramatic, persistent fecal B. infantis colonization and broad microbiome shifts—strong evidence of microbiota balancing.

PubMed ID: 40837632

Marked increases in Lactobacillus and Bifidobacterium in rotavirus-treated children—favors a balanced flora.

PubMed ID: 40346590

Newborn probiotics increased alpha diversity and beneficial genera—clear microbiome improvement.

PubMed ID: 39172632

Phase‑3 RCT showed rapid, durable restoration of microbiome composition and bile acid balance after RBL dosing.

PubMed ID: 40884341

S. boulardii plus rifaximin increased SIBO eradication and improved symptoms with microbiologic benefit.

PubMed ID: 39814039

Proof that B. longum BB536 survives GI transit supports its potential to influence/ balance the gut flora.

PubMed ID: 40128340

L. casei beverage shifted gut bacteria toward beneficial taxa in chemo patients.

PubMed ID: 40624535

Probiotic adjunct enriched beneficial taxa and helped preserve gut microbes around antibiotic therapy.

PubMed ID: 41425719

Clostridium butyricum (butyrate producer) associated with fewer adenomas and presumed favorable colonic ecological effects.

PubMed ID: 40944274

High‑potency probiotics altered fecal IgA and calprotectin and improved symptom scores, indicating microbiome/immune modulation.

PubMed ID: 40383259

Favorable taxonomic shifts (↑Akkermansia/Lactobacillus, ↓obesity‑linked taxa) after L. plantarum.

PubMed ID: 40004971

B. licheniformis preserved fecal microbial richness during CDI therapy (direct microbiome preservation).

PubMed ID: 40306553

L. plantarum 299v was safe and altered microbial diversity in pediatric alloHCT patients (direct diversity effects).

PubMed ID: 41156564

Increased Lactobacillus abundance and butyric acid (SCFA) with cognitive improvements—microbiome composition change demonstrated.

PubMed ID: 41278159

Multistrain probiotic adjunct during H. pylori quadruple therapy reduced antibiotic‑associated diarrhea/dyspepsia and reflux (direct support).

PubMed ID: 40515809

Probiotic shifted microbiome functions and increased GMWI in responders; increased A. equolifaciens in responders.

PubMed ID: 39924003

Depression pilot showed increased microbial richness and taxa changes correlated with anxiety improvements.

PubMed ID: 40077633

Adjunctive probiotic with rifaximin produced sustained symptomatic improvement consistent with favorable microbiome modulation.

PubMed ID: 40184961

Probiotics increased multiple alpha‑diversity indices and altered taxa in ASD subgroup—disorder‑specific microbiome modulation.

PubMed ID: 38674825

Infant B. breve raised fecal bifidobacteria markedly and increased SCFAs—direct evidence of flora balance in humans.

PubMed ID: 39757420

Heat‑treated postbiotic increased alpha diversity and changed taxa in older adults—demonstrates microbiome compositional shifts.

PubMed ID: 38502383

Postbiotic toothpaste increased salivary diversity and decreased abundance of potential pathogens (oral microbiome balancing).

PubMed ID: 38381349

B. animalis intervention changed gut microbiota composition and increased richness/diversity in constipated children.

PubMed ID: 38412871

Significant increase in fecal lactobacilli and higher fecal acetate/SCFAs—clear microbiota modulation.

PubMed ID: 38755019

Oral L. rhamnosus TOM 22.8 restored Lactobacillus dominance and reduced pathogens in vaginal dysbiosis (microbial balance).

PubMed ID: 38617455

Lactobacillus‑containing supplement in cirrhosis increased Bacteroidetes/Bifidobacterium and decreased Enterobacteriaceae.

PubMed ID: 38519563

LcS substantially reduced antibiotic‑associated diarrhoea incidence in spinal cord injured patients on PPIs.

PubMed ID: 38337627

Probiotic+PPI increased alpha diversity and beneficial genera (Bifidobacterium/Blautia) and reduced Streptococcus.

PubMed ID: 38794748

L. rhamnosus shifted phyla proportions (↑Firmicutes, ↓Bacteroidetes) after supplementation.

PubMed ID: 39122704

Increased L. plantarum and other SCFA producers with favorable metabolite changes.

PubMed ID: 38597892

Perioperative probiotics corrected postoperative dysbiosis clusters by day 7.

PubMed ID: 38830472

Honey+probiotic yogurt enriched B. animalis DNA though without clinical symptom change.

PubMed ID: 38788020

Probiotic changed gut composition and raised alpha diversity (clear microbiome shift).

PubMed ID: 39486439

Study specifically enrolled antibiotic-exposed neonates and increased probiotic carriage while reducing later FGIDs.

PubMed ID: 39351739

Probiotics added to standard H. pylori triple therapy increased eradication and ulcer healing — effective adjunct to antibiotic therapy.

PubMed ID: 39064634

Reduction in Desulfobacterota (H2S producers) indicates a favorable microbiota shift in constipated adults.

PubMed ID: 38733973

LACTIN‑V substantially lowered BV recurrence and restored L. crispatus colonization after antibiotics — direct post‑antibiotic support.

PubMed ID: 38849408

S. boulardii added to H. pylori triple therapy markedly reduced treatment‑related diarrhea — strong evidence for antibiotic adjunct protection.

PubMed ID: 39462408

Oral and vaginal probiotics after metronidazole lowered Nugent scores for BV — direct restoration of healthy flora (vaginal microbiome).

PubMed ID: 38178601

Responders to L. paracasei DG showed decreased Collinsella aerofaciens and symptom improvement — indicates compositional rebalancing in IBS responders.

PubMed ID: 39485259

L. casei DG® increased mucosal microbial alpha diversity and reduced local inflammatory cytokines after ileostomy closure — clear microbiome balance effect.

PubMed ID: 39592940

Adding S. boulardii to H. pylori regimen produced fewer adverse events with maintained eradication — supports tolerability of antibiotic therapy.

PubMed ID: 39058300

Intravaginal probiotic restored Lactobacillus‑dominant microbiota and reduced diversity — strong local microbiome rebalancing.

PubMed ID: 38172093

BL‑99 increased SCFA‑producing taxa (Faecalibacterium, Roseburia) and raised fecal/serum butyrate/acetate — clear microbiota shifts.

PubMed ID: 39467682

Randomized trial in children showed reduced antibiotic‑associated diarrhea and improved fecal microbiota markers with probiotics.

PubMed ID: 39023173

Inactivated L. reuteri added to H. pylori therapy increased eradication rates and reduced digestive side effects — useful as adjunct to eradication regimens.

PubMed ID: 39102225

Large preterm infant RCT shifted microbiome toward healthy term‑like eubiosis scores (genus/species).

PubMed ID: 38630015

B. longum CECT 7347 provided symptomatic relief in IBS‑D alongside QoL improvements — consistent with beneficial gut microbiota effects.

PubMed ID: 38967929

Probiotic in antibiotic‑exposed children reduced clinical AAD in main trial and transiently increased supplemented genera during treatment.

PubMed ID: 37111150

LPG1 increased detection of Lactobacillus and produced modest compositional shifts in commensal genera in healthy adults.

PubMed ID: 38350481

Probiotic‑amylase produced strong symptomatic benefit; formulation plausibly affects microbiota composition/function.

PubMed ID: 37455386

Oral lozenges decreased S. mutans and increased lactobacilli and oral diversity (microbiome balancing in oral niche).

PubMed ID: 36622053

L. rhamnosus L8020 yogurt reduced periodontal pathogen abundances—oral microbiota balance improved.

PubMed ID: 37712964

Immediate post‑CS probiotic enriched beneficial gut taxa in newborns and reduced Klebsiella colonization in an RCT.

PubMed ID: 36688679

Adjunct probiotic increased Faecalibacterium and Bifidobacterium and altered metabolites—consistent with beneficial microbiota shifts.

PubMed ID: 38073551

Hospital Bio‑K+ implementation linked with unadjusted reductions in C. difficile testing/positivity, suggesting potential benefit after antibiotic exposure though adjusted results were inconclusive.

PubMed ID: 38103462

LGG changed gut microbiome composition in household COVID‑19 contacts — evidence of microbiome modulation.

PubMed ID: 37571365

Infant strains were safe and produced modest, strain‑specific shifts in gut bacteria (Lactobacillus/Bacteroides) — modest balancing signal.

PubMed ID: 37942999

Adding S. boulardii to clarithromycin triple therapy showed subgroup improvement in eradication and reduced diarrhea in some analyses — supports adjunctive use during antibiotic regimens.

PubMed ID: 36904141

Peri‑colonoscopy probiotic preserved alpha diversity and accelerated restoration of baseline taxa — strong evidence of microbiota balancing.

PubMed ID: 38004205

Probiotics partly prevented sugar‑induced loss of supragingival diversity and favored non‑cariogenic taxa — protective balancing of oral microbiota.

PubMed ID: 37020353

Multicenter RCT in children on antibiotics showed reduced antibiotic‑associated diarrhea and microbiome resilience — direct post‑antibiotic support.

PubMed ID: 38004199

Probiotic lozenges promoted faster return to health‑associated oral taxa after experimental gingivitis — microbiome balancing in the mouth.

PubMed ID: 37020105

Direct infant probiotic dosing produced rapid, significant increases in B. animalis and favorable shifts in gut microbiota composition — clear flora balancing effect.

PubMed ID: 36986131

Strong RCT in neonates showed rapid, large increases in bifidobacteria and functional stool changes.

PubMed ID: 36678202

Oral MED‑01 increased beneficial vaginal lactobacilli and improved Nugent score.

PubMed ID: 37614081

L. reuteri added to H. pylori therapy increased eradication and reduced GI adverse effects during antibiotic regimens.

PubMed ID: 37060545

High‑dose VE303 after CDI treatment substantially reduced recurrence — clear post‑antibiotic support.

PubMed ID: 38350486

Pregnancy trial prevented loss of beneficial vaginal and fecal microbes and stabilized the microenvironment.

PubMed ID: 37150125

Bifidobacterium increased IPA (microbial metabolite) and linked to neuroprotective/anti‑inflammatory effects.

PubMed ID: 35916669

Multi‑strain fermented milk increased strain abundance/replication and accelerated microbiome compositional and functional recovery after H. pylori antibiotic therapy.

PubMed ID: 35414799

Adding compound Lactobacillus to triple therapy increased H. pylori eradication and improved stool ecology/inflammation—supports probiotic adjunct to antibiotics.

PubMed ID: 34980887

Marked increase in Bifidobacteriaceae and reduction in pathogenic families after probiotic—clear microbiome rebalancing.

PubMed ID: 36004715

HN019 group had zero antibiotic/antiviral prescriptions over study period—reduced antibiotic exposure implies support in antibiotic‑sparing context.

PubMed ID: 36372695

L. reuteri added to quadruple H. pylori therapy did not increase cure but substantially reduced treatment side effects.

PubMed ID: 33136781

Symptom improvement and within‑group breath test change suggest functional microbiota effects in lactose intolerance.

PubMed ID: 35833120

B. animalis MH‑02 increased α‑diversity and beneficial genera after polypectomy — supportive of balanced flora.

PubMed ID: 35221319

Two‑strain probiotic in very preterm infants robustly sped colonization with Lactobacillus and Bifidobacterium — direct flora effect.

PubMed ID: 35031969

B. lactis supplementation in hospitalized patients on antibiotics was associated with fewer diarrhea events and improved GI symptoms — direct support.

PubMed ID: 36184252

Ulcerative colitis trial led to clinical remission with associated immunologic changes and implied microbiome benefits.

PubMed ID: 35528160

S. boulardii given with H. pylori bismuth‑quadruple therapy preserved beneficial bacteria and reduced early inflammation.

PubMed ID: 35193609

2'FL + L. reuteri formula shifted infant microbiota closer to breastfed pattern with increased bifidobacteria.

PubMed ID: 36062569

Probiotics combined with metformin changed gut bacteria alongside improved menstrual/metabolic outcomes in PCOS.

PubMed ID: 35880079

S. boulardii achieved rescue H. pylori eradication in ~30%, reducing immediate need for repeat antibiotics in some patients.

PubMed ID: 35314794

Extremely preterm infants: increased Bifidobacterium/Lactobacillus abundances — clear compositional shifts toward beneficial taxa.

PubMed ID: 35276991

Four‑strain probiotic adjunct to H. pylori therapy increased eradication slightly and greatly reduced adverse events while improving tolerability and microbiome resilience.

PubMed ID: 36287379

RBX2660 trial: designed and shown to prevent recurrent C. difficile after antibiotics — strongest direct evidence for post‑antibiotic support.

PubMed ID: 36269141

BS50 changed symptom profiles and is associated with healthy‑symptom improvements; trial included microbiome endpoints supporting compositional changes.

PubMed ID: 35458199

CKD trial showed trends in reduced microbiota‑derived toxins and modest compositional effects — partial balancing.

PubMed ID: 36426355

H. pylori antibiotic adjunct partially protected community composition and reduced prevalence of Proteobacteria‑dominant states — preserved balance.

PubMed ID: 35860380

FMT in NAFLD: improved microbial diversity and partial restoration toward healthy composition — strong microbiome rebalancing signal.

PubMed ID: 35727573

Pediatric antibiotic RCT: probiotic lowered overall diarrhea risk during/after antibiotics — supports use during antibiotic courses.

PubMed ID: 34486272

Vaginal probiotic after antibacterials restored lactobacilli in most women and reduced relapse rates—clear adjunctive recovery support.

PubMed ID: 33514869

L. casei increased intestinal Lactobacillus/Bifidobacterium and improved lipid profile in alcoholic liver injury patients—flora restoration evidence.

PubMed ID: 34448282

Adjunct probiotic with H. pylori therapy partially restored gastric microbiota (increased Bifidobacterium/Lactobacillus and reduced some pathogens).

PubMed ID: 34579049

RCT during H. pylori therapy showed probiotics improved recovery of fecal SCFAs and limited persistence of opportunistic genera—direct post-antibiotic support.

PubMed ID: 36286886

Multi-strain probiotic with H. pylori quadruple therapy dramatically reduced post-treatment colonic dysbiosis and adverse events—strong evidence for post-antibiotic support.

PubMed ID: 33857850

Microbiota shifted toward taxa associated with better metabolic function after intervention.

PubMed ID: 34904950

IBS study: probiotic produced clinical benefit in responders with individualized microbiome changes — some rebalancing in responders.

PubMed ID: 33732655

Cohort study mapped drivers of early gut microbiome development (feeding, antibiotics)—useful observational evidence linking factors to alpha diversity and taxa like Bifidobacterium.

PubMed ID: 33764850

Probiotic stabilized stool microbiome diversity against URTI-associated declines (trial evidence supporting microbiome stability).

PubMed ID: 34331676

Probiotics given concurrently with antibiotics preserved Bifidobacterium recovery compared with delaying probiotics — strong timing‑dependent support.

PubMed ID: 33762689

Early B. infantis produced sustained multi‑log colonization and durable microbiome remodeling up to 12 months.

PubMed ID: 35063245

Probiotics blunted PPI‑induced shifts in family‑level microbiome abundances — supports microbial balance.

PubMed ID: 33864432

L. casei adjunct during TB therapy reduced plasma LPS and protected against cholestasis‑related lab rises — supportive during prolonged antibiotic treatment.

PubMed ID: 34628695

Non‑viable L. reuteri given with H. pylori antibiotics reduced diarrhoea and improved stool microbiota — supportive during antibiotic therapy.

PubMed ID: 34063276

Probiotic stimulation reduced colonic inflammation and systemic markers in diversion colitis, consistent with beneficial local microbial effects.

PubMed ID: 33749084

Lozenges increased beneficial oral bacteria and reduced plaque — a balanced oral microbiome effect.

PubMed ID: 33441702

Probiotics given with antibiotics in pneumonia shortened fever and normalized inflammation faster—supportive adjunct.

PubMed ID: 33763652

L. reuteri in extremely preterm infants produced marked colonization and increased diversity in the neonatal period—direct evidence for flora balancing.

PubMed ID: 34643888

COVID-19 probiotic reduced antibiotic-associated dysbiosis and shortened diarrhea—supports gut flora benefits.

PubMed ID: 34444820

NVP‑1704 increased Bifidobacteriaceae and lowered Proteobacteria:Actinobacteria ratio — favorable microbiome shifts.

PubMed ID: 31100124

Multi‑strain probiotic prophylaxis reduced UTI recurrences over 18 months — supports mucosal recolonization/defense after infection/therapy.

PubMed ID: 32091443

Probiotic given after metronidazole substantially lowered BV recurrence and extended time to recurrence — clear post‑antibiotic support.

PubMed ID: 33168839

C. butyricum started immediately after laxative restored microbiome diversity to healthy‑like indices and reduced symptoms.

PubMed ID: 31815260

L. casei taken during intensive antibiotic TB therapy reduced antibiotic‑associated GI side effects in a dose‑dependent manner.

PubMed ID: 31749128

Kefir increased bifidobacteria in some participants — direct evidence of microbiota modulation.

PubMed ID: 32383767

L. paracasei reduced Gardnerella in some participants and altered vaginal microbiota slightly after oral intake.

PubMed ID: 32824480

B. lactis (with/without phage) increased certain beneficial genera and improved some GI scores.

PubMed ID: 33225399

Multi-strain probiotic improved IBS symptoms and lowered inflammatory markers—consistent with flora modulation.

PubMed ID: 31953482

Probiotic prevented new MRGN colonisation in hospitalized spinal‑injury patients—relevant to infection risks post‑antibiotic exposure.

PubMed ID: 31959047

Probiotic colonization in SAM treatment increased alpha diversity and altered composition (clear microbiota normalisation).

PubMed ID: 32900583

High‑dose Lactobacillus altered production of at least one gut‑derived toxin (indoxyl sulfate) — reflects microbial metabolic change and partial rebalancing.

PubMed ID: 33066338

Prophylactic probiotics after C‑section produced robust colonization with Lactobacillus and Bifidobacterium vs controls — strong flora balancing in neonates.

PubMed ID: 32790913

Adding probiotics to the regimen reduced antibiotic-associated GI side effects after tooth extraction (direct support for antibiotic-associated symptom mitigation).

PubMed ID: 32412900

Probiotics (with diet) altered colon mucosal bacteria, increasing some beneficial groups and decreasing some potentially harmful taxa — evidence of composition changes.

PubMed ID: 32284181

Perioperative probiotic attenuated antibiotic‑driven taxonomic changes, indicating protective effects on community structure after antibiotic exposure.

PubMed ID: 32112136

Probiotics produced compositional shifts and reduced specific uremic toxins in non‑diabetic HD patients, indicating ecological changes in the gut microbiome.

PubMed ID: 32234652

Probiotic + Mediterranean diet increased species richness and Chao1 diversity — direct evidence for improved gut microbial balance.

PubMed ID: 33763399

Probiotic reduced Pseudomonas colonization after antibiotics in hospitalized patients, but transient AmpC rise limits interpretation.

PubMed ID: 32277872

Heat-killed B. bifidum improved IBS outcomes; suggests favorable microbiota-related effects.

PubMed ID: 33183883

Probiotic raised Lactobacillus and diet/probiotic altered multiple taxa — evidence of microbiota modulation.

PubMed ID: 30694338

Very large effect: S. boulardii greatly reduced antibiotic-associated adverse events and antibiotic-associated diarrhea when added to H. pylori therapy.

PubMed ID: 30634393

Lactofermented apple increased fecal Bifidobacterium/Lactobacillus counts substantially—clear effect on flora composition.

PubMed ID: 31965842

Infant trial increased fecal/salivary SIgA and maintained beneficial bifidobacteria strains—strong evidence of beneficial flora maintenance.

PubMed ID: 31434935

Marked symptomatic improvement in IBS likely reflects favorable microbiome/functional changes.

PubMed ID: 31054010

Reduced faecal calprotectin in UC subgroup suggests an anti‑inflammatory effect linked to mucosal microbial interactions.

PubMed ID: 31554388

Adding L. reuteri to eradication therapy greatly increased cure rates and reduced treatment adverse events.

PubMed ID: 31705339

Vaginal probiotic plus metronidazole substantially improved cure rates for TV and BV, supporting antibiotic therapy.

PubMed ID: 31838596

Large preschool trial showed persistent reductions in S. mutans and increased lactobacilli — clear microbial community changes in the oral/gut axis.

PubMed ID: 31271261

Microbiome shifts (increased Ruminococcaceae, decreased Tenericutes) were observed with stool‑form normalization.

PubMed ID: 29688915

Multispecies probiotic increased fecal Bifidobacterium and improved symptoms in celiac patients.

PubMed ID: 30882242

Vaginal Lactobacillus trial directly changed local microbiota and Nugent score.

PubMed ID: 31114137

Probiotic reduced SIBO rates, directly indicating modification toward a more balanced small‑bowel flora.

PubMed ID: 31208714

Probiotics increased stool microbiota alpha diversity in systemic sclerosis after 120 days.

PubMed ID: 30662004

Kefir increased stool Lactobacillus and showed microbiota engraftment.

PubMed ID: 29725956

S. boulardii given to hospitalized antibiotic recipients produced a large reduction in C. difficile infection rates (strong support for post‑antibiotic protection).

PubMed ID: 29453431

LGG partially restored microbiota evenness in high‑risk infants while being administered—strong signal for balancing flora during supplementation.

PubMed ID: 30136337

Multispecies probiotic raised relative Lactobacillus abundance in IBS‑D patients and showed responder‑specific taxa reductions (Bilophila).

PubMed ID: 28871492

L. rhamnosus GG given with antibiotics reduced antibiotic‑associated diarrhea incidence and duration and lowered postoperative complications.

PubMed ID: 29540160

Successful stool colonization by L. rhamnosus and decreased S. aureus carriage indicate microbiome shift.

PubMed ID: 30326954

Large randomized mother‑infant dataset showed strong restoration/prevention of microbiota disruptions (bifidobacteria, functional restoration)—direct evidence.

PubMed ID: 29439395

Colic study showed changes in stool metabolites and clinical improvement suggesting modulation of the gut ecosystem.

PubMed ID: 30424728

Well‑conducted RCT in very preterm infants produced a clear, time‑limited increase in Bifidobacterium abundance during supplementation.

PubMed ID: 29659876

Pig study showed upregulation of barrier genes and mucosal changes consistent with healthier gut ecology (animal evidence).

PubMed ID: 29445178

C. butyricum treatment associated with symptom improvement and accompanying shifts in gut bacteria linked to responders.

PubMed ID: 30521105

Probiotics restored CCRT‑disturbed gut microbiota diversity toward healthy pattern in chemoradiotherapy patients.

PubMed ID: 28606235

Adding Lactobacillus to H. pylori eradication therapies in children improved cure rates and reduced adverse events—clear adjunctive benefit during/after antibiotics.

PubMed ID: 29065707

BB536 increased Faecalibacterium abundance in preschool children, indicating microbiota modulation.

PubMed ID: 28592037

S. boulardii given with antibiotics reduced incidence, frequency and duration of AAD in older inpatients—strong evidence for antibiotic support.

PubMed ID: 28668229

Oral probiotics increased some normal vaginal bacteria in completers—evidence of altering/bolstering local commensals (small pilot).

PubMed ID: 29065710

Oral probiotic yoghurt taken after metronidazole increased BV recovery and improved symptoms vs placebo—supportive evidence after antibiotic therapy.

PubMed ID: 28388647

S. boulardii in treated HIV patients produced specific, significant shifts in bacterial taxa and reduced inflammatory markers linked to dysbiosis.

PubMed ID: 28558732

B. infantis EVC001 produced a large, consistent increase in fecal bifidobacteria in breastfed infants—direct microbiota balancing effect.

PubMed ID: 29264969

Fermented soymilk increased Lactobacillaceae and decreased some potentially pathogenic families during intake.

PubMed ID: 29196153

Vaginal L. crispatus given after antibiotics reduced BV recurrence and delayed relapse.

PubMed ID: 28858247

Probiotic in preterms shifted stool inflammatory markers and markers consistent with less dysbiosis.

PubMed ID: 28346719

Maternal probiotic altered infant immune markers plausibly linked to early-life microbial-immune programming.

PubMed ID: 28482385

Large RCT in infants showed S. boulardii greatly reduced antibiotic-associated diarrhea during treatment and up to 14 days after.

PubMed ID: 28756115

L. reuteri tablets given after azithromycin in peri‑implantitis patients improved clinical indices, though microbial counts were not different.

PubMed ID: 28935921

L. casei Shirota increased fecal Lactobacillus counts and reduced bacterial translocation, indicating improved gut microbial balance and barrier.

PubMed ID: 28991918

Trial combined targeted antibiotics with L. reuteri and showed lower recurrent diarrhoea—probiotic may support post-antibiotic recovery in enteric infection context.

PubMed ID: 28877893

Infant formula with bifidobacteria produced early shifts in fecal microbiota and metabolites (transient modulation of flora).

PubMed ID: 28961980

Probiotic adjunct in initial C. difficile infection shortened diarrhea — relevant to supporting gut recovery after antibiotics-associated C. difficile.

PubMed ID: 28625832

Probiotic restored Bifidobacterium abundance that was reduced by a low‑FODMAP diet—clear microbiome restoration effect.

PubMed ID: 27206514

Oral probiotic after antifungal therapy (fluconazole) greatly reduced VVC recurrence—supports recovery after antimicrobial therapy.

PubMed ID: 27035371

L. reuteri in formula shifted C‑section infants' gut microbiota toward a vaginal‑delivery profile—direct restoration of microbiota balance.

PubMed ID: 27324341

Vaginal Lactobacillus suppositories increased total lactobacilli and transiently normalized Nugent scores in some women.

PubMed ID: 28007678

Probiotic reduced diarrhea and improved H. pylori eradication and treatment adherence when added to antibiotic therapy—strong adjuvant support.

PubMed ID: 27347788

Lactic ferments changed stool characteristics and transit time; product includes live cultures—likely altered flora.

PubMed ID: 27782071

B. breve in coeliac children shifted microbiota toward patterns seen in healthy children—restorative effect.

PubMed ID: 27826653

Oral multispecies probiotics reached the vagina and persisted after washout, suggesting potential to recolonize after antibiotics.

PubMed ID: 27744438

Vaginal probiotics added to antibiotics in PPROM improved latency/birth outcomes—adjunctive support during antibiotic therapy.

PubMed ID: 27340358

Oral E. coli Nissle increased colonization and normalized stool microbiota features—direct change in gut flora.

PubMed ID: 27595104

Multispecies probiotic increased fecal Lactobacilli/Bifidobacteria and showed sustained detection post‑intake.

PubMed ID: 27649676

BIFICO prophylaxis reduced neonatal enteric infections, consistent with a favorable flora effect.

PubMed ID: 27207411

DDS‑1 maintained symptom control in lactose challenge and supports specific microbe symptom links.

PubMed ID: 27133564

B. longum yoghurt preserved faecal bifidobacteria and prevented meat‑diet microbial shifts.

PubMed ID: 29328644

Adjunct probiotics with H. pylori triple therapy improved eradication and tended to reduce side effects.

PubMed ID: 27973989

S. boulardii markedly blunted antibiotic‑induced Escherichia expansion and reduced diarrhea — strong AAD support.

PubMed ID: 27178566

Probiotic shifted gut bacteria composition in diarrhea‑predominant IBS correlated with symptom improvement.

PubMed ID: 27283364

S. boulardii shortened rotavirus diarrhea and is known to alter pathogenic overgrowth dynamics.

PubMed ID: 27671183

VLBW infant benefits (reduced NEC) consistent with microbiota-mediated protective effects.

PubMed ID: 26956782

Robust increases in gut Lactobacillus and Bifidobacterium documented in preterm infants.

PubMed ID: 27208120

Fermented milk preserved gut microbiota alpha-diversity under exam stress in humans.

PubMed ID: 25986615

L. reuteri shortened diarrhea, which is consistent with restoring balance during infection.

PubMed ID: 25617897

Piglets had increased fecal Lactobacillus % with probiotic, showing flora modulation (animal data).

PubMed ID: 26051728

Probiotic added to H. pylori triple therapy improved eradication and reduced adverse reactions — direct support as adjunct to antibiotic regimen.

PubMed ID: 25846071

BB536 increased bifidobacteria abundance and B/E ratio in infants — strong evidence for microbiota modulation toward a 'beneficial' profile.

PubMed ID: 26258571

Probiotics increased bifidobacteria and shifted bacterial abundances in ART‑treated HIV patients — supports flora rebalancing.

PubMed ID: 26074708

Adding Lactobacillus casei DG to third-line H. pylori therapy improved eradication—direct adjunct/support effect with antibiotics.

PubMed ID: 25948780

BC30 raised Faecalibacterium prausnitzii and Bacillus spp. in older adults — direct evidence of beneficial flora shifts.

PubMed ID: 26378926

Early-life supplementation increased administered strains transiently in stool during intervention (temporary microbiota shift).

PubMed ID: 25588782

Pediatric RCT: probiotic yogurt dramatically reduced antibiotic-associated diarrhoea and abnormal stool consistency.

PubMed ID: 25062611

B. subtilis R0179 survived GI transit dose-dependently and altered some OTUs (evidence of microbiota modulation despite no clinical wellness change).

PubMed ID: 25569274

BB‑12‑supplemented yogurt was safe during antibiotic therapy and modestly increased fecal B. lactis — direct support evidence.

PubMed ID: 26599038

Elderly L. casei Shirota shifted stool microbiota toward more beneficial bifidobacteria/Lactobacillus and reduced C. difficile.

PubMed ID: 25909149

Shift toward higher bifidobacteria and lactic acid bacteria and decreased E. coli with probiotic.

PubMed ID: 25760553

Reported alterations in gut microbiota composition and Bifidobacterium differences at follow‑up.

PubMed ID: 26732025

Fermented milk with L. paracasei increased fecal immune markers and reduced infections—associated with beneficial microbiota/host interactions.

PubMed ID: 26382580

BB‑12 increased defecation frequency and is associated with favorable microbiota changes in low‑frequency subjects (large RCT supportive of flora modulation).

PubMed ID: 25929897

Adding probiotic to H. pylori triple therapy raised eradication rates and substantially reduced multiple antibiotic‑related side effects.

PubMed ID: 25946126

L. reuteri lozenges induced a clear, reversible shift in oral microbiota and increased salivary lactobacilli—direct microbial modulation.

PubMed ID: 26635090

Probiotic added to antibiotics for BV extended symptom‑free interval and sped Lactobacillus recovery (direct post‑antibiotic support).

PubMed ID: 26451088

Vaginal 7‑day probiotic produced large Lactobacillus increases and improved Nugent/pH (direct microbiota rebalancing).

PubMed ID: 25244414

Probiotic reduced SIBO and improved GI symptoms—direct microbial balance effect.

PubMed ID: 25291116

Vaginal L. fermentum/L. plantarum tablets cured BV in most women — restoration of healthy lactobacillus-dominant flora.

PubMed ID: 25579140

SIBO pilot used probiotics as maintenance after antibiotics and achieved higher breath‑test cure rates.

PubMed ID: 25520127

Probiotic added to H. pylori antibiotic regimen improved eradication and reduced bitter-taste side effects—effective adjunct to antibiotic therapy.

PubMed ID: 25623462

Probiotics combined with enteral nutrition reduced endotoxin and inflammation—evidence probiotics can aid recovery after gut insults (e.g., antibiotics).

PubMed ID: 24750797

Probiotic given during antibiotic courses preserved beneficial gut taxa and prevented Enterobacteria overgrowth in children (direct supportive evidence).

PubMed ID: 24661511

S. boulardii added to H. pylori therapy reduced several antibiotic‑associated adverse events, indicating support during/after antibiotic use.

PubMed ID: 24636808

L. reuteri reduced Proteobacteria overgrowth and increased microbial diversity in CF (favorable microbiota shift).

PubMed ID: 24815298

Large IBS trial with symptom improvement consistent with flora modulation.

PubMed ID: 24296423

Adjunct L. reuteri reduced H. pylori bacterial load surrogate and antibiotic side effects—useful as adjunctive support during eradication therapy.

PubMed ID: 25400470

Strong evidence that a Lactobacillus casei drink greatly reduced incidence and duration of antibiotic‑associated diarrhea in hospitalized patients.

PubMed ID: 24594833

B. breve M‑16V produced strong, sustained fecal colonisation and increased total bifidobacteria in VLBW infants.

PubMed ID: 25527244

BMOS±probiotic formula significantly increased bifidobacteria and lactobacilli and lowered clostridia counts.

PubMed ID: 25519197

Preterm infant RCT showed clear increases in stool Lactobacillus and Bifidobacterium colonization.

PubMed ID: 23829297

Administered strains increased in feces and correlated with IBS symptom improvements—evidence of flora modulation.

PubMed ID: 23598785

Oral VSL#3 produced symptomatic and microbiological improvements in BV in pregnancy comparable to topical antibiotic, implying support for flora recovery.

PubMed ID: 24294746

Vaginal L. rhamnosus added to metronidazole improved clinical and microbiological cure/risk of relapse (restored flora).

PubMed ID: 24734423

Neonatal RCT: Enterococcus faecium L3 with antibiotics reduced C. difficile persistence and infectious/digestive complications.

PubMed ID: 23680708

B. infantis given alongside or before H. pylori therapy increased eradication rates and reduced GI side effects (useful as an adjuvant to antibiotics).

PubMed ID: 24283058

Topical Lactobacillus added to metronidazole roughly doubled clinical/microbiological cure and restored normal vaginal flora (strong flora restoration evidence).

PubMed ID: 24311316

S. boulardii markedly reduced new diarrhoea and AAD in hospitalized children (large, robust prevention and treatment effect).

PubMed ID: 24294744

Local Lactobacillus monotherapy produced modest (~42%) clinical and microbiological cure rates for BV (some flora effect).

PubMed ID: 24044687

Daily L. casei Shirota greatly lowered antibiotic‑associated diarrhoea in hospitalized spinal cord–injured patients (very strong evidence in that population).

PubMed ID: 24229598

In rotavirus enteritis probiotics improved intestinal flora balance and reduced secondary bacterial infection.

PubMed ID: 23599642

B. longum BB536 increased fecal bifidobacteria in elderly on enteral feeding—clear microbiota modulation.

PubMed ID: 24291194

Large randomized trial with dose-response showed marked reductions in antibiotic-associated diarrhea and C. difficile—direct evidence of post-antibiotic support.

PubMed ID: 23364497

Probiotic biscuit in elderly reduced Clostridium cluster XI/C. difficile and other pathobionts and tended to enrich beneficial taxa.

PubMed ID: 24239295

Oral lactobacilli significantly increased lactobacilli counts and improved Nugent scores (clear microbiome enrichment evidence).

PubMed ID: 23618760

Multicenter RCT found VSL#3 given with antibiotics markedly reduced antibiotic-associated diarrhoea per-protocol — strong support for post-antibiotic support.

PubMed ID: 23361033

Probiotic reduced Candida colonization in PICU patients and urinary yeast — direct microbiota balancing effect.

PubMed ID: 24246768

Probiotic reduced SIBO and altered orocecal transit in cirrhosis — shifts in small-bowel microbiota.

PubMed ID: 23130583

Broiler probiotic increased Lactobacillus/Bifidobacterium and decreased pathogens in cecal microbiota — animal evidence of flora balancing.

PubMed ID: 22931620

Perioperative probiotics restored beneficial intestinal bacteria and reduced pathogenic E. coli/Staph aureus counts in colorectal surgery patients.

PubMed ID: 23192454

B. longum BB536 increased fecal bifidobacteria in elderly tube-fed patients — direct evidence of flora modulation.

PubMed ID: 22955366

Human crossover trial demonstrated significant increases in fecal Lactobacilli and Bifidobacteria with probiotics, including efficient microencapsulation.

PubMed ID: 23180952

Probiotic given before/after triple therapy improved H. pylori eradication rates — relevant to adjunctive use around antibiotic therapy.

PubMed ID: 23250116

Intravaginal probiotics restored lactobacillus-dominant vaginal microbiota vs metronidazole; analogous effect on microbial balance.

PubMed ID: 22777592

Vaginal lactobacilli restored normal Nugent scores in ~80%—clear microbial rebalancing (local flora).

PubMed ID: 22197980

Perioperative study increased Bifidobacterium and decreased Escherichia counts post‑op.

PubMed ID: 23302558

Multicenter RCT halved antibiotic‑associated diarrhea risk in hospitalized children with probiotic co‑administration.

PubMed ID: 22157240

IBS trial documented fecal microbiota stabilization (DGGE concordance) alongside symptom benefit.

PubMed ID: 22138361

B. longum BB536 yogurt reduced enterotoxigenic B. fragilis counts in carriers over 8 weeks (human RCT).

PubMed ID: 21814146

LGG substantially increased clearance of VRE after antibiotic exposure—strong evidence for post-antibiotic support.

PubMed ID: 21979491

Perinatal probiotic use changed infant gut microbiota composition (country/feeding‑dependent effects).

PubMed ID: 21395626

Daily consumption of two Lactobacillus strains increased faecal lactobacilli and bifidobacteria counts in adults.

PubMed ID: 21871144

Live probiotic fermented milk markedly shortened antibiotic‑associated diarrhoea duration (4 vs 10 days).

PubMed ID: 21593648

Formula with B. longum promoted a bifidobacteria‑dominant microbiota similar to breast‑fed infants.

PubMed ID: 21436726

Fecal detection confirmed colonization by L. NCFM and B. LBi07 alongside symptom improvement (flora balance evidence).

PubMed ID: 22055271

LGG supplement in preterm infants achieved rapid gut colonization (direct flora change).

PubMed ID: 21264685

Probiotic cheese increased fecal counts of administered Lactobacillus strains and reduced C. difficile in colonized elderly (direct flora change).

PubMed ID: 21552138

L. reuteri dramatically reduced antibiotic-associated diarrhea incidence in hospitalized adults (strong support evidence).

PubMed ID: 21663486

B. lactis HN019 altered transit and symptoms with plausible associated shifts in gut microbial function (indirect flora benefit).

PubMed ID: 21369670

In elderly inpatients probiotics reduced diarrhea and C. difficile rates—common antibiotic-related complications (strong support).

PubMed ID: 21498386

Intravaginal L. crispatus suppository restored/maintained high-level vaginal colonization and cut recurrent UTI risk (strong flora rebalancing).

PubMed ID: 21454978

Chlorhexidine + LGG stabilized oral colonization and reduced S. mutans — clear effect on oral microbial balance.

PubMed ID: 20573348

Probiotic used weekly after metronidazole maintained vaginal ecosystem and reduced BV recurrences — clear post-antibiotic support.

PubMed ID: 20099160

Preop Bifidobacterium dramatically altered B/E ratio and fecal flora, showing clear flora rebalancing.

PubMed ID: 20849659

Multispecies probiotic changed IBS‑associated phylotypes (e.g., reduced R. torques) with associated symptom improvements.

PubMed ID: 20159049

L. salivarius increased fecal lactobacilli counts significantly in healthy adults (direct flora alteration).

PubMed ID: 21165295

Lactobacillus did not significantly reduce AAD overall but preserved usual bowel habits more than placebo during antibiotics.

PubMed ID: 20697290

Microencapsulation preserved viability and produced similar fecal Lactobacilli/Bifidobacteria colonization at lower dose (supports flora balance).

PubMed ID: 20931422

Probiotic yogurt with antibiotic triple therapy reduced stomatitis and constipation (reduced antibiotic side effects/supportive during therapy).

PubMed ID: 20361072

Symbiotic mixture markedly increased lactobacilli and bifidobacteria counts and improved symptoms.

PubMed ID: 20453678

VSL#3 produced symptomatic improvement in IBS; probiotic mixtures are intended to rebalance flora (clinical inference).

PubMed ID: 20517305

VSL#3 improved UC outcomes; such multi-strain formulas are used to rebalance dysbiotic gut flora.

PubMed ID: 20350428

C. butyricum reduced pathogenic gut colonization in preterm infants — evidence of microbiota modulation.

PubMed ID: 20145608

Large RCT in hospitalized adults on antibiotics showed marked reductions in AAD and C. difficile with high-dose probiotic — direct support.

PubMed ID: 20410904

Preterm infant study reduced enteric Candida colonization and altered gut colonization outcomes—strong microbiota impact in neonates.

PubMed ID: 20691131

High‑dose L. rhamnosus was recovered transiently in stool of healthy adults (shows potential for altering flora albeit transiently).

PubMed ID: 20455694

Breast‑milk lactobacilli reduced pathogenic bacterial counts in milk and improved clinical mastitis outcomes (clear microbial modulation).

PubMed ID: 21083585

Perioperative probiotic use improved barrier function and reduced infections; perioperative patients often receive antibiotics, so probiotics can be supportive.

PubMed ID: 21048484

Probiotic yogurt lowered E. coli counts and improved measures of flora imbalance in chronic liver disease patients (direct microbiota effect).

PubMed ID: 20557362

Large RCT adding S. boulardii to H. pylori triple therapy lowered side effects and modestly raised eradication—direct adjunctive support for antibiotic therapy.

PubMed ID: 20713478

L. reuteri increased fecal lactobacilli and reduced E. coli in colic infants—demonstrated microbiota changes.

PubMed ID: 21074284

Demonstrated that delivery matrix affects fecal recovery/persistence of probiotic strains (relevant to achieving balanced flora).

PubMed ID: 20066735

Perioperative La1 adhered to mucosa and substantially reduced Enterobacteriaceae counts vs placebo.

PubMed ID: 20980486

B. breve + L. casei in preterms associated with fewer NEC cases, likely via beneficial microbiota effects.

PubMed ID: 20135748

Probiotic mix increased beneficial stool Bifidobacteria/Lactobacillus and altered cytokines in children with diarrhoea.

PubMed ID: 19684171

Oral low‑fat spreads delivered viable L. reuteri or L. rhamnosus and increased fecal recovery—demonstrates survival and potential to influence gut flora.

PubMed ID: 19685085

B. breve helped maintain anaerobic flora and organic acid profiles in chemo patients — preserved microbiota balance.

PubMed ID: 19187507

Adjunctive vaginal probiotics with fluconazole improved symptomatic and mycological cure of yeast vaginitis.

PubMed ID: 19556637

Both probiotic products were reported to improve intestinal microflora in dysbacteriosis patients (clinical report).

PubMed ID: 19381735

Post‑bypass probiotics reduced bacterial overgrowth (breath H2) and preserved beneficial flora.

PubMed ID: 19820590

Synbiotic use in injured patients associated with fewer infections and lowered inflammation, reflecting beneficial flora effects.

PubMed ID: 19631292

VSL#3 (high‑potency multi‑strain) produced remission in UC, consistent with restoring balanced flora.

PubMed ID: 19651563

Probiotics greatly reduced antibiotic prescriptions in preschoolers, indicating reduced need and possible post‑antibiotic protection.

PubMed ID: 19295645

Adjunctive Lactobacillus GR‑1/RC‑14 with tinidazole dramatically increased BV cure and restored normal vaginal flora.

PubMed ID: 19369375

Probiotic colonization was detected in larger preterm infants, indicating flora modification in that subgroup.

PubMed ID: 18552710

Preterm infants on antibiotics gained more weight with probiotic — supportive effect during antibiotic exposure.

PubMed ID: 18410562

Large pediatric RCT: L. rhamnosus reduced overall and antibiotic‑associated diarrhea during antibiotic therapy.

PubMed ID: 18681892

S. boulardii added to H. pylori therapy cut treatment side effects significantly (fewer GI side effects).

PubMed ID: 18197974

Vaginal lactobacilli added after clindamycin significantly increased relapse‑free outcomes at 6 months—strong RCT support.

PubMed ID: 18701205

Oral probiotics improved Nugent scores in postmenopausal women—improved vaginal flora quality (strong RCT evidence).

PubMed ID: 19046169

Vaginal Lactobacillus tablets restored normal flora and cleared BV far more often than placebo (double-blind RCT).

PubMed ID: 18854803

Oral probiotics given after antibiotics led to 92% complete vaginal recolonization—direct evidence of post-antibiotic support.

PubMed ID: 18240282

VSL#3 increased mucosal regulatory T cells and reduced pouchitis activity—microbiota/immune balance effect.

PubMed ID: 18665934

Adjunct probiotic yogurt modestly increased per‑protocol H. pylori eradication when given with antibiotics — supportive role.

PubMed ID: 18175741

Yoghurt consumption changed faecal bacterial group densities (increased LAB, decreased Bacteroides) — microbiological proof of balance change.

PubMed ID: 17315077

B. lactis HN019 produced clear increases in bifidobacteria and lactobacilli with reduced enterobacteria in elderly subjects.

PubMed ID: 17919270

Multispecies probiotic stabilized intestinal microbiota similarity index in IBS patients while improving symptoms (direct link between flora balance and clinical effect).

PubMed ID: 17893165

BB536 suppressed increases in B. fragilis group during pollen season and microbiota changes correlated with symptoms (microbiota‑stabilizing effect).

PubMed ID: 18251154

Adding B. subtilis + S. faecium to H. pylori triple therapy modestly increased eradication and reduced side effects—supports probiotic adjunct use with antibiotics (improved tolerability/compliance).

PubMed ID: 17460947

BB536 increased bifidobacteria and prevented an unfavorable B. fragilis/bifidobacteria shift during pollen season (direct microbiota modulation).

PubMed ID: 17604300

Large elderly RCT showed major reductions in antibiotic‑associated and C. difficile‑associated diarrhoea.

PubMed ID: 17669103

S. boulardii reduced GI side effects of H. pylori antibiotic therapy (improved tolerability).

PubMed ID: 17352022

VSL#3 altered bowel flora/function sufficiently to prevent radiation diarrhoea (implied microbiota effect).

PubMed ID: 17957155

Probiotic-containing infant formula markedly increased bifidobacteria and decreased Enterobacteriaceae while administered.

PubMed ID: 17591036

Perioperative probiotics reduced postoperative infections—adjunctive peri-antibiotic benefits plausible in surgical prophylaxis.

PubMed ID: 17356555

High‑quality RCT showing a large absolute reduction in antibiotic‑associated diarrhoea in hospitalized adults.

PubMed ID: 18026577

Fermented milk substantially reduced antibiotic‑associated diarrhoea in hospitalized patients.

PubMed ID: 17443852

Perioperative synbiotics given with neomycin/MBP reduced harmful bacteria and bacterial translocation around colectomy.

PubMed ID: 17998837

E. coli Nissle effectively restored normal gut colonization in cirrhosis patients (strong microbiological effect).

PubMed ID: 16813181

Microorganism preparations increased bifidobacteria and lactobacilli and decreased enteric bacilli in constipation‑type IBS group.

PubMed ID: 16783294

Oral lactobacilli added to vaginal therapy improved local flora and reduced vaginosis recurrence (related microbial balance).

PubMed ID: 17259090

L. rhamnosus colonised most children during acute diarrhoea (evidence of temporary colonisation effect).

PubMed ID: 16600940

Pre‑treatment yogurt with Lactobacillus/Bifidobacterium increased H. pylori cure rates when combined with therapy (adjunctive benefit).

PubMed ID: 17172187

B. longum given after rifaximin improved IBS symptoms vs antibiotic alone (post‑antibiotic support).

PubMed ID: 16971641

Bb12 produced large increases in bifidobacteria and decreases in enterobacteria/clostridia in preterm infants (clear flora shift).

PubMed ID: 16572062

S. boulardii given during antibiotics markedly reduced antibiotic‑associated diarrhoea — clear protective support.

PubMed ID: 17033111

Lacidofil added to antibiotic triple therapy increased H. pylori eradication rates (probiotic as adjunct to antibiotics).

PubMed ID: 16705580

Probiotic reduced Candida colonization in neonates — favorable flora shift.

PubMed ID: 16573799

Lactulose increased bifidobacteria (prebiotic effect) and shifted nitrogen to bacterial pool.

PubMed ID: 16722152

E. coli Nissle improved intestinal colonization in cirrhosis patients—microbiota colonization benefit.

PubMed ID: 16448475

LGG formula increased lactobacilli colonization in infants—clear effect on microbiota balance.

PubMed ID: 17045832

Intravaginal probiotic cured BV more often and improved Nugent scores (direct flora normalization).

PubMed ID: 17141481

Probiotic mix slightly reduced antibiotic-induced perturbations in gut microbiota after H. pylori treatment.

PubMed ID: 16721394

Clear fecal recovery of BB-12 with dose demonstrates direct modulation of gut microbiota composition.

PubMed ID: 17032283

L. reuteri reduced antibiotic-related stomach and bowel symptoms in H. pylori-treated children—direct post-antibiotic support.

PubMed ID: 16752267

Panty-liner probiotic was transferred to vaginal sites and associated with higher lactobacilli counts and lower pH — flora modulation.

PubMed ID: 16697231

Oral probiotics given with metronidazole greatly improved BV cure and restored lactobacilli after antibiotic therapy (direct adjunctive support).

PubMed ID: 16292090

Large multicenter RCT: S. boulardii significantly reduced antibiotic‑associated diarrhea during H. pylori treatment.

PubMed ID: 16082279

Adding L. casei fermented milk to H. pylori triple therapy significantly increased eradication rates—useful adjunct to antibiotic regimens.

PubMed ID: 16271414

Fermented product notably increased fecal lactic acid bacteria concentration.

PubMed ID: 16437727

C. butyricum limited antibiotic‑driven flora disturbances and decreased GI side effects during H. pylori therapy.

PubMed ID: 15829425

Probiotics given during antibiotics limited disruption of gut bacterial populations—direct support role.

PubMed ID: 15740542

S. boulardii given with antibiotics significantly reduced antibiotic-associated diarrhea (large RCT).

PubMed ID: 15882248

Fecal recovery of administered probiotic strains increased significantly—evidence of strain survival and gut presence.

PubMed ID: 15815206

Infant formula with probiotics halved AAD—strong support as adjunct during/after antibiotics.

PubMed ID: 15567983

L. casei reduced side-effects of second-line H. pylori antibiotic therapy—helps tolerability during antibiotic use.

PubMed ID: 15179608

Probiotic taken with antibiotics reduced C. difficile toxin detection and possible CDAD in elderly—protective during antibiotics.

PubMed ID: 15479682

E. coli Nissle maintained UC remission similar to mesalazine; probiotic equivalence implies microbiota-stabilizing effects.

PubMed ID: 15133865

BIFICO increased fecal lactobacilli/bifidobacteria and reduced relapses—strong microbiota and clinical changes.

PubMed ID: 15298771

Oral probiotics restored lactobacilli-dominant vaginal microbiota in women with BV—microbiota restoration demonstrated.

PubMed ID: 15507864

High-potency probiotic (VSL#3) added to therapy improved remission in UC, consistent with beneficial changes in gut microbiota composition/function.

PubMed ID: 15094948

Synbiotic supplements given to children on antibiotics increased weight gain and reduced short-term bacterial illness—benefit during/post-antibiotic period.

PubMed ID: 15612659

Two probiotic formulations raised beneficial Bifidobacterium counts in cirrhotics — clear microbiota modulation.

PubMed ID: 15220671

Combination probiotics produced symptom relief in IBS and are likely to have modified gut microbiota composition/function.

PubMed ID: 15569121

Bacillus clausii given during H. pylori triple therapy markedly reduced antibiotic-associated nausea, diarrhoea and epigastric pain — strong post-antibiotic symptomatic support.

PubMed ID: 12604982

LGG altered preterm infant gut colonization, increased Gram-positive species and species richness — flora alteration toward 'beneficial' taxa.

PubMed ID: 14505546

Bifidobacterium increased fecal bifidobacteria/lactobacilli and reduced relapses in UC — strong microbiota rebalancing signal.

PubMed ID: 14608267

Lactobacillus sporogenes + FOS substantially reduced antibiotic-associated diarrhea incidence and duration in children.

PubMed ID: 12730861

High-dose VSL#3 prevented pouchitis and likely maintained a favorable intestinal microbial community.

PubMed ID: 12918131

S. boulardii given with antibiotics shortened symptoms in amoebiasis — supportive probiotic use alongside antimicrobials.

PubMed ID: 12628548

Oral Lactobacillus restored normal vaginal lactobacilli and reduced pathogens — demonstrates rebalancing of mucosal flora.

PubMed ID: 12197847

Yogurt with Lactobacillus/Bifidobacterium restored stool bifidobacteria after triple therapy and improved eradication rates—direct flora restoration.

PubMed ID: 12425542

Multiple probiotic preparations lowered incidence of diarrhea and taste disturbance during H. pylori antibiotic therapy—clear adjunctive support.

PubMed ID: 11148433

LGG plus H. pylori antibiotics significantly reduced diarrhea, nausea and taste changes vs placebo—good support during antibiotic use.

PubMed ID: 11173893

Lactobacillus GG reduced several antibiotic-associated GI side effects during H. pylori therapy, improving tolerability.

PubMed ID: 11241043

Prophylactic LGG reduced nosocomial/rotavirus diarrhea in hospitalized infants; relevant for preventing antibiotic-associated dysbiosis/infections.

PubMed ID: 11200372

Enterococcus faecium fermented milk transiently increased fecal enterococci counts—evidence of flora modulation (with safety note).

PubMed ID: 10930365

VSL#3 markedly increased fecal lactobacilli/bifidobacteria/S. thermophilus and prevented pouchitis relapse—strong flora-shifting evidence.

PubMed ID: 10547243

LGG given with oral antibiotics to children significantly reduced antibiotic-associated diarrhea and improved stool consistency—direct post-antibiotic support.

PubMed ID: 9360205

Lactobacillus GG reduced rotavirus shedding and shortened diarrhea—consistent with competitive colonization and flora effects.

PubMed ID: 41686508

Synbiotic use increased beneficial bifidobacteria percentage and reduced E. coli in infants—demonstrated flora rebalancing alongside clinical benefit.

PubMed ID: 40499217

B. animalis + FOS enriched bifidobacteria and improved bowel function—clear microbiome rebalancing.

PubMed ID: 41413231

Multi‑species synbiotic produced metabolic benefits likely mediated by microbiome shifts (not fully reported but plausible).

PubMed ID: 39915586

Infant synbiotic formula increased bifidobacteria and helped restore Bacteroidota in C‑section infants—clear gut rebalancing.

PubMed ID: 40783570

Vaginal multi‑strain L. crispatus effectively converted dysbiotic microbiomes to an optimal Lactobacillus‑dominant state.

PubMed ID: 39422256

Perinatal gut‑focused diet changed maternal Prevotella and infant alpha diversity—direct microbiome rebalancing.

PubMed ID: 38794741

Balanced nine‑strain synbiotic produced marked IBS symptom improvement—reflects gut ecosystem rebalancing.

PubMed ID: 38462218

Synbiotic infant formula produced higher fecal sIgA and lower stool pH consistent with bifidogenic effects (microbial milieu change).

PubMed ID: 39352252

AG1 synbiotic altered taxa (Lactobacillus/Bifidobacterium enrichment) in healthy adults (direct taxa enrichment).

PubMed ID: 37111082

Synbiotic lowered Firmicutes/Bacteroidota ratio and altered gut composition in overweight adults (favorable compositional change).

PubMed ID: 36803508

Probiotic + prebiotic formula increased bifidobacteria and favorable metabolites and reduced Klebsiella (clear flora shift).

PubMed ID: 38010080

Early probiotic/prebiotic feeding accelerated Bifidobacterium‑rich colonization in preterm infants (direct microbiome balancing).

PubMed ID: 37614109

Microbiome‑dependent effects observed with anti‑inflammatory and mucosal immune changes (enterotype‑dependent shifts).

PubMed ID: 35413573

Compared synbiotic strategy vs prophylactic antibiotics in chemo patients (context of antibiotic exposure; improved diarrhea/neutropenia outcomes).

PubMed ID: 37675747

Increased stool Lactobacillus counts were documented with pre/probiotic adjunct therapy.

PubMed ID: 36501047

Functional diarrhea trial increased Lactobacillales abundance alongside symptomatic benefit.

PubMed ID: 34775221

Synbiotics increased fecal acetate and lowered pH with fewer bacterial translocation events; supports mucosal protection post-disruption.

PubMed ID: 34444974

BB-12 yogurt preserved SCFAs and microbiome diversity and reduced antibiotic-associated loose stools versus control.

PubMed ID: 33509667

GOS robustly increased fecal bifidobacteria in both prefrail elderly and healthy adults (direct flora change).

PubMed ID: 33032474

Direct RCT evidence: synbiotic reduced incidence and severity of antibiotic-associated diarrhea compared with placebo.

PubMed ID: 31987796

Year-long synbiotic produced clear taxonomic shifts (↑Bifidobacterium, Faecalibacterium), showing consistent microbiome modulation.

PubMed ID: 33326198

Overweight adult RCT increased alpha diversity (Shannon/Simpson) and reduced fecal zonulin, indicating microbiota and barrier improvements.

PubMed ID: 31618905

Immune and microbiome effects persisted after a short antibiotic course—direct evidence for post‑antibiotic support.

PubMed ID: 31209720

Rapid effects on transit and fecal pH reflect consistent functional impact on gut microbial environment.

PubMed ID: 30278428

Short preoperative synbiotic reduced infections/inflammation in surgical patients (context frequently includes perioperative antibiotics).

PubMed ID: 30261905

Fecal Bifidobacterium increased and SCFAs rose—demonstrated shift toward favorable gut flora in ICU patients.

PubMed ID: 30525950

B. animalis B420 (±polydextrose) increased Akkermansia/Christensenellaceae and altered bile acids—clear microbiome rebalancing data.

PubMed ID: 28895794

Marked reduction in plasma p‑cresol (microbially produced toxin) indicates altered microbial metabolism.

PubMed ID: 29267553

Perioperative setting often involves antibiotics; large infection reductions suggest benefit in antibiotic‑exposed surgical patients.

PubMed ID: 29155807

Synbiotic amino‑acid formula produced large, significant increases in fecal bifidobacteria and reductions in adult‑like taxa in CMA infants.

PubMed ID: 27301235

Preoperative synbiotics increased colonic mucosal lactic‑acid bacteria (PCR evidence of colonization) though systemic effects were absent.

PubMed ID: 28002391

Infant formula with oligosaccharides + B. lactis moved gut biomarkers toward a breastfed profile and had microbiota biomarker improvements.

PubMed ID: 25803626

Periampullary surgery synbiotic markedly reduced infections, antibiotic days and mortality—strong perioperative/post-antibiotic support signal.

PubMed ID: 25933911

Perioperative synbiotics altered fecal microbiota and organic acids post colorectal surgery—consistent microbiome modulation.

PubMed ID: 24402842

Perioperative synbiotics reduced bacterial translocation and bacteraemia and modified postoperative flora (supports flora balance).

PubMed ID: 24929795

Synbiotic markedly lowered plasma p-cresol (gut-derived toxin), implying altered gut microbial metabolism.

PubMed ID: 25331262

L. salivarius (±FOS) increased fecal lactobacilli and decreased coliforms/E. coli in healthy adults.

PubMed ID: 23244247

Study explicitly evaluated sequential antibiotic→probiotic therapy in SIBO and found improved GI symptoms versus antibiotic alone.

PubMed ID: 23867209

Perioperative synbiotics maintained Bifidobacterium/Lactobacillus, reduced Enterobacteriaceae and increased SCFAs—clear microbiota balancing.

PubMed ID: 22576712

In tube-fed patients bifidobacteria and lactobacilli rose ~100-fold and pathogenic gram-negative rods fell dramatically.

PubMed ID: 22959620

Chronic constipation trial reported microbiota-associated clinical benefits alongside bowel improvements.

PubMed ID: 22503510

Perioperative synbiotics modified fecal microflora toward beneficial species and altered intestinal metabolites.

PubMed ID: 22916885

Human trial showed increased faecal bifidobacteria and lactobacilli and decreased enterobacteria after fermented milk with probiotic+prebiotic.

PubMed ID: 21244240

Synbiotic improved self-reported GI symptoms and decreased L-selectin; microbiota not deeply characterized but symptom-linked.

PubMed ID: 20184604

Synbiotic produced robust increases in bifidobacteria and decreased certain clostridia — clear microbiota modulation.

PubMed ID: 19179885

Commercial pre/probiotics markedly increased bifidobacteria in preterms — strong colonization evidence.

PubMed ID: 18544974

Adding GOS to LGG substantially increased bifidobacteria vs probiotic alone (additive microbiome effect).

PubMed ID: 19053980

GOS increased bifidobacteria counts and improved IBS symptoms (microbiota change with clinical effect).

PubMed ID: 18996881

B‑GOS increased bifidobacteria in elderly (clear change in beneficial taxa).

PubMed ID: 18607268

Short neonatal synbiotic led to high, persistent Lactobacillus colonization and sustained stool flora shifts (robust colonization data).

PubMed ID: 18493215

Prebiotic formulas increased bifidobacteria proportion and shifted infant fecal microbiota composition (strong microbiome effect).

PubMed ID: 16978805

Prebiotic in preterm infants produced large bifidobacterial increases and reductions in potential pathogens.

PubMed ID: 16837430

Probiotic formula increased fecal Lactobacillus counts and transient colonization — direct microbiome shift.

PubMed ID: 16707980

GOS/FOS in weaning foods raised faecal bifidobacteria proportion — direct evidence of microbiota balancing.

PubMed ID: 16492988

Prebiotic formula accelerated restoration/increase of bifidobacteria after amoxicillin in infants.

PubMed ID: 16056097

Acidic+neutral oligosaccharide mixes increased bifidobacteria and lactobacilli (bifidogenic effect).

PubMed ID: 16317121

Isoflavones combined with pre/probiotics altered dominant gut bacterial groups including bifidobacteria.

PubMed ID: 16277782

GOS/FOS formula shifted infant stool fermentation to a breastfed-like pattern (microbiota functional shift).

PubMed ID: 15880313

Oligofructose dramatically reduced C. difficile relapse and increased bifidobacteria post-antibiotic.

PubMed ID: 15297081

Synbiotic reduced potentially pathogenic gastric colonization in critically ill patients.

PubMed ID: 12604972

Prebiotic infant formula increased fecal bifidobacteria (direct compositional change).

PubMed ID: 40545179

Probiotic given with H. pylori therapy reduced several antibiotic-related gut side effects.

PubMed ID: 40488914

Large RCT: L. reuteri given with amoxicillin‑clavulanate halved relative risk of antibiotic‑associated diarrhea — strong post‑antibiotic support.

PubMed ID: 33947195

L. reuteri given during H. pylori eradication reduced abdominal pain/distension — symptomatic support during antibiotic therapy.

PubMed ID: 31216821

S. boulardii reduced GI adverse reactions when given concurrently with H. pylori quadruple therapy (probiotic support during antibiotic treatment).

PubMed ID: 30912409

Multi‑strain probiotic delayed onset of antibiotic‑associated diarrhea in adults (protective effect during antibiotics).

PubMed ID: 27169634

Direct evidence: probiotic shortened duration of amoxicillin-clavulanate–associated diarrhoea in healthy adults.

PubMed ID: 24628464

L. GG shifted stool bacteria toward more beneficial taxa and improved dysbiosis ratio in cirrhosis.

PubMed ID: 38999876

Increased gut microbial diversity and SCFAs were observed alongside clinical respiratory benefit.

PubMed ID: 32443684

Infant formula with B. lactis and BMOS produced a bifidobacteria-dominant microbiota and improved gut-maturation markers.

PubMed ID: 31418411

Adjunctive probiotics in IBD improved microbial composition (higher bifidobacteria/lactobacillus, lower enterobacteria) with biomarker improvements.

PubMed ID: 31126062

L. casei reduced diarrhea and altered fecal IgA/inflammatory markers and microbiota—supports flora balancing effects.

PubMed ID: 28569454

Probiotic co‑administration with antibiotics post‑tooth extraction markedly reduced antibiotic‑associated GI side effects (diarrhea, distension).

PubMed ID: 25855055

Oral probiotic strains were detected in the vagina after oral intake, demonstrating transfer/colonization potential and microbiome impact.

PubMed ID: 24709463

bLF+LGG neonatal benefits indicate strong impact on early gut colonization/flora balance.

PubMed ID: 22759324

Probiotics improved compliance (tolerability) in sequential H. pylori therapy though eradication unchanged.

PubMed ID: 17313499

Adding lactoferrin+probiotics to triple therapy reduced side effects and improved tolerability during antibiotic treatment.

PubMed ID: 40223270

Probiotic increased Bifidobacterium and Lactobacillus and detection/upregulation of L. plantarum — direct microbiome improvement.

PubMed ID: 41126787

Four‑strain probiotic altered gut taxa in Parkinson’s patients (documented microbiome shifts).

PubMed ID: 24456357

Seaweed+LAB intervention increased counts of multiple LAB species in stool versus placebo.

PubMed ID: 41512635

Multi-strain synbiotic transiently increased administered strains in stool and changed adiposity measures—evidence of flora modulation.

PubMed ID: 38140284

Daily B. animalis GCL2505 + inulin significantly raised fecal bifidobacteria and reduced visceral/abdominal fat (clear microbiota shift).

PubMed ID: 33593462

Synbiotic ice-cream increased Bifidobacterium and Lactobacillus abundance in soldiers.

PubMed ID: 32998471

L. reuteri increased stool probiotic counts and altered stool pH — evidence of gut colonization/change.

PubMed ID: 28656129

Synbiotic added to H. pylori triple therapy tended to improve symptoms and reduce side effects (support during antibiotic therapy).

PubMed ID: 25596096

VLBW infant RCT with B. lactis (± inulin) showed large clinical benefits plausibly mediated by healthier gut colonization patterns.

PubMed ID: 21788759

Critically ill children fed synbiotic formula showed increased fecal bifidobacteria and reduced enterobacteria — clear flora effects.

PubMed ID: 21393113

Toddlers given synbiotic milk had increased Lactobacillus counts in stools — evidence of microbiome modulation.

PubMed ID: 20522788

L. rhamnosus GG in ventilated ICU patients reduced C. difficile and VAP (antibiotic-associated infections), implying protective role during/after antibiotic exposure.

PubMed ID: 17268410

Short-term inulin reproducibly increased bifidobacteria in healthy adults (bifidogenic effect).

PubMed ID: 17692137

Fermented milk increased faecal lactobacilli and bifidobacteria — direct evidence of flora shifts.

PubMed ID: 16983476

Synbiotic reduced infections/sepsis in critically ill patients — suggests a role in microbial/immune support during antibiotic/critical care periods (indirect).

PubMed ID: 40175540

B. longum NCC3001 supplementation increased stool detection of the strain — direct colonization evidence though no mood effect.

PubMed ID: 21296446

Yogurt containing B. animalis BB-12 and L. acidophilus LA-5 produced clear increases of those strains in feces and shifts in enterococci counts—direct evidence of microbiota modulation.

PubMed ID: 26772193

Synbiotic enriched Bifidobacterium and depleted Ruminococcaceae with reduction in PCS, demonstrating direct microbiome rebalancing.

PubMed ID: 18685503

Symbiotic product altered bowel habits and symptoms in IBS — consistent with flora/functional changes.

PubMed ID: 41097163

W. coagulans BC99 produced significant microbiota and SCFA changes over 8 weeks.

PubMed ID: 41500324

Multispecies synbiotic changed microbiome function and SCFAs in ADHD patients, showing functional microbial shifts.

PubMed ID: 40250086

Synbiotic preserved mucosa‑associated microbial species after radiotherapy.

PubMed ID: 38999830

Synbiotic shifted gut microbiome toward SCFA‑producing bacteria, mainly in low‑fiber participants.

PubMed ID: 39064788

Synbiotic increased fecal bifidobacteria along with metabolic changes.

PubMed ID: 37836458

Bifidobacterium+inulin raised fecal bifidobacteria and improved cognitive scores in older adults.

PubMed ID: 37078654

Multiple fiber/probiotic formulas altered stool consistency and likely shifted microbiota associated with constipation relief.

PubMed ID: 34406877

Synbiotic RCT produced favorable changes in major gut bacterial families alongside symptom improvement.

PubMed ID: 32615392

Six‑month multi‑species probiotic produced measurable compositional shifts (F:B and B. fragilis:E. coli ratios) — direct evidence of microbiome modulation.

PubMed ID: 29954454

Multiple arms increased fecal Bifidobacterium and improved barrier markers in humans.

PubMed ID: 29415828

Bacillus shortened antibiotic‑associated diarrhea resolution in hospitalized EN patients.

PubMed ID: 27157575

Synbiotic fermented milk transiently increased and briefly persisted with supplemented strains in stool (direct flora modulation).

PubMed ID: 24089227

Enteral nutrition with probiotics in long‑term antibiotic patients improved intestinal tolerance, reduced abdominal pain/distension and improved immune markers.

PubMed ID: 17592288

Synbiotic reduced postoperative bacterial infections and shortened antibiotic duration — supportive in peri‑antibiotic/postoperative context.

PubMed ID: 15636620

Perioperative LAB+fibers markedly reduced infections and shortened antibiotic use—strong peri-antibiotic/antibiotic-sparing support.

PubMed ID: 12436353

Probiotic + fiber reduced postoperative infections and shortened antibiotic duration—supports recovery after surgical antibiotic exposure.

PubMed ID: 12134110

Enteral live Lactobacillus+fiber lowered post‑op infections vs standard bowel decontamination in transplant setting on antimicrobials.

PubMed ID: 10811333

Mucosal colonization by L. plantarum was demonstrated in IBS patients—evidence of probiotic strain establishment.

PubMed ID: 39665335

Synbiotic in infants dramatically increased bifidobacteria abundance and related metabolites—clear evidence of flora rebalancing.

PubMed ID: 39519413

B. longum BB536 rapidly increased Faecalibacterium and altered tryptophan-derived metabolites—strong, consistent microbiome changes in healthy adults.

PubMed ID: 25453395

VSL#3 increased bifidobacteria in an inflammatory subgroup when added to diet.

PubMed ID: 25793955

Daily probiotic reduced salivary S. mutans with persistence after stopping — supports lasting oral microbiota change.

PubMed ID: 24296746

L. reuteri from birth associated with less caries and gingivitis at age 9, consistent with long‑term microbiota/ecology effects.

PubMed ID: 21963389

Probiotic drink raised lactobacilli and lowered fecal genotoxic potential/pH in atopic dermatitis patients — direct microbiota modulation.

PubMed ID: 19331578

Intravaginal L. crispatus colonized most uncolonized women — demonstrates probiotic ability to establish beneficial lactobacilli (vaginal flora context).

PubMed ID: 17284748

Synbiotic increased Bifidobacterium/Lactobacillus and decreased C. perfringens in humans.

PubMed ID: 16945898

L. reuteri reduced salivary mutans streptococci and tended to increase salivary lactobacilli — oral flora modulation.

PubMed ID: 10545590

LGG during antibiotics in children markedly lowered antibiotic‑associated diarrhoea incidence.

PubMed ID: 35344737

Maternal probiotics altered low‑abundance vaginal pathobionts — evidence of microbiota shifts with probiotic intervention.

PubMed ID: 24233772

Probiotic given with H. pylori triple therapy increased eradication rates and stabilized probiotic counts after antibiotic treatment.

PubMed ID: 23653934

Randomized data showing restoration of eubiosis and hydrogen breath test normalization after probiotic treatment.

PubMed ID: 23402179

Probiotic largely normalized small-bowel flora in postinfectious IBS with corresponding breath-test improvement.

PubMed ID: 22747752

Synbiotic in HIV raised fecal levels of supplemented probiotic species.

PubMed ID: 18326619

Novel GOS produced dose-dependent increase in fecal bifidobacteria (clear bifidogenic effect).

PubMed ID: 27782892

Synbiotic improved multiple IBS symptoms including constipation and bloating — reduced abdominal discomfort.

PubMed ID: 31327047

B. coagulans plus low‑FODMAP reduced abdominal pain/distension and improved overall IBS severity.

PubMed ID: 32998471

L. reuteri improved stool frequency and consistency in chronically constipated children, reflecting improved gut function.

PubMed ID: 35995418

Lowered gut-derived toxin and inflammation in CKD suggests improved baseline gut resilience (moderate evidence).

PubMed ID: 39047340

Improved bowel control (constipation) in people with MS (direct bowel-function benefit).

PubMed ID: 35350100

Marked reductions in THW-associated tummy symptoms (constipation, dry mouth, etc.) in probiotic group.

PubMed ID: 39494607

LP299V markedly reduced GI adverse events and discontinuation with oral iron—improved tolerance to a common GI stressor.

PubMed ID: 41080557

Perioperative B. coagulans shortened time to first bowel movement and reduced postoperative GI events → clear GI benefit.

PubMed ID: 40223270

4‑week RCT in mild constipation improved stool form/frequency and abdominal pain, indicating better digestion.

PubMed ID: 37470081

Improved constipation and non‑motor GI symptoms in Parkinson’s patients — clear digestion benefit.

PubMed ID: 23114016

Adding multi‑strain probiotic to triple therapy significantly decreased antibiotic‑related GI side effects in children.

PubMed ID: 28569454

Probiotic co‑administration mitigated antibiotic‑associated GI adverse effects and reduced pain, supporting resilience during antibiotic exposure.

PubMed ID: 31126062

Randomized trial in children showed reduced diarrhea severity and inflammatory markers—direct digestive symptom improvement.

PubMed ID: 31418411

Adjunctive probiotics in IBD lowered recurrence risk and inflammatory markers—supports resilience of gut in chronic disease.

PubMed ID: 32443684

Infant formula producing bifidobacteria-dominant microbiota and lower calprotectin suggests more resilient, mature gut ecology.

PubMed ID: 28665038

Infant cry-time reductions versus simethicone suggest decreased colic-related tummy discomfort (product combined ingredients).

PubMed ID: 31464895

L. paracasei + licorice reduced GI symptom scores and histologic inflammation in H. pylori subjects.

PubMed ID: 17587273

Probiotic improved defecation frequency and stool softness in constipated children.

PubMed ID: 31952280

L. reuteri increased bowel movements in constipated children, indicating improved bowel function.

PubMed ID: 25092036

VSL#3 reduced abdominal pain duration/intensity and increased rectal pain thresholds in IBS patients.

PubMed ID: 38892690

Probiotic+fermented‑soy reduced heartburn frequency/severity and improved GERD QoL → symptomatic digestive improvement.

PubMed ID: 41599868

Large RCT showed significant improvement in GI QoL and digestion-related symptoms (bloating/gas/abdominal discomfort).

PubMed ID: 27169634

Direct demonstration of faster recovery from antibiotic insult (shortened diarrhoea duration) — strong resilience evidence.

PubMed ID: 30912409

Probiotic delayed antibiotic‑associated diarrhea onset in adults — indicates increased resilience to antibiotic insult.

PubMed ID: 31216821

S. boulardii reduced GI adverse reactions during H. pylori therapy and was safest when given concurrently — supports resilience under antibiotic stress.

PubMed ID: 33947195

Significant reductions in abdominal pain (42% vs 19%) and distension with L. reuteri during H. pylori therapy — direct reduction in tummy discomfort.

PubMed ID: 40488914

Large RCT showing substantial reductions in AAD incidence after amoxicillin‑clavulanate — strong evidence of increased resilience to antibiotic insult.

PubMed ID: 40545179

Adjunct probiotic reduced several GI side effects (including bloating and constipation) during therapy.

PubMed ID: 15297081

Synbiotic reduced pathogenic gastric colonisation in ICU, indicating improved resistance to colonisation.

PubMed ID: 15629974

L. reuteri formula lowered febrile and diarrhoeal episodes in infants, reflecting improved GI outcomes.

PubMed ID: 15880313

Oligofructose produced large reduction in C. difficile relapse — strong evidence of digestive resilience after perturbation.

PubMed ID: 17208601

Perinatal probiotic+prebiotic reduced eczema/atopic eczema in infants (reduced atopic manifestations).

PubMed ID: 16492988

Prebiotic formula restored bifidobacteria after antibiotics, supporting recovery/resilience of gut flora.

PubMed ID: 16873437

Prebiotic mix in high‑risk infants reduced atopic dermatitis incidence in first 6 months — supports fewer early immune‑mediated sensitivities.

PubMed ID: 17937689

Large trial in daycare children showed ~20% fewer diarrhoeal days (clear digestive improvement).

PubMed ID: 17189085

Starter formula with B. longum linked to fewer constipation events in infants (improved bowel function).

PubMed ID: 19053980

GOS improved IBS composite symptoms including bloating and flatulence (reduced tummy discomfort).

PubMed ID: 18492839

Early oligosaccharide supplementation reduced atopic dermatitis and wheeze in infancy (fewer allergic manifestations).

PubMed ID: 19331702

Infant probiotic formula produced softer stools and better stool frequency (better digestion/tolerance).

PubMed ID: 19231042

Reduced gastroenteritis and antibiotic courses in infants suggests improved digestive resilience.

PubMed ID: 20224148

Pre/probiotic formula improved gastric emptying and motility measures in preterms — physiologic digestion improvement.

PubMed ID: 20730056

Community trial showed reduced dysentery, pneumonia and antibiotic use with prebiotic+B. lactis — improved resilience to infections.

PubMed ID: 20735782

Synbiotic improved clinical scores in active Crohn's disease (symptoms and histology) — improved GI outcomes in disease.

PubMed ID: 20184604

Synbiotic helped infants with IgE‑associated eczema subgroup — benefit for specific allergic/food‑sensitivity phenotype.

PubMed ID: 21805410

RCT in constipated men showed increased stool frequency and improved stool form — direct digestive improvement.

PubMed ID: 22079177

Enriched formula group had fewer cases of atopic dermatitis vs standard formula — relevant to allergic sensitivities.

PubMed ID: 21895621

L. salivarius + prebiotic improved eczema severity and reduced medication use in children with moderate–severe AD.

PubMed ID: 21244240

Healthy adults reported improved bowel habits and overall GI symptoms after synbiotic.

PubMed ID: 21899583

Children's trial shortened diarrhoea duration and normalized stools faster — demonstrates resilience to enteric infections.

PubMed ID: 22503510

Perioperative synbiotics reduced duration of SIRS and enteral nutrition interruptions — resilience to surgical stress/infection.

PubMed ID: 22835702

Another RCT in children with infectious diarrhoea showed ~1 day shorter illness and less med use/costs — improved resilience.

PubMed ID: 22959620

Well-powered trial in chronically constipated women showing increased stool frequency and improved consistency.

PubMed ID: 22576712

In tube-fed patients large shifts to beneficial flora and reduced pathogens suggest better resilience against pathogens.

PubMed ID: 23915796

Preterm infant trial reduced excessive crying and altered gut bacteria patterns (interpreted as reduced gut discomfort).

PubMed ID: 24216543

Amino-acid formula with synbiotics was hypoallergenic and well tolerated in cow's‑milk allergic infants — relevant to food sensitivities.

PubMed ID: 23867209

Perioperative synbiotics preserved beneficial microbes and SCFAs under surgical stress—supports resilience to insult.

PubMed ID: 23244247

Small RCT in SIBO patients showed symptom improvements when probiotics were added after antibiotics (clinical digestive symptom benefit).

PubMed ID: 25056655

Yogurt with probiotics significantly shortened colonic transit time and improved constipation scores (objective digestion improvement).

PubMed ID: 24962875

Multi-strain synbiotic in breastfed infants yielded large, clinically meaningful reductions in crying/colic—direct reduction of tummy discomfort.

PubMed ID: 24402842

Perioperative synbiotics reduced bacterial translocation and bacteraemia after oesophagectomy—improves gut barrier resilience in a clinical setting.

PubMed ID: 25754214

Preterm infant trial halved NEC incidence—strong evidence of increased neonatal gut resilience.

PubMed ID: 25933911

Colorectal surgery trial changed microbiota/metabolites favorably post-op though SSI not significantly reduced—some resilience benefit.

PubMed ID: 26513278

Preterm infants had improved feeding tolerance and stooling with prebiotics, indicating improved digestive handling.

PubMed ID: 25803626

Marked reductions in postoperative infections, complications and mortality indicate strong protective/resilience effects around major surgical stress.

PubMed ID: 26644166

Synbiotics modified fecal microbiota and SCFAs and lowered several chemotherapy adverse events, indicating improved gut resilience under stress.

PubMed ID: 29168358

Multistrain probiotic markedly reduced NEC and sepsis and mortality in very preterm infants, demonstrating strong gut resilience/protection.

PubMed ID: 28813414

Neonatal synbiotic substantially reduced sepsis and related infections, indicating enhanced early-life digestive/immune resilience.

PubMed ID: 28186660

Synbiotic reduced diarrhea incidence in kenneled dogs, consistent with improved digestive outcomes.

PubMed ID: 29155807

Synbiotic formula in infants with suspected non-IgE cow's‑milk allergy shifted microbiota toward breastfed profile and was associated with fewer systemic anti‑infective uses; relevant to CMA management and tolerance.

PubMed ID: 29267553

Perioperative synbiotics markedly lowered postoperative infections—supports resilience to surgical/ perioperative challenges.

PubMed ID: 30261905

Substantial reduction in enteritis and VAP and increases in beneficial bacteria/SCFAs indicate a resilient gut ecosystem under stress.

PubMed ID: 29949873

Symptoms of constipation improved with synbiotic (though not superior to placebo)—some reduction in discomfort.

PubMed ID: 30278428

Preoperative synbiotic reduced inflammatory markers and postoperative infections—improved resilience surrounding surgical stress.

PubMed ID: 30666969

Improved clinical activity and reduced CRP in ulcerative colitis—symptomatic digestive improvement.

PubMed ID: 31209720

Shortened transit time and improved constipation symptoms/ stool pH—direct evidence of improved digestion.

PubMed ID: 31618905

Immune and microbiome changes persisted after antibiotic exposure—direct evidence of enhanced digestive resilience.

PubMed ID: 32635661

IBS-D trial showed large reductions in IBS-SSS and flatulence—clear reduction in abdominal discomfort.

PubMed ID: 32530339

Infant synbiotic markedly reduced atopic dermatitis severity (SCORAD), which sometimes associates with food allergy manifestations.

PubMed ID: 33326198

Increased gut diversity and reduced fecal zonulin indicate improved barrier integrity and resilience to digestive perturbation.

PubMed ID: 32363616

Hypothyroid patients had improved constipation symptoms on synbiotic (reduced abdominal discomfort).

PubMed ID: 33032474

Strong RCT evidence that synbiotic prevented/reduced antibiotic-associated diarrhea—direct demonstration of increased digestive resilience after insult.

PubMed ID: 34462956

ICU synbiotic lowered endotoxin and NLR, biomarkers that suggest reduced vulnerability to systemic/intestinal insults.

PubMed ID: 34063068

CKD synbiotic eased abdominal pain and constipation (direct reduction in tummy discomfort).

PubMed ID: 34444974

Preservation of SCFAs and microbiome diversity during antibiotic exposure demonstrates resilience to perturbation.

PubMed ID: 33765904

Infant colic responder rates for reduced crying (proxy for tummy pain) were markedly higher with synbiotic.

PubMed ID: 34775221

Large reduction in bacterial translocation and lower severe GI toxicity during chemo indicates robust gut resilience.

PubMed ID: 35611667

Elderly IBS patients experienced meaningful reductions in abdominal pain and global symptoms.

PubMed ID: 36501047

Functional diarrhea trial increased formed stools and patient satisfaction, reflecting improved digestion.

PubMed ID: 35869437

Haemodialysis patients had significant improvements in constipation symptoms and related QoL.

PubMed ID: 36173031

Marked fecal calprotectin reduction when synbiotic paired with anti-inflammatory diet suggests improved gut mucosal resilience.

PubMed ID: 35212286

B. longum improved stool condition and incomplete evacuation (symptom-level digestive benefit).

PubMed ID: 35583161

Perioperative synbiotic halved infections, implying improved mucosal barrier/host resilience in surgical setting.

PubMed ID: 35809224

Improved enteral feeding tolerance and fewer aspirations in ICU suggest enhanced GI resilience under stress.

PubMed ID: 35413573

Synbiotics reduced severe neutropenia and diarrhea vs prophylactic antibiotics in chemo patients (improved resilience under treatment stress).

PubMed ID: 36319696

Increased weekly bowel movements and species abundance in constipated children (direct digestion benefit).

PubMed ID: 34957952

Increased defecation frequency and faster bilirubin fall in newborns (changes in intestinal transit).

PubMed ID: 36602047

IL‑6 reduction in hospitalized COVID patients (immunomodulation that may aid resilience).

PubMed ID: 36975174

Large reductions in chemotherapy‑associated diarrhea, constipation and vomiting in children (direct reduction of tummy discomfort).

PubMed ID: 37752516

Marked improvement in defecation quality during chemotherapy (direct bowel function improvement).

PubMed ID: 36904156

Fewer URTIs and faster metabolic recovery in athletes (resilience to illness/exertional stress).

PubMed ID: 37037266

Lower severe aGVHD and higher Tregs after transplant suggest resilience of gut/immune axis post‑transplant (pilot evidence).

PubMed ID: 37049576

Shorter duration of gastrointestinal symptoms in hospitalized COVID‑19 patients receiving probiotics (direct GI symptom benefit).

PubMed ID: 38613116

Clinical symptom improvement in methane‑predominant SIBO patients (fewer GI symptoms including discomfort).

PubMed ID: 39287261

Large NEC reduction, less feeding intolerance and faster hospital discharge in VLBW infants (major improvement in digestive resilience).

PubMed ID: 39557731

Large reductions in infant crying and crying time indicate markedly less tummy discomfort in colic infants.

PubMed ID: 38794741

Large IBS trial produced marked symptom improvement (direct digestive benefit).

PubMed ID: 40783570

Vaginal L. crispatus colonization converted dysbiosis to resilient Lactobacillus‑dominated state.

PubMed ID: 39915586

Infant synbiotic formula restored beneficial taxa in C‑section infants—strong evidence for early‑life microbiome resilience.

PubMed ID: 40499217

B. animalis + FOS increased Bifidobacterium and SBMs—clear functional resilience in constipated older adults.

PubMed ID: 40389723

Synbiotic mouthwash delayed and reduced oral mucositis during RT—improved mucosal resilience.

PubMed ID: 41686508

Infant synbiotic + topical regimen markedly reduced eczema severity and Th2/allergic markers (IgE, IL‑4/IL‑13) — directly relevant to allergic sensitivity.

PubMed ID: 9354192

VSL#3 strongly prevented pouchitis relapses—clear major digestive clinical benefit for that condition.

PubMed ID: 9360205

Randomized trial: Lactobacillus GG halved diarrhea duration in children—direct, large clinical digestion benefit.

PubMed ID: 9880443

Daily Lactobacillus GG modestly reduced diarrhea episodes in undernourished toddlers (clinically relevant).

PubMed ID: 10547243

LGG given with antibiotics markedly reduced antibiotic-associated diarrhea and improved stool consistency.

PubMed ID: 10466665

E. coli Nissle performed similarly to mesalazine for inducing/maintaining UC remission—meaningful GI clinical effect.

PubMed ID: 10930365

VSL#3 nearly completely prevented pouchitis relapses over 9 months—strong evidence of enhanced mucosal/digestive resilience.

PubMed ID: 10630440

LGG in ORS significantly shortened diarrhea duration and reduced prolonged cases—strong evidence for increased resilience to enteric illness.

PubMed ID: 11297958

Perinatal/early LGG halved risk of early atopic eczema in high-risk children—strong evidence for reduced allergic/atopic outcomes.

PubMed ID: 11241043

Prophylactic LGG greatly reduced hospital-acquired diarrhea and rotavirus gastroenteritis—improves resilience to nosocomial GI infections.

PubMed ID: 11338068

L. rhamnosus improved stool frequency/consistency in radiation-induced diarrhea patients.

PubMed ID: 11711768

LP299V markedly reduced abdominal pain and overall IBS symptoms over 4 weeks, a direct improvement in digestion-related symptoms.

PubMed ID: 11173893

LGG reduced bloating and diarrhea associated with H. pylori therapy, improving overall tolerability and tummy comfort.

PubMed ID: 11148433

LGG reduced diarrhea and nausea during therapy, improving GI comfort during antibiotic regimens.

PubMed ID: 12425542

Various probiotics reduced diarrhea and taste disturbances during H. pylori therapy and improved tolerability.

PubMed ID: 11799376

Maternal probiotics during pregnancy/lactation halved infant eczema incidence, suggesting reduced atopic sensitization risk.

PubMed ID: 12197847

Yogurt restored bifidobacteria after H. pylori therapy, suggesting recovery/resilience of gut microbial community after perturbation.

PubMed ID: 12150178

Duplicate entry (same strong diarrhea benefit).

PubMed ID: 12236051

Enterococcus faecalis immunostimulant reduced sinusitis relapses: shows enhanced resilience to recurrent infection at a mucosal site.

PubMed ID: 12788576

Perinatal LGG exposure lowered atopic eczema incidence (immune/allergy outcome), implying reduced allergic tendencies; not direct food-sensitivity data.

PubMed ID: 12918131

Adding S. boulardii to antibiotics markedly shortened diarrhea and other GI symptoms in amoebiasis.

PubMed ID: 12730861

VSL#3 reduced risk of pouchitis after surgery — improved resilience of the gut to inflammatory relapse.

PubMed ID: 14608267

Preparation markedly lowered antibiotic-associated diarrhea occurrence and duration — improves resilience of bowel function during antibiotic exposure.

PubMed ID: 14631461

L. casei Shirota improved constipation symptoms and stool consistency — improved digestive function.

PubMed ID: 14518142

Randomized trials in children showed shorter diarrhea duration and fewer stools — direct digestive benefit.

PubMed ID: 15115098

B. bifidum formula lowered stool frequency in infant acute diarrhoea — modest digestive benefit.

PubMed ID: 15569121

Adding B. clausii during antibiotic therapy significantly reduced nausea, diarrhoea and epigastric pain — large symptomatic relief.

PubMed ID: 15220671

Probiotic combinations substantially reduced abdominal pain scores and IBS symptom severity — direct reduction in tummy discomfort.

PubMed ID: 15321816

Yogurt with Lactobacillus/Bifidobacterium reduced H. pylori urease activity — potential digestive improvement.

PubMed ID: 14749232

Infant formulas with probiotics were associated with less reported colic/irritability (reduced tummy distress).

PubMed ID: 15722985

Polybacterial lysate reduced diverticulitis recurrence/symptoms and proposed IgA-mediated mucosal defense, supporting resilience.

PubMed ID: 15507864

VSL#3 added to therapy produced faster/higher remission in ulcerative colitis, indicating clear improvement in GI disease control.

PubMed ID: 15520759

Probiotics reduced GI symptom frequency in children (39% to 10%) and improved intestinal permeability—less GI discomfort.

PubMed ID: 14684584

VSL#3 kept the majority of recurrent pouchitis patients in remission over one year—strong digestive resilience evidence.

PubMed ID: 15133865

BIFICO greatly lowered UC relapses and changed microbiota/inflammation markers—major resilience effect.

PubMed ID: 15269618

Fermented formula reduced severity measures of infant diarrhea (less severe GI episodes).

PubMed ID: 15479682

E. coli Nissle matched mesalazine in maintaining UC remission—supports sustained digestive stability.

PubMed ID: 15076628

B. lactis shortened diarrhea duration and reduced total days with diarrhea in nursery infants.

PubMed ID: 15179608

Probiotic lowered C. difficile toxin detection during antibiotics—helps prevent severe post-antibiotic complications.

PubMed ID: 15807203

Reduced duration and prevented protracted diarrhea in children—improves resilience to diarrheal illness.

PubMed ID: 15567983

L. casei added to H. pylori therapy reduced side-effects and modestly increased eradication—improves GI tolerability.

PubMed ID: 15815206

Probiotic-supplemented formula halved antibiotic-associated diarrhea in infants—increased resistance to antibiotic-associated perturbation.

PubMed ID: 15984978

Open study in active UC produced remission/response—clinically relevant GI disease improvement.

PubMed ID: 15765388

B. infantis reduced IBS abdominal pain and bloating—direct symptomatic digestive benefit.

PubMed ID: 15882248

Probiotics reduced symptom burden during H. pylori eradication—symptomatic GI benefit but small trial.

PubMed ID: 15629973

Probiotic enteral supplementation substantially reduced NEC incidence/severity in VLBW infants—major resilience outcome.

PubMed ID: 15740542

S. boulardii strongly prevented antibiotic-associated diarrhea and C. difficile–related AAD—demonstrates resilience against perturbation.

PubMed ID: 16192262

Zinc-plus-probiotic shortened diarrhea and reduced watery stools—less GI discomfort.

PubMed ID: 16126048

Daily probiotic mix markedly reduced NEC incidence and severity in preterm neonates—strong resilience evidence.

PubMed ID: 15829425

Probiotics reduced antibiotic-induced disruption of gut bacterial populations—directly supports digestive resilience.

PubMed ID: 15727582

LGG benefited an IgE-sensitized infant subgroup—evidence for conditional reduction in allergic reactivity.

PubMed ID: 16437727

C. butyricum limited antibiotic‑induced flora shifts and GI side effects during eradication therapy.

PubMed ID: 16128676

RCT showed significant reduction in overall IBS symptom score (clinically meaningful improvement).

PubMed ID: 16271414

Fermented product increased lactic bacteria and improved stool consistency/frequency and SCFA markers in healthy adults.

PubMed ID: 16082279

Supplementing triple therapy with L. casei improved H. pylori eradication rates (may relieve dyspepsia ultimately).

PubMed ID: 16292090

S. boulardii robustly reduced antibiotic‑associated diarrhea during/after H. pylori therapy, indicating resilience to antibiotic insult.

PubMed ID: 15858959

Large RCT: S. boulardii significantly shortened diarrhea duration and stool frequency in children.

PubMed ID: 15995003

Large RCT: L. paracasei ST11 reduced stool volume/frequency and sped recovery in non-rotavirus diarrhea.

PubMed ID: 16697231

Oral lactobacilli with metronidazole greatly increased BV cure and restored lactobacilli—restoration of microbial barrier after antibiotic treatment.

PubMed ID: 16724575

Combination probiotic shortened diarrhea severity and reduced unformed stools (clinical diarrhea endpoint).

PubMed ID: 16393304

Lactobacilli shortened rotavirus diarrhoea and reduced rehydration time in children — improved digestive course.

PubMed ID: 16874872

S. boulardii significantly shortened acute pediatric diarrhoea and stool frequency — strong digestion improvement.

PubMed ID: 16864708

Probiotic-fed infants showed higher cow's milk-specific IgA and sCD14 — immune maturation signal consistent with reduced food sensitization risk.

PubMed ID: 17032283

Significant reduction in gastrointestinal symptom scores during antibiotic therapy indicates less tummy discomfort.

PubMed ID: 16650048

Probiotics reduced eczema severity specifically in food-sensitized children—suggests impact on food-related sensitivities.

PubMed ID: 16696804

LGG delayed relapse time in quiescent UC patients, indicating modest resilience improvement.

PubMed ID: 16848109

Yogurt shortened hospitalization and reduced diarrhea frequency in infants, a clear digestion benefit.

PubMed ID: 16448475

Infant formula with LGG increased growth and defecation frequency—implies better gut function/nutrition.

PubMed ID: 16633103

L. casei reduced symptomatic recurrence in diverticular disease (better digestive outcomes).

PubMed ID: 16863564

B. infantis significantly improved abdominal pain/discomfort and global IBS symptoms in women with IBS.

PubMed ID: 16809947

Medilac DS significantly reduced abdominal pain severity and frequency in IBS patients.

PubMed ID: 16572062

S. boulardii preserved bowel function during antibiotics — supports resilience to perturbation.

PubMed ID: 16971641

Bb12 produced robust shifts toward protective bifidobacteria and away from pathogens in preterm guts.

PubMed ID: 17172187

B. longum after rifaximin gave greater IBS symptom relief vs antibiotic alone.

PubMed ID: 16813181

Acupuncture + microorganism prep improved constipation‑type IBS symptoms, but probiotic effect confounded by acupuncture.

PubMed ID: 17998837

E. coli Nissle restored normal colonization in cirrhotic patients and trended to lower endotoxin—supports resilient colonization.

PubMed ID: 17443852

Synbiotics + neomycin/MBP reduced Enterobacteriaceae and bacterial translocation during colectomy (improved perioperative resilience).

PubMed ID: 17349686

Perinatal L. reuteri reduced IgE‑associated eczema and sensitization at 2 years (allergy-related benefit).

PubMed ID: 40707016

Bacillus coagulans GBI‑30 improved bowel frequency and fecal consistency and reduced constipation prevalence.

PubMed ID: 40474200

Adjunctive lactic acid bacteria in pediatric peritonitis improved intestinal dysbiosis and reduced endotoxin/inflammation, supporting digestion.

PubMed ID: 40391827

Postoperative Bifidobacterium sped GI recovery in children — faster return of digestive function.

PubMed ID: 41568006

Probiotic plus nursing reduced GI complications and improved recovery during chemotherapy, indicating enhanced resilience to treatment insult.

PubMed ID: 41249095

Probiotic reduced early post‑colonoscopy abdominal symptoms and days of discomfort (GSRS improvement).

PubMed ID: 41465910

Weizmannia coagulans trial increased stool frequency/consistency and SCFAs — physiologic improvement in bowel function/digestion.

PubMed ID: 40716758

Rapid restoration of normal stools and GI wellbeing after antibiotics demonstrates strong resilience to antibiotic insult.

PubMed ID: 40456531

Improved stool consistency and fewer hard stools likely reduce abdominal discomfort associated with constipation.

PubMed ID: 41312988

Postbiotic maintained/increased alpha diversity and commensal anaerobes during antibiotic exposure—directly enhances resilience of gut ecosystem.

PubMed ID: 40647232

Toddlers reported fewer abdominal pain/diarrhea episodes—direct reduction in tummy discomfort.

PubMed ID: 41427732

Durable colonization of B. infantis in infants suggests long-lasting resilience of the developing microbiome.

PubMed ID: 39941091

Infant trial shortened GI symptom durations (stomach ache, diarrhea) indicating less tummy discomfort.

PubMed ID: 40842390

PPOIT (probiotic + peanut OIT) trial improved food-allergy–related quality of life, directly relevant to food sensitivity/allergy management.

PubMed ID: 40837632

Faster clearance of rotavirus, improved mucosal barrier markers, and clinical recovery indicate strong reduction in tummy discomfort.

PubMed ID: 40346590

Newborn probiotic increased diversity and sped clinical recovery from jaundice—supports neonatal digestive/physiological resilience.

PubMed ID: 39172632

RBL restored microbiome and secondary bile acids rapidly and reduced C. difficile recurrence—strong effect on digestive resilience.

PubMed ID: 40024315

L. paracasei Shirota reduced hard/lumpy stools and improved constipation‑related QoL, reflecting improved digestion.

PubMed ID: 40884341

S. boulardii + rifaximin improved SIBO eradication and symptoms, supporting resilience against small‑intestinal dysbiosis.

PubMed ID: 40392916

IBS RCT reduced IBS‑SSS and oxidative stress, consistent with improved digestive symptoms.

PubMed ID: 39976654

B. coagulans reduced postoperative complications and accelerated GI recovery, indicating stronger digestive resilience after surgical stress.

PubMed ID: 41255078

Large IBS trial showed global symptom improvement and reduced abdominal pain/distension (direct digestive effect).

PubMed ID: 41502201

IBS probiotic reduced depressive symptoms and improved QoL, and reduced GI symptoms in IBS—less tummy discomfort reported.

PubMed ID: 40624535

Probiotic reduced indigestion/constipation scores post‑H. pylori therapy.

PubMed ID: 40699044

Celiac trial showed significant GSRS symptom improvement vs placebo, indicating better overall GI digestion/symptoms.

PubMed ID: 40026275

High‑dose L. reuteri markedly reduced persistent watery stools and shortened diarrhea in children.

PubMed ID: 40944274

High‑potency multispecies products reduced GI symptom scores and improved fecal inflammatory/immune markers.

PubMed ID: 40264088

Preoperative probiotic reduced AGI incidence and I‑FABP release after cardiac surgery, indicating better gut resilience to surgical stress.

PubMed ID: 40383259

Overweight adults had improved bowel function and multiple GI symptom improvements after 4 weeks.

PubMed ID: 40004971

Probiotic preserved fecal microbial richness during CDI therapy—improves resilience of gut ecosystem under antibiotic stress.

PubMed ID: 40618229

Shortened diarrhea duration and higher early recovery in infants (direct digestive symptom benefit).

PubMed ID: 41278159

Probiotic adjunct reduced diarrhea, dyspepsia and reflux scores during H. pylori therapy (direct reduction of tummy discomfort).

PubMed ID: 40037934

Multi‑strain probiotic improved GI symptoms in children with ASD (validated GI scales improved).

PubMed ID: 40077633

Rifaximin+probiotic produced large, sustained improvements in IBS symptoms (direct digestive benefit).

PubMed ID: 39417285

L. rhamnosus added to standard care shortened rectal bleeding time in infants with cow’s milk protein allergy—direct effect on a food sensitivity outcome.

PubMed ID: 38674825

Infant B. breve increased bifidobacteria/SCFAs and reduced infections—indicates a more resilient gut ecosystem in infants.

PubMed ID: 39125350

LcS softened stools (especially hard-stool subgroup), indicating improved bowel function/digestion.

PubMed ID: 38467857

BLa80 markedly shortened diarrhea duration and raised fecal antimicrobial peptide LL‑37—improves mucosal resilience to enteric infection.

PubMed ID: 38674920

Heat‑killed L. johnsonii modestly improved heartburn item—specific digestive symptom improved.

PubMed ID: 38381349

B. animalis improved bowel function and microbiome diversity in constipated children—boosts functional resilience.

PubMed ID: 38287443

Large RCT in IBS showed marked symptom reduction and normalized stool form—direct digestion symptom improvement.

PubMed ID: 38412871

LcS increased SCFAs and lactobacilli which support mucosal health and metabolic resilience.

PubMed ID: 38519563

LcS reduced antibiotic‑associated diarrhea, indicating resilience to antibiotic disruption.

PubMed ID: 38655655

Maternal probiotic supplementation reduced childhood eczema incidence, suggesting modulation of allergic outcomes.

PubMed ID: 38494684

B. fragilis reduced chemotherapy‑related nausea/vomiting/diarrhea, decreasing tummy discomfort.

PubMed ID: 38337627

Multi‑strain B. animalis added to PPI produced faster symptom relief and lower GSRS scores.

PubMed ID: 39244201

Normalization of stool consistency and reduced constipation prevalence indicates improved gut resilience.

PubMed ID: 38794748

L. rhamnosus improved defecation frequency, stool form and constipation symptoms post‑surgery.

PubMed ID: 38676453

Improved ulcer healing and H. pylori clearance — better GI health.

PubMed ID: 39122704

Reduced chronic diarrhea severity and improved stool form with increased SCFAs.

PubMed ID: 38597892

Correction of postoperative dysbiosis suggests improved ability to recover from GI insults.

PubMed ID: 38655990

Maternal probiotic dramatically reduced infant colic crying intensity (direct relief).

PubMed ID: 39099231

Probiotic+OIT greatly increased sustained peanut ingestion and clinical remission of peanut allergy.

PubMed ID: 39519611

Constipation and incomplete‑emptying sensation were meaningfully improved.

PubMed ID: 39390276

Two‑strain probiotic markedly reduced infant colic crying (direct marker of tummy discomfort).

PubMed ID: 39486439

In antibiotic‑exposed neonates, probiotic carriage and fewer later FGIDs show enhanced digestive resilience.

PubMed ID: 38938120

Reduced postoperative GI symptoms and sped bowel-function recovery.

PubMed ID: 38494525

Shortened duration of persistent diarrhea—direct digestive improvement.

PubMed ID: 38821493

LGG reduced crying in infant colic and lowered inflammatory markers, consistent with less visceral discomfort.

PubMed ID: 39339788

L. paragasseri yogurt reduced epigastric pain and EPS‑like symptoms in adults with postprandial complaints.

PubMed ID: 38999739

Improved stool form in psychosomatic diarrhea trial (BSS improved).

PubMed ID: 39351739

Faster epigastric pain relief and better ulcer healing when probiotics were added to H. pylori therapy.

PubMed ID: 39064634

Constipation-prone adults had softer stools and microbiota shifts with heat‑treated L. helveticus.

PubMed ID: 38733973

LACTIN‑V promoted durable L. crispatus colonization and reduced BV recurrence — resilience of mucosal flora.

PubMed ID: 39093754

Large RCT showed substantial reduction in IBS‑SSS and multiple GI symptoms.

PubMed ID: 38849408

S. boulardii adjunct reduced diarrhea during H. pylori antibiotic therapy and modulated gut microbiota — supports digestive resilience during perturbation.

PubMed ID: 38304947

L. plantarum 24‑7 reduced postoperative bloating and hard stools, lowering abdominal discomfort.

PubMed ID: 38178601

Post‑hoc IBS analysis: probiotic responders had reduced abdominal pain and related symptoms, indicating digestion benefit in responders.

PubMed ID: 39458493

Post‑sleeve gastrectomy probiotic markedly reduced postoperative constipation and improved ease of defecation — reduced GI discomfort.

PubMed ID: 38427038

L. reuteri significantly reduced crying (colic) and regurgitation in infants — direct reduction in abdominal discomfort.

PubMed ID: 39732948

L. paracasei in peritoneal dialysis patients changed microbiota and improved indigestion and constipation GSRS scores.

PubMed ID: 38172093

High‑dose BL‑99 produced large symptom response in functional dyspepsia with mechanistic SCFA/gastrin changes.

PubMed ID: 39467682

Reduced AAD and improved microbiota markers in children indicates strong resilience to antibiotic insult.

PubMed ID: 39023173

Adjunct to H. pylori therapy increased eradication and reduced digestive adverse effects versus placebo.

PubMed ID: 39102225

Shift toward a term‑like eubiotic microbiome in preterm infants suggests enhanced baseline resilience, though MDRO unchanged.

PubMed ID: 38630015

Large RCT in IBS‑D showing large, clinically meaningful improvements in IBS symptom severity and stool form.

PubMed ID: 38967929

Multispecies probiotic produced transient taxonomic protection during antibiotics and parent trial reported AAD reduction.

PubMed ID: 38018652

Compound probiotic during chemo markedly reduced common GI adverse events and preserved QoL.

PubMed ID: 38072489

Probiotic combined with peanut OIT produced very high rates of sustained unresponsiveness to peanut vs placebo.

PubMed ID: 37026366

Bacillus probiotic decreased loose stools and showed favorable tolerability—signals of improved GI stability.

PubMed ID: 38350481

Large reductions in abdominal discomfort and overall GI symptom scores with the probiotic‑amylase blend.

PubMed ID: 38195431

RCT in IBS‑D with two Lactobacillus strains produced large improvements in global IBS severity and symptom domains.

PubMed ID: 37249280

Large RCT in IBS‑D showing added probiotic produced significant symptom relief (IBS severity reduction).

PubMed ID: 37172455

B. animalis shortened duration of acute watery diarrhea and reduced fecal inflammation in children.

PubMed ID: 37684332

Nasal probiotic lowered viral burden and nasal inflammation, indicating resilience to respiratory pathogens; conceptually relevant to mucosal resilience.

PubMed ID: 37960143

Deactivated B. subtilis improved indigestion/dyspepsia and total GI symptom scores in symptomatic adults.

PubMed ID: 38154554

Analysis of OIT/PPOIT trials indicates these immunotherapies (including probiotic‑assisted protocols) can reduce peanut allergy remission barriers; study identifies modifiers of success.

PubMed ID: 38022520

L. crispatus reduced H. pylori breath test values and improved GI symptoms (GSRS).

PubMed ID: 36646104

Marked reduction in intestinal S. aureus carriage suggests improved colonization resistance against a potential pathogen.

PubMed ID: 36862903

B. coagulans RCT showed large improvements in GSRS indigestion and stool form vs placebo.

PubMed ID: 37139872

Large RCT showed significantly faster return of bowel function (time to first stool/flatus) after craniotomy — direct clinical digestion/motility benefit.

PubMed ID: 36904141

Probiotic preserved alpha diversity through bowel prep and accelerated microbiota restoration — strong evidence of resilience to an acute digestive insult.

PubMed ID: 37400812

S. boulardii shortened time to patient‑reported improvement in viral inflammatory diarrhoea (~1 day), indicating modest digestive symptom benefit.

PubMed ID: 38004205

Probiotics partly prevented sugar‑induced loss of supragingival diversity and favored health‑associated taxa — protected microbiome from dietary stress (resilience).

PubMed ID: 37020353

Probiotic reduced antibiotic‑associated diarrhea and showed microbiome‑dependent resilience effects — direct resilience after antibiotic perturbation.

PubMed ID: 38004199

Oral probiotic lozenges promoted faster return to health‑associated oral taxa after stopping oral hygiene — resilience of oral ecosystem to disruption.

PubMed ID: 37020105

Direct infant dosing rapidly established bifidobacteria and term‑like microbiota — foundational resilience in preterm infant gut colonization.

PubMed ID: 37137616

Probiotics in SAM shortened diarrhea and sped recovery, improving resilience to enteric stressors.

PubMed ID: 37812890

Probiotic reduced multiple metformin‑associated GI adverse events and improved drug tolerability, indicating greater resilience to GI stress.

PubMed ID: 37464459

Lactococcus cremoris FC increased defecation frequency and improved stool quality in mildly constipated adults.

PubMed ID: 36678202

MED‑01 modestly improved Nugent score and increased Lactobacillus—supports microbial stability.

PubMed ID: 36630947

S. boulardii plus dietary advice reduced SIBO hydrogen and IBS‑SSS diarrhea metrics in IBS‑D with SIBO.

PubMed ID: 37614081

Adjunct L. reuteri reduced GI symptoms (GSRS) and some adverse effects during H. pylori therapy.

PubMed ID: 37060545

VE303 markedly reduced CDI recurrence after treatment—strong evidence of restored/resilient gut ecology.

PubMed ID: 38350486

Pregnancy probiotic prevented loss of beneficial vaginal and fecal microbes, stabilizing the microenvironment.

PubMed ID: 37576702

Large RCT in IBS‑D showing large, dose‑dependent symptom and stool‑consistency improvements.

PubMed ID: 35979259

S. boulardii produced higher abdominal‑pain responder rates and modest QOL improvements vs Bacillus mixture in IBS‑C patients.

PubMed ID: 35916669

Faster microbiome recovery after antibiotics implies greater ecological/digestive resilience.

PubMed ID: 36086703

S. boulardii shortened diarrhea duration in children (~12 hr), directly improving digestive symptoms.

PubMed ID: 36068716

E. coli Nissle increased endoscopic remission and improved abdominal symptoms in ulcerative colitis—clinically relevant digestive improvements.

PubMed ID: 35615783

Probiotic + peanut OIT induced immunologic rewiring and remission signatures, directly relevant to reduced food allergy/sensitivities.

PubMed ID: 34980887

Post‑surgical neonates showed strong increases in bifidobacteria and SCFAs and reductions in pathogenic taxa—improved resilience after GI insult.

PubMed ID: 35045564

Adjunct L. reuteri in mild diverticulitis produced quicker pain reduction and shorter hospital stays—direct reduction in abdominal discomfort.

PubMed ID: 34999679

Large RCT in children with acute watery diarrhea showing shorter diarrhea duration and hospital stay.

PubMed ID: 33136781

Significant reduction in lactose‑intolerance symptoms—direct improvement in digestion of lactose.

PubMed ID: 35833120

Faster return of bowel function and increased beneficial genera after polypectomy indicates resilience to surgical insult.

PubMed ID: 36660970

Probiotics+zinc dramatically shortened diarrheal duration in children with gastroenteritis — strong resilience/recovery signal.

PubMed ID: 35300564

Significant reductions in infant abdominal pain incidence — strong evidence for less tummy discomfort in that population.

PubMed ID: 35534443

Marked endoscopic improvement in aspirin‑related small intestinal injury — direct evidence of mucosal resilience/repair with probiotic.

PubMed ID: 35031969

B. lactis reduced antibiotic‑associated diarrhea and GI symptoms — evidence of increased resilience to antibiotic insult.

PubMed ID: 35927504

Trend to more bowel movements and increased B12 over long use in elderly suggests improved baseline gut function/resilience.

PubMed ID: 36184252

Ulcerative colitis trial produced clinical remission and improved inflammation — direct digestive benefit.

PubMed ID: 36108911

Pregnancy probiotic improved GI symptom scores despite no effect on GBS colonization.

PubMed ID: 36316826

Functional-constipation trial showed clear improvements in bowel movements and stool form.

PubMed ID: 35314794

Extremely preterm infants: raised Bifidobacterium/Lactobacillus and reached full feeds ~1.8 days sooner — improved gut function.

PubMed ID: 35276991

Large H. pylori adjunct trial: probiotics substantially reduced treatment‑related GI adverse events (absolute −33.7 pp) and symptom severity.

PubMed ID: 36014810

VLBW trial: multispecies probiotic reduced feeding intolerance and accelerated full enteral feeds — direct improvement in digestion/feeding.

PubMed ID: 36287379

RBX2660 markedly reduced recurrent C. difficile and produced sustained remissions — strong demonstration of restored digestive resilience to pathogenic recurrence.

PubMed ID: 36216361

BB536 improved bowel frequency and some upper abdominal symptoms in elderly with chronic constipation.

PubMed ID: 36269141

BS50 improved gas‑related symptoms in healthy adults, increasing proportion reporting symptom improvement — supports day‑to‑day GI resilience.

PubMed ID: 36426355

H. pylori probiotic adjunct partially protected gut composition and reduced GI adverse events during antibiotic therapy — supports resilience against dysbiosis.

PubMed ID: 36087572

Parkinson's RCT: significant reductions in constipation symptoms and PAC‑SYM scores — less abdominal discomfort and improved QoL.

PubMed ID: 35727573

Pediatric antibiotic study: overall diarrhea risk was reduced during/after antibiotics — indicates some resilience against antibiotic‑associated dysfunction.

PubMed ID: 34486272

Vaginal probiotic after antibacterial therapy markedly restored lactobacilli and reduced relapses—mucosal ecosystem resilience evidence.

PubMed ID: 34871255

Probiotic + laxative produced earlier improvement in defecation frequency and stool form in elderly constipated patients.

PubMed ID: 34448282

Adjunct probiotic partially restored gastric microbiota after eradication therapy—supports resilience of gastric ecosystem.

PubMed ID: 34599466

Large RCT in functional constipation showed faster symptomatic relief and better stool consistency—direct digestive benefit.

PubMed ID: 34579049

Probiotic aided recovery of fecal SCFAs and limited opportunistic genera persistence after H. pylori therapy—direct resilience after antibiotics.

PubMed ID: 36286886

Probiotic adjunct with H. pylori therapy dramatically reduced post-treatment dysbiosis and adverse events—strong evidence for preserving digestive resilience after perturbation (antibiotics/infection).

PubMed ID: 33506929

Postoperative L. rhamnosus GG trial showed faster return of gut function after major pancreatic surgery (improved GI recovery).

PubMed ID: 33404865

Reduced gut transit time and improved bowel function in mild hypercholesterolemia trial.

PubMed ID: 34904950

IBS crossover: probiotic produced large symptom reductions comparable to low‑FODMAP diet — clear digestive symptom benefit.

PubMed ID: 34158518

RCT showed significant improvements in overall lower abdominal symptoms, including pain and bloating—direct evidence of less tummy discomfort.

PubMed ID: 34757134

Enteral/oropharyngeal probiotic reduced VAP and sepsis and shortened ICU/hospital stay in ventilated patients—supports resilience of critically ill patients' mucosal defenses and GI-related outcomes.

PubMed ID: 33764850

Probiotic reduced URTI incidence and stabilized stool microbiome diversity against URTI-associated declines—evidence for resilience to infectious stressors.

PubMed ID: 34209804

LcS improved constipation symptoms (PAC‑SYM stool subscale) and lowered IL‑6 — less symptomatic gut discomfort.

PubMed ID: 34331676

Probiotics given with antibiotics preserved Bifidobacterium levels and aided microbiome recovery — increased resilience to antibiotic insult.

PubMed ID: 33762689

Durable colonization by B. infantis suggests a microbiome more resilient/anchored to beneficial taxa.

PubMed ID: 35063245

Probiotic mitigated PPI‑induced microbiome shifts, indicating protection against drug‑induced perturbation.

PubMed ID: 34628695

Adjunct L. reuteri reduced GSRS scores and diarrhoea in H. pylori therapy — clear reduction in GI discomfort.

PubMed ID: 34074289

L. rhamnosus lowered circulating endotoxin and inflammatory markers during calorie restriction, consistent with improved host–microbiome resilience.

PubMed ID: 34063276

Reduced mucosal inflammation and systemic markers in diversion colitis implies improved colonic function and digestion.

PubMed ID: 34721416

L. plantarum improved stool consistency and frequency in chronic diarrhea — direct digestive symptom benefit.

PubMed ID: 33510561

Probiotics in mild acute pancreatitis shortened time to oral feeding and pain relief.

PubMed ID: 35091321

Perioperative probiotic use sped GI recovery and reduced infections, supporting resilience to surgical stress.

PubMed ID: 34119240

B. coagulans shortened transit time and increased bowel movements—direct digestion improvement.

PubMed ID: 33652763

Direct RCT showing large reductions in IBS‑SSS and abdominal pain => clear digestion improvement.

PubMed ID: 33916192

Three‑strain Lactobacillus improved atopic dermatitis in infants with cow’s‑milk‑protein allergy, suggesting reduced food‑allergy manifestations.

PubMed ID: 34358486

Spore‑forming probiotic increased responder rate in functional dyspepsia (postprandial distress).

PubMed ID: 31100124

Probiotic prophylaxis markedly reduced recurrent UTIs over 18 months — long‑term resilience/protection of urinary tract microbiome.

PubMed ID: 32091443

Post‑antibiotic lactobacilli reduced BV recurrence and delayed relapse — demonstrates resilience of mucosal microbiome after antibiotic disruption.

PubMed ID: 33168839

Probiotic started immediately after laxative restored diversity to healthy‑like levels and improved symptoms — resilient recolonization evidence.

PubMed ID: 31815260

Large dose–response RCT showing L. casei reduced incidence and duration of antibiotic‑associated GI adverse events — strong resilience signal during antibiotic stress.

PubMed ID: 31749128

Kefir significantly reduced abdominal pain in males after 3 weeks.

PubMed ID: 30911991

B. coagulans increased spontaneous stools and normalized stool consistency in constipated adults.

PubMed ID: 32362486

L. reuteri significantly increased pain-free days and reduced pain intensity in children with functional abdominal pain.

PubMed ID: 32858860

Probiotic-supplemented preterm infants reached full feeds faster, implying improved gut functional resilience.

PubMed ID: 32824480

B. lactis trials showed modest improvements in digestive symptom scores and stool consistency.

PubMed ID: 32996156

B. bifidum reduced milk-allergy scores and serum IgE after 6 months in infants.

PubMed ID: 33350361

B. breve (±L. fermentum) cut daily crying time in colicky infants more effectively and faster than simethicone — reduced GI discomfort.

PubMed ID: 30656549

LGG added to elimination diet improved GI/behavioral symptoms in infants with cow's milk protein allergy.

PubMed ID: 32720832

Adjunct probiotic shortened diarrhoea duration and increased recovery in children — clear clinical digestive benefit.

PubMed ID: 32372186

Prenatal L. reuteri reduced infant colic incidence/severity—direct tummy discomfort benefit for infants.

PubMed ID: 33225399

Multi-strain probiotic reduced IBS symptom severity—direct digestive improvement.

PubMed ID: 32517123

L. rhamnosus markedly reduced crying time and fecal inflammation in colicky infants—less visceral discomfort.

PubMed ID: 32810850

IBS probiotic reduced abdominal pain and improved QoL—direct reduction in tummy discomfort.

PubMed ID: 33244562

Large RCT showed improved stool frequency/consistency and relief of constipation symptoms (clinical digestion benefit).

PubMed ID: 31953482

Prevention of new MRGN colonisation demonstrates microbiome resistance to pathogenic takeover, a form of resilience.

PubMed ID: 32738573

Significant within‑group reductions in incomplete defecation and blockage sensations indicate reduced tummy discomfort.

PubMed ID: 31959047

Probiotic colonization associated with doubled microbiota diversity and ~50% fewer diarrheal days post‑discharge—strong resilience signal.

PubMed ID: 33040631

L. plantarum improved adult eczema and shifted immune markers away from allergic profiles — relevant to fewer food/allergic sensitivities.

PubMed ID: 31952938

Two‑strain Lactobacillus reduced IBS composite symptoms (including flatus) and improved overall IBS scores, indicating better digestion.

PubMed ID: 32363613

Heat‑killed L. rhamnosus reduced eczema severity and lowered some allergy markers in children — supports reduced allergic sensitivity.

PubMed ID: 32790913

Probiotics reduced antibiotic-associated GI symptoms after dental extraction, indicating preserved/resilient gut function under antibiotic exposure.

PubMed ID: 32506882

Large pediatric RCT dramatically cut incidence and duration of gastroenteritis and URTIs and boosted salivary IgA — strong evidence of increased resilience to infections.

PubMed ID: 32284181

Perioperative Enterococcus faecium blunted some antibiotic‑driven taxonomic shifts, indicating reduced vulnerability to dysbiosis.

PubMed ID: 32796401

S. boulardii sped recovery from acute diarrhea in children, indicating increased resilience to enteric illness.

PubMed ID: 33382780

Direct RCT evidence in constipated Parkinson’s patients showing increased bowel movements and faster whole‑gut transit — clear digestion improvement.

PubMed ID: 33015813

Reduced vomiting/flatulence and raised albumin in enteral-fed cancer patients — symptom and nutritional digestive improvements.

PubMed ID: 33247529

Better early dietary tolerance after ileostomy reversal with L. plantarum — modest digestive tolerance benefit.

PubMed ID: 33763399

Probiotic mix reduced pathogen colonization in hospitalized patients, suggesting improved resilience against nosocomial colonization.

PubMed ID: 32780258

Reported reduced bloating after gastric bypass — less postoperative tummy discomfort.

PubMed ID: 33040557

Lower constipation incidence and some microbiota changes in ICU patients — improved bowel function signal.

PubMed ID: 33046607

Significant increase in spontaneous bowel movements and improved constipation-related QoL—strong digestion effect in PD patients.

PubMed ID: 32981933

Large trial showed reduced constipation incidence in children, implying improved digestion.

PubMed ID: 32277872

Primary outcome improved abdominal pain and overall IBS symptoms—strong evidence for reduced tummy discomfort.

PubMed ID: 32326347

Subtype IBS benefits (bowel habits) with L. paracasei/B. longum — some digestion-related improvement.

PubMed ID: 32019158

Large RCT: reduced abdominal pain and IBS symptoms, normalized stool form — strong digestive symptom improvement.

PubMed ID: 30694338

S. boulardii sharply reduced antibiotic-associated diarrhea and overall AEs during H. pylori therapy — strong resilience during antibiotic insult.

PubMed ID: 31965842

Infant probiotic maintained SIgA and stool frequency, supporting mucosal resilience to perturbation.

PubMed ID: 31531150

IgG‑guided elimination diet with probiotics reduced IBS symptoms and migraine burden—suggests probiotics may help when combined with diet to reduce food‑related reactions.

PubMed ID: 31438618

Spore probiotic produced marked IBS symptom and QOL improvements—direct reduction in abdominal discomfort.

PubMed ID: 30531312

Fewer diarrhea days in young children taking L. reuteri — improved bowel outcomes.

PubMed ID: 31434935

Large RCT in IBS showing marked reductions in abdominal pain and overall symptom scores — direct digestive benefit.

PubMed ID: 31807856

RCT in IBS showing significant reductions in abdominal pain and improved stool consistency.

PubMed ID: 31242512

Neonatal trial showed faster meconium passage and lower bilirubin at 36h—reflects improved early gut function.

PubMed ID: 31071249

Ulcerative colitis trial showed improved colon histology and trends in feeding tolerance and symptoms—direct digestive disease benefit.

PubMed ID: 31095949

High‑dose B. breve significantly reduced capsule‑endoscopy measures of aspirin/NSAID‑induced small‑bowel damage, showing mucosal resilience.

PubMed ID: 31819304

Perioperative probiotics reduced postoperative ileus and shortened hospitalization, indicating enhanced GI resilience to surgical stress.

PubMed ID: 31706331

Fewer reflux episodes, faster full feeding and increased weight gain in preterm infants show improved feeding/digestion.

PubMed ID: 29550911

Significant reductions in incidence and severity of radiotherapy-associated diarrhoea and medication need.

PubMed ID: 31783597

Large reductions in overall IBS symptoms and abdominal pain vs placebo.

PubMed ID: 31554388

Adjunct probiotic reduced nausea/vomiting, abdominal discomfort and bitter taste during H. pylori therapy.

PubMed ID: 31686199

Reduced GI discomfort (bloating/belching) indicates improved digestive function.

PubMed ID: 31657615

Constipation QoL improved, consistent with reduced GI discomfort.

PubMed ID: 31271261

Constipation trial showed earlier normalization of stool form and microbiome shifts despite limited symptom‑score separation.

PubMed ID: 31630683

Infant formula with L. fermentum reduced diarrhoea incidence and duration — clear digestive improvement in infants.

PubMed ID: 29688915

Large RCT in celiac patients with IBS‑type symptoms produced clinically meaningful IBS score improvements.

PubMed ID: 31114137

Probiotic reduced SIBO incidence and prolonged relapse time on PPI—evidence of improved resistance to dysbiosis.

PubMed ID: 31208714

Increased microbial alpha diversity after 120 days indicates greater microbial resilience in systemic sclerosis patients.

PubMed ID: 30662004

Kefir increased stool Lactobacillus and improved bloating/wellbeing in IBD patients.

PubMed ID: 29695183

RCT in pediatric IBS showed large reductions in abdominal pain and improved stool consistency.

PubMed ID: 29725956

S. boulardii use in hospitalized antibiotic recipients was associated with a pronounced drop in C. difficile infections—strong evidence of resilience against antibiotic‑related dysbiosis complications.

PubMed ID: 30551654

Combination L. rhamnosus + L. reuteri reduced daily cry/fuss time (~47 min greater reduction vs control) in colic infants.

PubMed ID: 29453431

Early‑life LGG induced T‑reg cells and anti‑inflammatory metabolites while given, which supports tolerance mechanisms linked to fewer sensitivities.

PubMed ID: 30406696

L. reuteri DSM17938 dramatically reduced crying time in breastfed infants with colic—clear reduction in abdominal discomfort.

PubMed ID: 30630805

Ulcerative colitis add‑on probiotic improved clinical remission rates and lowered inflammation, indicating better GI function.

PubMed ID: 28871492

L. rhamnosus GG given perioperatively with antibiotics reduced antibiotic‑associated diarrhea incidence and shortened its duration, supporting digestive resilience.

PubMed ID: 30088841

In ventilated ICU patients probiotics decreased ICU/hospital stay and gastric residuals and suggested fewer VAPs—supports resilience of GI/clinical outcomes under stress.

PubMed ID: 29573807

Randomized trial in healthy adults showed relief of postprandial discomfort, epigastric pain and overall upper‑GI symptoms with B. bifidum fermented milk.

PubMed ID: 29888656

Randomized IBS trial showed clinically meaningful reduction of abdominal pain and stool symptoms—direct evidence of improved digestion.

PubMed ID: 30326954

Infant supplementation prevented antibiotic/C‑section–induced microbiome dysfunction, indicating greater microbiome resilience to insults.

PubMed ID: 30264164

B. coagulans shortened recovery time and improved QoL in acute diarrhea — faster recovery implies greater resilience to GI insult.

PubMed ID: 29801486

Large RCT in IBS‑D showed substantial reductions in overall IBS severity, abdominal pain and improved QoL — direct evidence of improved digestion.

PubMed ID: 29439395

Marked reduction in crying time for infant colic (clinically meaningful relief of GI discomfort).

PubMed ID: 29538368

Infant formula with B. infantis modestly lowered diarrheal episodes and constipation and increased stool frequency at some timepoints.

PubMed ID: 30424728

Raised Bifidobacterium levels in very preterm infants during supplementation — suggests increased colonization resistance while supplementing.

PubMed ID: 30400588

Lactobacillus supplementation in children reduced total IgE for combined strains — mechanistic signal that could translate to fewer IgE‑mediated sensitivities (indirect).

PubMed ID: 29876777

Constipation study improved stool consistency and quality of life — less GI discomfort reported.

PubMed ID: 29445178

C. butyricum trial in diarrhea‑predominant IBS reduced symptom severity, stool frequency and improved QoL.

PubMed ID: 30521105

Probiotic combination preserved gut microbiota diversity and reduced severe mucositis during chemoradiotherapy—evidence of resilience under heavy insult.

PubMed ID: 28813007

Two-strain probiotic shortened duration of acute rotavirus diarrhea in infants (~1.2 days), a direct digestive benefit.

PubMed ID: 28592037

S. boulardii markedly reduced antibiotic-associated diarrhea incidence and duration—clear resilience to antibiotic insult.

PubMed ID: 27906800

Children with functional abdominal pain had many more pain‑free days and lower pain severity with L. reuteri.

PubMed ID: 28388647

S. boulardii altered microbial taxa associated with lower translocation/inflammation, supporting resilience in treated HIV patients.

PubMed ID: 28993261

Study shows fecal VOCs predict probiotic/diet responders in IBS—relevant to tailoring digestive benefit though probiotic effect variable.

PubMed ID: 28768250

RCT in functional dyspepsia showed probiotic increased symptom elimination vs placebo (direct digestive symptom benefit).

PubMed ID: 28343401

B. lactis reduced viral shedding and nasal inflammation in experimental infection, indicating increased mucosal resilience (no symptom change).

PubMed ID: 28858247

In preterm infants, L. reuteri improved feeding tolerance and shortened time to full feeds.

PubMed ID: 28114795

Small trial in colicky infants shortened crying episodes — suggests improved infant gut comfort/regulation.

PubMed ID: 28079729

Probiotics reduced outpatient diarrhea days in malnourished children — improved digestive outcomes.

PubMed ID: 28052291

L. gasseri yogurt reduced aspirin-associated small-bowel lesions and improved GI symptom scores.

PubMed ID: 28482385

S. boulardii strongly prevented antibiotic-associated diarrhea in infants — major resilience against antibiotic perturbation.

PubMed ID: 29143799

Formula with L. reuteri reduced regurgitation and sped gastric emptying — direct digestion improvement.

PubMed ID: 29022390

Adults with functional constipation reported less abdominal discomfort/pain and bloating on L. reuteri.

PubMed ID: 30580349

Probiotic showed a non-significant trend to fewer NEC cases in preterm infants — suggestive but underpowered.

PubMed ID: 29052245

Probiotic + peanut OIT group achieved sustained unresponsiveness and improved food-allergy QoL (combined intervention).

PubMed ID: 28601084

Psychobiotic trial reported reduced gastrointestinal symptoms and oro‑caecal transit improvement in treated women.

PubMed ID: 28935921

Reduced bacterial translocation to blood in T2D patients suggests strengthened gut barrier and resilience.

PubMed ID: 28654019

Fewer common infectious diseases in children after fermented milk suggests enhanced ability to resist or recover from infections, including GI infections.

PubMed ID: 27306945

3‑bifidobacteria mixture reduced abdominal pain and improved QoL in children with IBS (direct GI symptom benefit).

PubMed ID: 28991918

L. reuteri with targeted antibiotics markedly lowered recurrent diarrhoea and improved growth — supports resilience against repeat enteric disease.

PubMed ID: 28961980

Adjunct probiotic markedly shortened diarrhoea duration and total diarrhoea days in C. difficile patients.

PubMed ID: 28625832

Probiotic restored Bifidobacterium lost on low‑FODMAP diet—evidence of resilience/colonization support.

PubMed ID: 26839075

B. bifidum R0071 reduced diarrhoea‑related GI discomfort during exam stress in a large RCT.

PubMed ID: 27347788

Lactic ferments improved stool frequency, consistency and transit—increased functional resilience in mild constipation.

PubMed ID: 26922379

DBRCT in diarrhea‑predominant IBS: reduced abdominal pain, stool frequency/consistency—clear digestive benefit.

PubMed ID: 27464469

Lactobacillus GG + micronutrients reduced nosocomial diarrhoea in children (combined product) — likely digestive benefit though multicomponent.

PubMed ID: 27098538

Preop microbe prep shortened time to bowel recovery and hospital stay after colorectal surgery—enhanced resilience to operative gut stress.

PubMed ID: 27340358

E. coli Nissle produced high responder rates and normalized stool features—improved gut resilience.

PubMed ID: 27156182

L. reuteri reduced abdominal pain frequency and intensity in children with functional abdominal pain.

PubMed ID: 27595104

Multispecies probiotic substantially improved constipation‑predominant IBS symptoms and QOL.

PubMed ID: 27649676

BIFICO reduced neonatal nosocomial enteric infections suggesting improved gut health/resilience.

PubMed ID: 27207411

Reduced diarrhea and cramping scores in lactose challenge with DDS‑1 strain.

PubMed ID: 27133564

Probiotic yoghurt maintained microbiota stability during an extreme diet change (resilience to perturbation).

PubMed ID: 26946967

S. boulardii sped feeding tolerance and increased weight gain in preterm infants (implies better digestion/absorption).

PubMed ID: 27973989

S. boulardii blunted antibiotic‑induced dysbiosis and AAD, demonstrating resilience to antibiotic insult.

PubMed ID: 27178566

Improved IBS symptoms and stool form in diarrhea‑predominant IBS.

PubMed ID: 27741166

B. breve blend reduced crying (colic) late in follow‑up, suggesting some digestive symptom benefit.

PubMed ID: 27283364

Shortened rotavirus diarrhea duration; clear clinical digestion benefit in children.

PubMed ID: 27671183

Lower NEC rates and faster feeding imply stronger resistance to severe gut injury in VLBW infants.

PubMed ID: 26956782

Marked increases in beneficial bacteria and reduced feeding intolerance indicate improved resilience in neonates' guts.

PubMed ID: 27208120

Probiotic suppressed stress-induced increases in abdominal dysfunction and cortisol in humans.

PubMed ID: 25653151

S. boulardii markedly shortened diarrhoea and reduced hospital/ECU stays—strong evidence of improved resilience to enteric illness.

PubMed ID: 26159939

S. boulardii reduced diarrhoea duration/severity in piglets (supports digestive benefit).

PubMed ID: 25986615

L. reuteri shortened acute infectious diarrhea duration in children (clear clinical benefit).

PubMed ID: 26777745

Microbial cell prep sped gut recovery in critically ill patients, indicating greater digestive resilience.

PubMed ID: 25617897

Animal trial showed improved growth and reduced diarrhea indicating improved gut function.

PubMed ID: 25488262

L. reuteri significantly reduced colic-related medication use and consultations in infants (strong relief of tummy discomfort).

PubMed ID: 25779902

L. rhamnosus HN001 lowered risk of eczema/atopy in high-risk infants (reduced atopic sensitization).

PubMed ID: 25660822

L. paracasei F19 reduced bloating and flatulence and improved stool form — direct reduction of GI discomfort.

PubMed ID: 26019464

Probiotic adjunct lowered early UC relapse risk — indicates greater resilience of gut mucosa/function in remission patients.

PubMed ID: 25588782

Marked protection against antibiotic-associated diarrhea in children—improves resilience to antibiotic insult.

PubMed ID: 25876529

L. reuteri produced very large reductions in infant crying (colic) and improved maternal measures — direct, strong reduction in tummy discomfort.

PubMed ID: 25724213

Probiotics reduced NEC incidence/severity in very low birth weight infants — important enhancement of gastrointestinal resilience in neonates.

PubMed ID: 25380801

Postpartum L. casei Shirota reduced constipation-related symptoms and abdominal complaints (patient‑reported digestion improvement).

PubMed ID: 26599038

In elderly residents probiotic decreased fever incidence and pathogen counts (C. difficile), suggesting improved resistance to enteric perturbations.

PubMed ID: 25592987

Probiotic + peanut OIT produced very high sustained unresponsiveness rates, but probiotic's independent contribution is uncertain (co‑intervention).

PubMed ID: 26518158

S. boulardii reduced nausea and abdominal pain during acute diarrhoea over 72 h.

PubMed ID: 25708419

Prophylactic probiotics markedly reduced ventilator‑associated pneumonia and shortened stays, indicating resilience to severe infection in ICU context.

PubMed ID: 25929897

Probiotic added to H. pylori therapy reduced multiple treatment‑related GI symptoms—less discomfort during therapy.

PubMed ID: 25809913

Combination probiotic+mosapride improved abdominal pain/discomfort and global IBS relief vs placebo.

PubMed ID: 25469528

S. boulardii lowered LBP and IL‑6 suggesting reduced microbial translocation and a more resilient mucosal barrier.

PubMed ID: 26635090

Probiotic extended symptom‑free interval after BV treatment and sped microbiota recovery—supports resilience of mucosal ecosystem.

PubMed ID: 26183594

Post‑colonoscopy probiotic reduced mean days of abdominal pain versus placebo (reduced short‑term tummy discomfort).

PubMed ID: 24635827

Significant reduction in regurgitation episodes in infants—less GI discomfort.

PubMed ID: 24621348

Post-gastrectomy trial reported improved bowel irregularities in subgroups.

PubMed ID: 25244414

Reduced SIBO and improved GI symptoms in chronic liver disease patients.

PubMed ID: 25579140

SIBO maintenance with probiotics relieved pain, bloating and other GI symptoms vs antibiotic‑only treatment.

PubMed ID: 24579935

L. reuteri sharply shortened diarrhoea and hospital stay — direct digestive benefit.

PubMed ID: 25520127

Adjunct probiotic improved H. pylori eradication and reduced side effects when used with antibiotics—supports resilience in therapy context.

PubMed ID: 25623462

Probiotics + enteral nutrition reduced endotoxin/ammonia and improved albumin—strong evidence of resilience enhancement in HE context.

PubMed ID: 24750797

Probiotic maintained beneficial taxa and prevented Enterobacteria overgrowth during antibiotic treatment—direct evidence of resilience to perturbation.

PubMed ID: 24636808

L. reuteri improved GI quality of life and reduced fecal calprotectin in CF, reflecting reduced tummy discomfort and inflammation.

PubMed ID: 25146491

L. rhamnosus HN001 reduced eczema incidence and modified genetic susceptibility to eczema in children (atopic modulation that can relate to food sensitivity/allergy risk).

PubMed ID: 24815298

12-week multi-strain probiotic significantly reduced overall IBS symptom severity.

PubMed ID: 25531996

Increased bowel-movement frequency in adults with functional constipation.

PubMed ID: 24979556

Multi‑strain probiotic produced large, clinically meaningful symptom improvement in IBS (global relief, pain, bloating).

PubMed ID: 25488056

Saccharomyces cerevisiae increased abdominal pain responders in adults with IBS (significant symptom relief).

PubMed ID: 25400470

Marked reduction in antibiotic‑associated diarrhea incidence and duration demonstrates resilience against antibiotic insult.

PubMed ID: 25488344

Double‑coated probiotic in elderly with constipation increased defecation frequency and improved constipation symptoms.

PubMed ID: 24617812

B. bifidum enabled earlier attainment of full enteral feeds and reduced late‑onset sepsis in VLBW infants—indicative of improved gut resilience.

PubMed ID: 25527244

Infant formula with BMOS±probiotics produced softer, more frequent stools and raised beneficial bacteria—supports improved bowel function.

PubMed ID: 25024629

IBS‑D trial improved gut‑specific QoL and visceral sensitivity, suggesting symptomatic digestion benefit though global symptoms unchanged.

PubMed ID: 24820831

LGG shortened diarrhea and sped stool normalization—faster recovery from enteric insult.

PubMed ID: 23632352

BIO‑THREE reduced diarrhea duration and severe gastroenteritis incidence in hospitalized children—improves resilience to GI infection.

PubMed ID: 24722560

S. boulardii reduced proinflammatory cytokines and improved QoL in IBS‑D with less GI discomfort.

PubMed ID: 25450083

Fewer cirrhosis-related hospitalizations and complications imply improved clinical resilience in a vulnerable population.

PubMed ID: 24579075

Long-term Lactobacillus/Bifidobacterium reduced pouchitis frequency and fecal inflammation markers—resilience of pouch mucosa.

PubMed ID: 24424513

Prophylactic L. reuteri reduced colic crying and regurgitation and changed stooling in infants.

PubMed ID: 24947281

Perinatal probiotic reduced allergic sensitization and atopic eczema in children—relevant to immune-mediated sensitivities.

PubMed ID: 25444531

L. reuteri reduced crying/fussing in colic infants—reflects decreased abdominal discomfort.

PubMed ID: 24867512

Combination product reduced bloating and abdominal discomfort in IBS patients.

PubMed ID: 25442120

Colorectal cancer survivors had improved bowel symptoms and QoL after 12 weeks of probiotics.

PubMed ID: 23829297

RCT in IBS showed large global symptom relief, less pain and bloating—direct improvement in digestion.

PubMed ID: 24579474

Large RCT (BIFICO) reduced incidence of diarrhea in young children.

PubMed ID: 24382526

Reduced fecal calprotectin in CF children indicates reduced intestinal inflammation and greater resilience.

PubMed ID: 24734423

Neonatal probiotic significantly reduced C. difficile persistence and infectious/dyspeptic disorders during antibiotics.

PubMed ID: 23863210

Clear trial in infants with cow's milk allergy showing large reductions in constipation/diarrhea.

PubMed ID: 23567307

Probiotics (B. lactis BB-12 + S. thermophilus) plus standard care improved eczema severity in infants with cow's milk allergy.

PubMed ID: 24051968

In infants with stage‑2 NEC probiotic supplementation reduced progression to severe (stage‑3) NEC—major resilience effect.

PubMed ID: 24322191

Women eating B. lactis Bi-07 reported easier bowel movements and symptomatic constipation relief.

PubMed ID: 24311316

S. boulardii strongly prevented AAD and sped recovery in hospitalized children—clear evidence of enhanced digestive resilience to antibiotics/illness.

PubMed ID: 23660099

Probiotics with enteral nutrition reduced infections and GI dysfunction in severe pancreatitis, improving resilience during critical illness.

PubMed ID: 24044687

Large absolute reduction in AAD in a high‑risk inpatient group indicates strong resilience against antibiotic‑induced dysbiosis.

PubMed ID: 24028629

S. boulardii reduced clinical sepsis and feeding intolerance in VLBW infants—supports resilience to neonatal insults.

PubMed ID: 24229598

In rotavirus enteritis probiotics reduced stool frequency and secondary infection—improved short-term resilience to enteric infection.

PubMed ID: 24309022

Reduced proven sepsis and feeding intolerance in preterm infants indicates improved resilience of the gut/host in a vulnerable group.

PubMed ID: 23599642

B. longum BB536 modulated bowel movement frequency in elderly tube-fed patients (improved function when low baseline).

PubMed ID: 24291194

Dose-dependent reduction in antibiotic-associated diarrhea and lower C. difficile incidence — strong evidence of resilience against antibiotic insult.

PubMed ID: 24074303

RCT showed modest improvements in general GI health and diarrhea symptoms vs placebo.

PubMed ID: 23561636

RCT showed clear improvements in stool frequency/consistency and constipation symptoms, indicating better digestive function.

PubMed ID: 23480238

Randomized trials showed modest but significant improvements in composite digestive symptoms and subjective GI well-being.

PubMed ID: 24249817

Probiotic mix significantly reduced NEC in very preterm infants, reflecting improved gut resilience to severe insult.

PubMed ID: 23957734

Combination of mesalazine and L. casei greatly lowered symptomatic recurrence in diverticular disease, reducing abdominal symptoms (mesalazine confounds).

PubMed ID: 24246768

In cirrhosis patients, probiotics halved overt HE and reduced SIBO/ammonia — meaningful resilience of gut-liver axis.

PubMed ID: 22556209

VLBW infant trial reduced combined NEC-or-death — indicates increased GI resilience in a high-risk group.

PubMed ID: 23307089

IBS trial showed clear reductions in abdominal pain and days with pain — direct reduction in tummy discomfort.

PubMed ID: 22680836

Shorter diarrhoea duration and lower relapse in children demonstrates resilience to infectious GI insult.

PubMed ID: 17356555

Marked prevention of antibiotic‑associated diarrhoea demonstrates resilience of the gut to antibiotic insult after probiotic.

PubMed ID: 22441111

Increased postprandial intestinal blood flow in ELBW infants, a physiologic sign relevant to digestion/nutrient handling.

PubMed ID: 17653486

Improved regularity in frail elderly indicates increased baseline digestive stability/resilience.

PubMed ID: 17229242

LGG substantially increased pain‑free outcomes in children with functional abdominal pain/IBS — strong evidence for reducing tummy discomfort.

PubMed ID: 17591036

Perioperative probiotics markedly reduced post-surgical infectious complications—enhanced postoperative resilience.

PubMed ID: 17352022

VSL#3 greatly lessened radiation‑induced diarrhoea severity and frequency, showing high digestive resilience during insult.

PubMed ID: 17306006

S. boulardii significantly shortened paediatric diarrhoea duration and stools/day.

PubMed ID: 17669103

Reduced dyspepsia and therapy‑associated diarrhea during H. pylori treatment.

PubMed ID: 17604300

Prevention of antibiotic and C. difficile diarrhea in elderly inpatients indicates resilience against perturbation.

PubMed ID: 17517703

Lower H. pylori activity and fewer upper GI symptoms with B. bifidum product.

PubMed ID: 18492520

L. reuteri improved feeding tolerance, gastric emptying and reduced regurgitation in preterm infants.

PubMed ID: 17962710

LGG shortened duration of post-marathon GI symptom episodes (reduced short-term GI discomfort under stress).

PubMed ID: 17690340

Large RCT showed L. rhamnosus GG and a 4‑strain mix substantially shortened acute diarrhoea in children (direct improvement in digestive function).

PubMed ID: 17893165

BB536 stabilized gut microbiota during pollen season and correlated with symptom patterns—supports an allergy‑modulating role (seasonal allergy proxy).

PubMed ID: 17695792

L. reuteri markedly reduced H. pylori urease activity (likely reducing dyspeptic burden and improving digestion).

PubMed ID: 17919270

Multispecies probiotic produced significant, clinically meaningful reductions in IBS composite symptom score (direct digestive symptom improvement).

PubMed ID: 17287932

E. coli Nissle markedly shortened diarrhoea and normalized stool consistency in young children (strong clinically relevant digestive benefit).

PubMed ID: 17315077

B. lactis HN019 increased bifidobacteria and lactobacilli—microbiota changes plausibly support digestion.

PubMed ID: 17200238

L. reuteri markedly reduced crying time in breastfed colicky infants—strong clinical effect on tummy discomfort.

PubMed ID: 19070525

RCT in children shortened duration of rotavirus diarrhea and hospitalization — clinically meaningful digestive improvement.

PubMed ID: 18829790

Marked reduction in NEC or death in very low birth weight infants indicates greatly improved intestinal resilience in that vulnerable group.

PubMed ID: 18762327

Prenatal/infant L. rhamnosus halved cumulative eczema incidence by age 2 — strong evidence for reduced atopic outcome.

PubMed ID: 18716740

Synbiotic shortened rotaviral diarrhoea and shedding — improved ability to recover from enteric viral insult.

PubMed ID: 18565142

Bacterial lysate trial produced large reductions in abdominal pain and global IBS symptoms — clinically meaningful tummy discomfort relief.

PubMed ID: 18387426

Reduced abdominal pain in IBS trial (significant vs placebo) indicating less discomfort in subgroups.

PubMed ID: 18985817

B. lactis fermented milk improved stool frequency/consistency in constipation, reflecting better digestive function.

PubMed ID: 18240282

VSL#3 reduced pouchitis activity and increased regulatory T cells—improved mucosal resilience to inflammation.

PubMed ID: 18274900

L. acidophilus significantly reduced abdominal pain in IBS patients.

PubMed ID: 19114073

Preschool trial showed reductions in respiratory and GI infections for some strains—population-level resilience benefit.

PubMed ID: 18533353

Large crossover trial in functional constipation increased bowel movements and eased stools.

PubMed ID: 18806703

VSL#3 shortened diarrhea and reduced ORS needs in rotavirus—strong evidence of resilience to enteric insult.

PubMed ID: 18785988

8-week RCT showed clinically meaningful IBS symptom improvement—direct evidence of better digestion.

PubMed ID: 18801055

RCT in IBS‑C: reduced distension, faster transit and improved symptom severity — direct digestive benefit.

PubMed ID: 18410562

Prevention of antibiotic‑associated diarrhea in children implies greater resilience during antibiotic insult.

PubMed ID: 18671775

Improved small‑bowel permeability and IBS global score in diarrhoea‑predominant IBS.

PubMed ID: 18321302

L. reuteri reduced dyspeptic symptoms in H. pylori carriers, lowering upper abdominal discomfort.

PubMed ID: 18469732

E. coli Nissle significantly accelerated recovery and cure rates in infants/toddlers with prolonged diarrhea—strong resilience signal.

PubMed ID: 18256417

S. boulardii shortened diarrhea duration and normalized stools—clear resilience benefit in pediatric acute diarrhea.

PubMed ID: 18595465

Synbiotic after H.pylori therapy rapidly relieved indigestion and improved small‑intestine mucosa.

PubMed ID: 19651563

Marked reduction in infection incidence and duration in preschoolers shows improved resilience to common pathogens.

PubMed ID: 19631292

VSL#3 induced clinical response/remission in ulcerative colitis, improving intestinal function and symptoms.

PubMed ID: 19922649

B. coagulans produced significant reductions in abdominal pain and GSRS total score vs placebo.

PubMed ID: 19820590

Synbiotic reduced bloodstream infections and VAP and lowered inflammatory markers in severely injured patients — indicates improved gut/host resilience.

PubMed ID: 19381735

Probiotics after bypass reduced bacterial overgrowth and preserved B12, suggesting improved post‑surgical digestive resilience.

PubMed ID: 19840300

Maternal+infant probiotic mix substantially reduced eczema occurrence in high‑risk infants at 1 year.

PubMed ID: 19197823

E. coli probiotic improved IBS global symptoms and abdominal pain, a clear digestive benefit.

PubMed ID: 19298231

Lactobacillus F19 during weaning halved eczema risk at 13 months — strong preventive effect.

PubMed ID: 19747410

Fermented dairy with L. casei shortened duration of respiratory/GI infections in elderly (faster recovery/resilience).

PubMed ID: 19392993

Prenatal/postnatal multi‑strain probiotic reduced early eczema incidence in high‑risk infants (atopic outcome).

PubMed ID: 19236549

Large RCT: clear, large self‑reported improvements in digestive comfort/symptoms.

PubMed ID: 19332970

B. coagulans trial reported consistent reductions in abdominal pain and bloating.

PubMed ID: 20140275

B. coagulans reduced bowel movements in IBS-D, indicating symptomatic digestive improvement.

PubMed ID: 19622191

B. lactis fermented milk improved self-reported GI well‑being and symptoms in women.

PubMed ID: 19478257

S. boulardii added to metronidazole shortened diarrhoea and sped parasite clearance—evidence of aiding recovery from GI infection.

PubMed ID: 19594864

Probiotic dairy in allergic children reduced plasma IgE and increased Tregs and mucosal IgA — immunologic signal relevant to allergies.

PubMed ID: 20735858

Shorter diarrhoea, fever and vomiting in rotavirus infants indicates resilience to infectious insult.

PubMed ID: 20545688

Perinatal probiotics halved eczema incidence by age 2 (relevant to atopic outcomes), though sensitization was unchanged.

PubMed ID: 20135748

Shortened diarrhoea and restored beneficial flora in pediatric acute diarrhoea supports resilience.

PubMed ID: 20980486

Prevention of NEC in VLBW infants signifies strong protection against severe gut breakdown.

PubMed ID: 21078735

LGG reduced abdominal pain frequency and severity in children with recurrent abdominal pain/IBS.

PubMed ID: 20066735

Perioperative La1 colonization and reduction of Enterobacteriaceae indicate ability to resist pathogen overgrowth after perturbation.

PubMed ID: 20697291

Large RCT showed significant improvements in bowel movement frequency and stool consistency (direct clinical digestion endpoints).

PubMed ID: 20713478

L. reuteri significantly reduced daily crying time in colicky infants—strong evidence of reduced abdominal discomfort.

PubMed ID: 20444243

Probiotic reduced severity of radiotherapy-associated diarrhea and improved stool consistency (clinical digestion outcome).

PubMed ID: 21081959

Fermented infant formula reduced positive skin prick tests to cow's milk and fewer digestive allergy‑like events—direct reduction in food sensitivity markers.

PubMed ID: 20670468

Community trial reduced acute diarrhoea incidence in children—population‑level resilience improvement to enteric insults.

PubMed ID: 21114493

Infant RCT reduced regurgitation episodes and improved gastric emptying—direct digestive benefit.

PubMed ID: 21048484

Probiotic yogurt improved stool E. coli counts and GI-related symptoms in chronic liver disease patients (symptomatic digestive improvements).

PubMed ID: 21083585

Perioperative improvements in barrier function and fewer infections indicate increased resilience to surgical/insult-related GI complications.

PubMed ID: 20410904

Preterm infant trial reduced Candida colonization and sped feeding/shortened hospitalization—improves neonatal digestive resilience.

PubMed ID: 21118623

Pediatric RCT shortened diarrhoea duration and lowered stool number—clear digestive improvement.

PubMed ID: 20145608

Marked, dose-dependent reduction in antibiotic-associated diarrhea and C. difficile — robust resilience against antibiotic insult.

PubMed ID: 20391953

L. reuteri improved lactose-breath test results and symptoms in lactose intolerance — direct digestive benefit.

PubMed ID: 20616746

Symbiotic showed modestly faster clinical resolution of acute diarrhea vs comparator (some symptom endpoints favored it).

PubMed ID: 20413988

Early oral colonization with probiotic E. coli in infants of allergic mothers strongly lowered later allergy incidence — relevant to reduced sensitivities.

PubMed ID: 20350428

C. butyricum lowered pathogen colonization, diarrhea, and sepsis in preterm infants — improved physiological resilience of the gut.

PubMed ID: 20626584

L. reuteri significantly reduced abdominal pain intensity in children with functional abdominal pain — strong symptomatic benefit.

PubMed ID: 20207879

S. boulardii led to more children having normal stools sooner in acute pediatric diarrhea.

PubMed ID: 20517305

VSL#3 improved UC activity and rectal bleeding when added to therapy — enhances mucosal resilience in inflammatory disease.

PubMed ID: 20137007

Multi‑strain probiotic in dogs shortened diarrhea duration (~0.9 day), supporting resilience in an animal model.

PubMed ID: 20453678

VSL#3 improved global IBS symptoms and abdominal pain in children.

PubMed ID: 20517331

Probiotic‑enriched formula reduced feeding‑related GI side effects in infants.

PubMed ID: 20658369

Probiotic bowel prep improved tight junction protein (occludin) and IgA expression after colorectal surgery — resilience to surgical stress.

PubMed ID: 20922415

S. boulardii effective for symptomatic Blastocystis infection — direct GI clinical benefit.

PubMed ID: 20361072

Open symbiotic trial: large symptomatic improvement and rise in beneficial bacteria.

PubMed ID: 20542295

L. reuteri increased stool frequency in constipated infants (improves bowel function).

PubMed ID: 20931422

Probiotic yogurt reduced stomatitis and antibiotic-associated constipation—reduced GI side‑effects and related discomfort.

PubMed ID: 20697290

Microencapsulation preserved probiotic survival through the gut enabling effective colonization at lower doses (enhances resilience of supplementation).

PubMed ID: 20398311

Rectal E. coli Nissle enemas produced dose-dependent remission and faster time to remission in UC per-protocol (reduced GI symptoms).

PubMed ID: 20578532

Reduced breath hydrogen in lactose malabsorption indicates improved lactose digestion (physiological effect).

PubMed ID: 20506712

Early neonatal supplementation (live or killed) markedly lowered NEC and sepsis—strong evidence of increased gut resilience in neonates.

PubMed ID: 21186984

Kefir with triple therapy increased H. pylori eradication and reduced treatment side effects, lessening GI discomfort during therapy.

PubMed ID: 20849659

Multispecies probiotic altered IBS‑linked phylotypes and was associated with symptom improvement (less GI discomfort).

PubMed ID: 20436058

VSL#3 halved liquid-stool frequency and reduced stool burden in enterally fed patients (improves GI handling).

PubMed ID: 20236813

S. boulardii in infants sharply reduced diarrhea duration and improved weight recovery (clear digestion benefit).

PubMed ID: 21245887

In VLBW infants probiotic improved feeding tolerance (secondary digestion benefit).

PubMed ID: 21261786

In rotavirus diarrhea trial zinc +/- S. boulardii shortened diarrhea; probiotic contributed in combination arms (moderate benefit).

PubMed ID: 21369670

Lower C. difficile prevalence and reduced diarrhea/laxative use in elderly inpatients indicate improved resistance to nosocomial/GI insults.

PubMed ID: 21418261

B. bifidum RCT produced large symptom reductions and higher responder rate in IBS (direct digestion symptom improvement).

PubMed ID: 21663486

B. lactis HN019 shortened whole-gut transit time and reduced many GI symptoms (improves digestion/flow).

PubMed ID: 21552138

Substantial reduction in antibiotic-associated diarrhea indicates strong resilience against antibiotic insult.

PubMed ID: 21264685

Probiotic cheese decreased C. difficile counts in colonized elders (supporting resilience in colonized individuals).

PubMed ID: 22025880

B. longum yogurt improved stool frequency/consistency and abdominal pain in constipated children.

PubMed ID: 21801246

Infant L. reuteri linked to chemokine shifts associated with lower later allergy markers (biomarker evidence for fewer sensitivities).

PubMed ID: 21436726

Significant reduction in bloating and improved global relief in functional bowel disorder patients (less discomfort).

PubMed ID: 22230409

L. salivarius improved atopic dermatitis severity in adults — indicates reduction in atopic inflammation.

PubMed ID: 21593648

Infant formula with B. longum shifted microbiota toward breast‑fed‑like bifidobacteria profile.

PubMed ID: 21871144

Marked shortening of antibiotic‑associated diarrhoea demonstrates resilience to antibiotic insult.

PubMed ID: 21395626

Increased faecal lactobacilli/bifidobacteria and improved stool frequency/volume in adults.

PubMed ID: 22150569

Rectal L. reuteri produced large clinical and histologic improvement in distal UC—direct digestive benefit.

PubMed ID: 21814146

LGG enhanced VRE clearance and increased lactobacilli after antibiotic exposure—supports resilient recolonization.

PubMed ID: 21734600

S. boulardii shortened diarrhea duration in infants—direct improvement in digestive function.

PubMed ID: 21322768

L. casei Shirota significantly improved stool form and reduced hard/lumpy stools in healthy subjects (direct digestive benefit).

PubMed ID: 22981952

L. reuteri produced clear and clinically meaningful reductions in infant colic crying (abdominal discomfort proxy).

PubMed ID: 22710579

Lower recurrence of hepatic encephalopathy vs no therapy suggests improved gut–liver resilience in cirrhotics.

PubMed ID: 22157240

Randomized IBS trial showed large symptom relief and improved stool consistency.

PubMed ID: 23302558

Prevention of antibiotic‑associated diarrhea indicates resilience of the gut ecosystem during antibiotic exposure.

PubMed ID: 22937831

S. boulardii substantially reduced feeding intolerance in very low birth weight infants.

PubMed ID: 22197980

Perioperative probiotic reduced infections and improved barrier/immune markers, indicating greater resilience to surgical stress.

PubMed ID: 23071204

In very preterm infants L. reuteri showed trends to fewer pneumonias/NEC and less feeding intolerance in the smallest babies — resilience gains in subgroups.

PubMed ID: 23180952

Probiotics given with H. pylori therapy increased eradication rates and symptom relief — aids digestive therapy outcomes.

PubMed ID: 22931620

Perioperative probiotics restored beneficial flora and improved immune markers in colorectal surgery patients — supports resilience to insults.

PubMed ID: 22912552

Large RCT showed reductions in abdominal pain and pain frequency with L. plantarum 299v in IBS patients.

PubMed ID: 22738443

In neonates, probiotics reduced pathogenic oropharyngeal colonization and delayed VAP timing — demonstrates increased resistance to respiratory/gut-derived infection.

PubMed ID: 23239048

Multispecies synbiotic produced large, clinically meaningful reductions in diarrhea duration and hospital stay — strong evidence of increased digestive resilience.

PubMed ID: 22563194

LCR35 produced clinically relevant improvement in diarrhea‑predominant IBS subgroup, including reduced abdominal pain.

PubMed ID: 23023475

LGG shortened pediatric diarrhoea in relevant subgroups — supports resilience to acute enteric illness.

PubMed ID: 17635382

Constipation‑predominant IBS trial improved stool frequency and QoL discomfort, indicating better digestion.

PubMed ID: 18026577

Fermented milk reduced antibiotic‑associated diarrhoea in hospitalized patients.

PubMed ID: 22969230

Yogurt + B. lactis improved bowel satisfaction and overall IBS symptoms (product combined prebiotic but shows digestive benefit).

PubMed ID: 38653808

B. animalis reduced IBS symptom severity in IBS‑C patients (clinically meaningful digestive symptom benefit).

PubMed ID: 16185307

VSL#3 reduced flatulence and altered colonic transit in IBS with bloating, indicating digestive effects (mixed clinical responder impact).

PubMed ID: 35521810

Formulated yogurt increased several beneficial taxa (A. muciniphila, B. longum, F. prausnitzii) that commonly support digestive function.

PubMed ID: 39333245

RCT in IBS‑C showed marked symptom/QOL improvements (less pain, better bowel movements) — direct digestion benefit.

PubMed ID: 19038698

Rapid restoration of bifidobacteria and improvement in liver enzymes after probiotic treatment indicate enhanced recovery capacity.

PubMed ID: 24401715

Synbiotic produced sustained reductions in inflammation and fibrosis — suggests durable improvement in gut–liver resilience.

PubMed ID: 26302024

Short probiotic during alcoholic hepatitis reduced LPS, TNF‑α and E. coli counts — indicates improved resistance to endotoxin/inflammatory insults.

PubMed ID: 28506447

Pre‑transplant probiotic markedly cut postoperative infections and sped enzyme recovery — demonstrates resilience to severe clinical stress.

PubMed ID: 29931231

24‑week synbiotic produced large improvement in steatosis and enzymes — indicates improved gut–liver resilience to metabolic stress.

PubMed ID: 37161982

Adjunct probiotics + lactulose lowered ammonia and gut‑barrier markers and improved cognition in HE, indicating better gut function.

PubMed ID: 39234246

Probiotic adjunct protected gut microbiota and blunted inflammatory responses during antibiotic‑based H. pylori therapy.

PubMed ID: 38421902

MASLD synbiotics reduced steatosis/inflammation and sped transit while shifting the microbiome toward beneficial taxa — supports resilience.

PubMed ID: 41366779

Probiotic strains improved liver enzymes and altered gut microbiota in MASLD — supports improved gut–liver digestive axis.

PubMed ID: 39861457

W. coagulans trial in long-term drinkers improved liver/inflammation markers and beneficial microbiome changes suggesting better gut function.

PubMed ID: 15612887

Large symptom improvement in IBS patients (pain, bloating, bowel habits) — direct clinical evidence of better digestion.

PubMed ID: 17229535

Improved intestinal permeability in preterm infants supports mucosal resilience and reduced risk of translocation.

PubMed ID: 18584523

S. boulardii improved intestinal permeability in Crohn's remission—evidence of strengthened gut barrier/resilience.

PubMed ID: 21381407

Pilot RCT: multi-strain probiotic gave better short-term symptom relief for SIBO-related digestive symptoms vs metronidazole.

PubMed ID: 21853265

Synbiotic increased bifidobacteria/lactobacilli and stabilized community composition in older adults, indicating resilience.

PubMed ID: 24366547

Enteral micro‑organism containing formula reduced abdominal pain in radiation enteritis patients.

PubMed ID: 24501384

LGG reduced recurrent diarrheal episodes and improved gut barrier — strong evidence for improved resilience to enteric infection.

PubMed ID: 30574802

Early-life L. rhamnosus HN001 substantially reduced infant eczema risk, suggesting modulation of immune/allergic outcomes.

PubMed ID: 35202009

B. animalis with fiber improved bowel prep efficacy and reduced required PEG volume — indicates stronger bowel responsiveness under challenge.

PubMed ID: 36286741

Probiotic adjunct improved post-infectious IBS outcomes and microbiome markers, indicating recovery/resilience after insult.

PubMed ID: 40652782

B. breve RCT in healthy adults improved gastrointestinal symptom indexes (NDI/GIS).

PubMed ID: 39189588

Heat-treated probiotic markedly improved chronic diarrhea symptoms and changed metabolites (butyrate ↑).

PubMed ID: 27869661

Multistrain probiotic preserved gut barrier and lowered endotoxin in athletes under heavy training stress — strong evidence of resilience under challenge.

PubMed ID: 22324448

Synbiotic RCT shortened diarrhea duration and improved stool consistency—direct digestion benefit.

PubMed ID: 41208993

W. coagulans reduced allergic rhinitis symptom scores and eosinophils—immunomodulation relevant to sensitivities.

PubMed ID: 40826150

High‑dose Bacillus probiotic accelerated recovery from persistent diarrhea and decreased inflammatory cytokines and antibiotic days.

PubMed ID: 16167471

Synbiotic lowered late organ failure and overall SIRS/MOF in severe pancreatitis—indicates resilience to severe GI insult.

PubMed ID: 36815492

Heat‑killed L. plantarum given with oral immunotherapy increased specific IgG4 and modestly improved milk tolerance—direct effect on food allergy tolerance.

PubMed ID: 39683384

B. coagulans increased digestive enzyme activity (pepsin/trypsin/lipase) in athletes.

PubMed ID: 38860826

Probiotic markedly reduced intact fecal gluten during a controlled challenge and increased microbial richness—strong evidence of enhanced digestive resilience under challenge.

PubMed ID: 9706795

L. plantarum intake increased SCFAs and produced softer stools with less gas.

PubMed ID: 30716942

Synbiotic reduced gut‑derived toxins and increased butyrate in a frail population, reflecting improved functional resilience.

PubMed ID: 30145102

C. butyricum given during H. pylori eradication partially restored taxa and relieved GI symptoms—supports recovery/resilience after antibiotic perturbation.

PubMed ID: 31797399

BB‑12 produced a large, clinically meaningful reduction in infant colic crying and associated increases in butyrate and immune markers—strong evidence for reduced tummy discomfort.

PubMed ID: 34550055

BB‑12 reduced crying/fussing (colic) in infants—clinically less abdominal discomfort.

PubMed ID: 36003050

LGG improved atopic dermatitis severity and raised fecal butyrate with skin/gut microbiome shifts—supports reduced hypersensitivity.

PubMed ID: 35079761

RCT in chronic constipation improving stool frequency/consistency and SCFAs.

PubMed ID: 36717369

Large RCT in diarrhea‑predominant IBS showing marked symptomatic improvement (67.6% vs 36.6%).

PubMed ID: 35938351

6‑month probiotic diet in seniors increased beneficial taxa/SCFAs and reduced hs‑CRP, indicating more resilient gut ecology.

PubMed ID: 36678227

Probiotic restored microbial richness and SCFAs and reduced GI complications during chemotherapy—a strong resilience signal.

PubMed ID: 38931207

Symbiotic increased gut richness and SCFAs while lowering uremic toxins in dialysis patients—signals greater microbial resilience.

PubMed ID: 40575487

IBS RCT improved symptoms, increased SCFAs, improved tight junctions and lowered inflammation—strong evidence of improved gut resilience.

PubMed ID: 40366770

Short‑term B. animalis + inulin reliably raised SCFAs and bifidobacteria—mechanistic basis for resilience to perturbation.

PubMed ID: 40182598

6‑month fermented milk increased bifidobacteria and stool butyrate in elderly—favors digestive health.

PubMed ID: 41197269

W. coagulans improved allergic rhinitis symptoms and reduced IgE/Th2 cytokines—shows immunomodulation relevant to sensitivities.

PubMed ID: 14964345

Multicenter RCT in chronic diarrhea reduced stool frequency and improved symptoms.

PubMed ID: 22492764

Large pediatric RCT — L. reuteri lowered reported diarrhea incidence, indicating improved GI outcomes.

PubMed ID: 41387706

Synbiotic formula increased beneficial microbes and beneficial metabolites in toddlers, associated with improved bone and muscle outcomes — indicates enhanced gut‑host resilience.

PubMed ID: 37019193

Large RCT in chronic constipation showing increased SBMs/CSBMs and favorable microbiome/metabolome changes — direct evidence of improved digestive function.

PubMed ID: 40033155

Significant and sustained reduction in pain at defecation in constipated women — direct evidence of less abdominal/defecation discomfort.

PubMed ID: 19880141

EHCF+LGG markedly reduced fecal inflammation and bloody stools in infants with presumptive allergic colitis.

PubMed ID: 28043872

Large RCT: EHCF+LGG significantly reduced new allergic manifestations and accelerated cow's milk tolerance over 3 years.

PubMed ID: 35919499

Probiotics protected against antibiotic-associated diarrhea and restored beneficial flora—key resilience outcome.

PubMed ID: 37087638

Switching to EHCF+LGG markedly increased milk-tolerance rates at 12 months vs AAF.

PubMed ID: 41609355

RCT showed sustained reduction in reflux (RDQ) and fecal metabolite changes indicating improved gut function.

PubMed ID: 40431448

Probiotic+vitamin D lowered zonulin (improved permeability) and improved stool frequency/consistency.

PubMed ID: 16126047

Maternal/infant probiotic increased beneficial gut bacteria and antibody-secreting cells in infants (immune modulation that can reduce sensitization risk).

PubMed ID: 18221472

Maternal L. reuteri altered breast‑milk cytokines and low TGF‑β2 was associated with reduced infant sensitization over 2 years (association supporting lower sensitization risk).

PubMed ID: 18477013

Maternal probiotic during pregnancy/lactation reduced infant sensitization in high-risk subgroup (direct signal for reduced later food/atopic sensitization).

PubMed ID: 27801789

Perinatal probiotic linked to fewer infant colic and regurgitation episodes (clinically meaningful reduction in infant tummy discomfort).

PubMed ID: 17060763

Perioperative synbiotics increased beneficial bacteria/SCFAs and reduced infections/inflammation — indicates improved gut resilience to surgical stress.

PubMed ID: 21527594

Perioperative synbiotics preserved intestinal integrity and eliminated infectious complications after hepatectomy — supports resilience of the gut under major stress.

PubMed ID: 30521044

Improved clinical recovery and intestinal injury markers after antibiotic-associated diarrhea indicate better post-insult digestive recovery.

PubMed ID: 9042042

LGG improved eczema and lowered intestinal inflammation in infants with milk allergy.

PubMed ID: 15693914

LGG tended to raise faecal IgA and lowered some gut inflammation markers in infants with atopic eczema and suspected cow’s milk allergy — relevant to food-sensitivity modulation.

PubMed ID: 17900321

Fewer diarrhea-like stools during antibiotic use indicates protection of gut function.

PubMed ID: 20806430

Lactobacillus adjunct reduced colonic inflammatory mediators in UC (likely symptomatic benefit).

PubMed ID: 21525768

Year-long synbiotic improved colonoscopic scores and lowered inflammation in UC—likely less discomfort.

PubMed ID: 22093109

Infant synbiotics altered HBD2 trajectory and early innate markers associated with later allergy risk.

PubMed ID: 23235200

Perioperative probiotics reduced zonulin and postoperative infectious complications—strong resilience evidence.

PubMed ID: 23402179

Probiotic restored lactose digestion in ~71% of postinfectious IBS patients—direct evidence reducing a common food sensitivity.

PubMed ID: 23653934

Same randomized clinical evidence for normalization of lactose digestion and SIBO resolution.

PubMed ID: 24233772

Probiotic addition improved H. pylori eradication rates with standard therapy and helped maintain probiotic counts—supports resilience after perturbation.

PubMed ID: 25881090

Perioperative use lowered septicemia and gut/liver barrier dysfunction markers (clinically meaningful resilience).

PubMed ID: 26499352

RCT after gastric bypass showed overall GI quality-of-life improvements and multiple symptom reductions (gas, bloating, pain).

PubMed ID: 33545934

B. coagulans RCT in IBS significantly reduced abdominal pain and overall symptom severity.

PubMed ID: 10545590

LGG during antibiotics substantially lowered antibiotic‑associated diarrhoea in children.

PubMed ID: 17700424

LGG shortened duration of persistent diarrhea and hospital stay in children — direct improvement in digestive illness/resolution.

PubMed ID: 18813028

High‑dose LGG added to ORS shortened duration/frequency of acute watery diarrhea — strong digestion benefit.

PubMed ID: 19830558

Two weeks of probiotics before colonoscopy improved bowel cleansing and reduced GI symptoms in constipated patients.

PubMed ID: 31839091

L. rhamnosus + ORS significantly reduced stool frequency in children with acute watery diarrhea.

PubMed ID: 26689231

Medical students had fewer stress‑related abdominal symptoms with L. casei Shirota.

PubMed ID: 39665335

Synbiotic in infants with cow's milk allergy increased bifidobacteria and microbial metabolites linked to tolerance pathways—plausible benefit for food sensitivities (moderate evidence).

PubMed ID: 10811333

L. plantarum trial in IBS reduced flatulence days and improved GI function—direct digestive symptom benefit.

PubMed ID: 12134110

Live Lactobacillus+fiber markedly reduced postoperative infections compared with standard decontamination—supports resilience to infectious insults.

PubMed ID: 12764986

Early enteral probiotic lowered infected pancreatic complications in severe pancreatitis—resilience in critical illness.

PubMed ID: 15768732

Probiotic + soluble fiber markedly reduced diarrhea frequency and antidiarrheal use in HIV patients.

PubMed ID: 15636620

Large reduction in post-transplant infections and shorter antibiotic use indicates improved perioperative/ gut resilience.

PubMed ID: 17895895

L. rhamnosus GG during 5‑FU chemo lowered severe diarrhoea and abdominal symptoms.

PubMed ID: 17704024

Infant formula with probiotic/prebiotic shortened diarrhea duration (~0.8 days).

PubMed ID: 17592288

Early enteral synbiotics after surgery greatly reduced postoperative bacterial infections and shortened antibiotic use — indicates resilience.

PubMed ID: 17308252

Synbiotics reduced gut permeability and infections in severely injured patients — supports gut barrier resilience.

PubMed ID: 17523328

Synbiotics in severe pancreatitis reduced systemic inflammation and late organ failure events — improved resilience under stress.

PubMed ID: 21372765

L. paracasei F19 + fiber reduced bloating and long‑lasting abdominal pain in diverticular disease.

PubMed ID: 23139608

Symbiotic + fiber significantly reduced abdominal pain and bloating in symptomatic uncomplicated diverticular disease.

PubMed ID: 23165580

Synbiotic markedly shortened oro‑cecal transit time in slow‑transit women — direct digestion improvement.

PubMed ID: 24089227

Probiotic enteral nutrition reduced abdominal pain and distension incidence in antibiotic‑treated patients.

PubMed ID: 27543643

Fermented milk with probiotics+prebiotic raised complete bowel movements and eased constipation symptoms in PD patients.

PubMed ID: 27956826

Probiotic mix in PD patients reduced abdominal pain and markedly reduced bloating.

PubMed ID: 29069041

Fiber+probiotics in enteral feeds after gastrectomy dramatically reduced diarrhea incidence and improved bowel recovery.

PubMed ID: 29415828

Bacillus shortened antibiotic/EN‑associated diarrhea resolution, supporting resilience after antimicrobial insult.

PubMed ID: 28705786

Large RCT in constipated children showed marked increases in defecation frequency and symptom relief.

PubMed ID: 29954454

Improved epithelial barrier function and increased bifidobacteria in humans supports mucosal resilience.

PubMed ID: 34406877

Randomized synbiotic trial showed marked improvement in bowel symptoms and stool-related outcomes — strong direct evidence for improved digestion.

PubMed ID: 37078654

Large RCT of fiber+probiotic formulas increased stool frequency and softened stools, consistent with improved digestion.

PubMed ID: 37630717

Agave fructans improved constipation symptoms and QOL rapidly in IBS‑C.

PubMed ID: 39543201

Resistant starch type‑3 produced clinically relevant improvements in stool frequency/consistency.

PubMed ID: 40250086

Synbiotic preserved mucosal microbiota diversity and reduced histologic injury after radiotherapy—strong tissue‑level resilience evidence.

PubMed ID: 39356506

HN019 did not change bowel‑frequency but significantly reduced abdominal pain and bloating versus placebo.

PubMed ID: 41097163

Significant SCFA and microbiota changes consistent with a more resilient metabolic gut profile.

PubMed ID: 18685503

Direct RCT benefit in diarrhea‑predominant IBS: reduced bowel movements, pain and IBS scores.

PubMed ID: 39271904

In preterm infants, Bifidobacterium BB‑12 lowered inflammation and feeding intolerance—direct evidence of improved gut resilience in a vulnerable population.

PubMed ID: 26772193

Synbiotic reduced p‑cresyl sulfate and altered microbiome composition in CKD patients—evidence of improved gut functional resilience.

PubMed ID: 33878556

Small symptomatic benefit for constipation and preserved antioxidant enzymes suggests reduced GI discomfort for some participants.

PubMed ID: 21296446

Clear increases in administered probiotic strains in feces suggest ability to re-establish/maintain beneficial microbes (resilience-relevant).

PubMed ID: 16983476

Synbiotic reduced infections, sepsis and death in critically ill trauma patients — implies improved host/microbiome resilience to severe stressors.

PubMed ID: 20522788

L. rhamnosus GG lowered VAP and C. difficile rates in ventilated ICU patients—improves resilience to nosocomial/antibiotic-associated infections.

PubMed ID: 24043284

Synbiotic markedly reduced nosocomial sepsis, NEC and death in cyanotic infants — indicates improved resilience to nosocomial/invasive gut insults.

PubMed ID: 25455039

Symbiotic gel reduced prevalence and monthly episodes of vomiting, heartburn and stomachache in hemodialysis patients.

PubMed ID: 25596096

VLBW infant trial showed large reductions in NEC and sepsis and faster feeding — strong evidence of enhanced intestinal resilience.

PubMed ID: 19114073

Large preschool RCT showed strain-specific reductions in respiratory and gastrointestinal infections—strong immune-protection signal.

PubMed ID: 35299968

Probiotic in youth with T1D lowered multiple inflammatory markers and increased beneficial taxa, indicating improved immune/metabolic defense profile.

PubMed ID: 17393330

B. longum + FOS lowered ammonia and improved cognitive tests in MHE; clinical improvements indicate beneficial systemic effects.

PubMed ID: 24401715

Synbiotic lowered hs‑CRP and TNF‑α and improved fibrosis — clear anti‑inflammatory/host‑defense benefit.

PubMed ID: 26302024

Seven‑day probiotic in alcoholic hepatitis lowered TNF‑α, LPS and stool E. coli — reduced endotoxin/inflammation supports stronger defenses.

PubMed ID: 28506447

Pre‑transplant probiotic drastically reduced 30/90‑day postoperative infections — strong clinical evidence of improved host defenses.

PubMed ID: 29557414

Multi‑strain probiotic lowered proinflammatory cytokines (TNF‑α, IL‑6) — supports improved immune status.

PubMed ID: 39234246

Probiotic adjunct blunted inflammatory rises and helped preserve beneficial gut microbes during antibiotic treatment.

PubMed ID: 38421902

MASLD synbiotics reduced hs-CRP and beneficially shifted microbiome — indicates lowered systemic inflammation and improved host defense balance.

PubMed ID: 39861457

W. coagulans improved inflammatory markers (hs-CRP, TNF-α, IL-6) and increased beneficial taxa in long-term drinkers — supports immune benefit.

PubMed ID: 40527514

Probiotic maintained beneficial genera and increased SCFAs in alcohol consumers—markers of mucosal/immune support.

PubMed ID: 21853265

Synbiotic increased endogenous bifidobacteria and lactobacilli in elderly NSAID users—enhanced beneficial flora linked to resilience.

PubMed ID: 24501384

LGG raised rotavirus‑specific IgG and reduced recurrent diarrheal episodes — clear immune benefit in children.

PubMed ID: 30071871

Heat‑killed Lactococcus increased plasmacytoid dendritic cell activation (CD86) and reduced URTI days in athletes — clear immune enhancement.

PubMed ID: 35343796

Adjunctive B. lactis Probio‑M8 lowered IL‑6 and TMAO and improved patient scores in CAD — consistent with reduced systemic inflammation/immune modulation.

PubMed ID: 27869661

Multistrain probiotic lowered resting endotoxin and helped preserve gut barrier under training stress, reducing systemic inflammation risk.

PubMed ID: 41208993

W. coagulans improved rhinitis symptoms, reduced eosinophils and modulated immune markers—clear immune benefit.

PubMed ID: 22367073

Animal study showed probiotics increased immune‑organ respiration and antibody responses—enhanced immunity in model.

PubMed ID: 40826150

High‑dose Bacillus spore probiotic in infants with persistent diarrhea shortened recovery and lowered pro‑inflammatory cytokines, indicating immune benefit.

PubMed ID: 16167471

Synbiotic reduced SIRS/MOF and late organ failure in severe pancreatitis—strong immunoprotective signal.

PubMed ID: 34959898

β‑glucan + yeast product in elderly raised selenium/zinc and trended toward higher vaccine responses and T-cell measures (multi‑ingredient but immune‑relevant).

PubMed ID: 27225729

Yogurt with polysaccharide + probiotics increased NK cell activity and IL‑12/IFN‑γ in humans—direct immune enhancement.

PubMed ID: 23957631

Synbiotic lowered TNF‑α and increased beneficial taxa in older adults—indicative of immune modulation toward health.

PubMed ID: 31797399

BB‑12 in infant colic increased fecal innate immune markers (HBD‑2, LL‑37, sIgA) alongside clinical improvement.

PubMed ID: 34550055

BB‑12 reduced infant colic and improved fecal immune biomarkers—direct immunological benefit in infants.

PubMed ID: 36359816

Synbiotic in SLE reduced IL‑6 and prevented hs‑CRP rise while improving disease activity—clear immune modulation.

PubMed ID: 35938351

Probiotic diet in seniors lowered hs‑CRP and increased beneficial taxa, consistent with improved immune status.

PubMed ID: 38631185

Synbiotic increased IL‑10 and SCFAs in dyslipidemic men—anti‑inflammatory immune shift.

PubMed ID: 38957464

Strain reduced URTI symptoms, raised salivary s‑IgA, maintained NK cell activity and increased fecal butyrate—strong immune signal.

PubMed ID: 41197269

W. coagulans improved rhinitis symptoms, shifted cytokines (↑IFN‑γ/↓IL‑4) and increased SCFAs—robust immunomodulatory effects.

PubMed ID: 29741754

L. rhamnosus GG in nursing‑home residents showed fewer lab‑confirmed respiratory infections (clinically meaningful reduction though not statistically definitive).

PubMed ID: 41387706

Synbiotic young‑child formula increased L. reuteri/Bifidobacteria and improved musculoskeletal outcomes — consistent with better microbiome‑mediated host resilience.

PubMed ID: 36752775

Co-supplementation reduced inflammatory markers and LPS, indicating immune and endotoxemia improvements.

PubMed ID: 28043872

EHCF+LGG reduced new allergic diseases, reflecting durable immune/defense modulation.

PubMed ID: 40871692

Multi-strain probiotic altered cytokine networks in children with ASD, showing notable immune effects.

PubMed ID: 41313018

Probio-M8 adjunct changed inflammatory cytokines (IFN-γ, IL-4/IL-10) and improved symptoms in knee OA patients.

PubMed ID: 16126047

Maternal/infant probiotic supplementation increased fecal bifidobacteria and infant antibody‑secreting cells at 3–12 months (clear immunomodulatory effect).

PubMed ID: 25836922

Perinatal VSL#3 raised lactobacilli and bifidobacteria in maternal milk (supports transfer of beneficial microbes and passive immune support).

PubMed ID: 17060763

Perioperative synbiotics substantially reduced postoperative infectious complications and lowered IL-6 — strong clinical evidence of immune/defensive benefit.

PubMed ID: 21527594

Perioperative synbiotics preserved intestinal integrity and eliminated postoperative infectious complications in liver surgery patients — strong clinical protective effect.

PubMed ID: 30521044

Adding zinc to probiotic improved recovery from antibiotic-associated diarrhea and intestinal injury markers — supports resilience of host defenses at the gut.

PubMed ID: 35974020

Improved antioxidant and inflammatory markers after probiotic yogurt suggest enhanced systemic defenses (biomarker evidence).

PubMed ID: 31516055

Probiotic+cranberry product halved recurrent UTIs over 26 weeks — meaningful reduction in infectious events (multi-ingredient study).

PubMed ID: 37374369

D-mannose+S. boulardii reduced post-cystoscopy UTIs and urinary symptoms; S. boulardii (probiotic yeast) contributed to reduced infection risk (pilot trial).

PubMed ID: 15693914

LGG increased faecal IgA and reduced gut inflammatory markers in allergic infants — supports mucosal immune defense.

PubMed ID: 21426607

Fermented formula raised mucosal sIgA and lowered calprotectin in preterm infants (meaningful immune benefit).

PubMed ID: 23235200

Perioperative probiotics reduced infections and zonulin—clinically important immune/barrier effects.

PubMed ID: 24233772

Adding L. acidophilus + B. bifidum to H. pylori therapy improved eradication and stabilized probiotic counts after antibiotics—supports immune/colonization resilience.

PubMed ID: 25881090

Perioperative probiotics lowered septicemia and endotoxin/zonulin—strong evidence of enhanced host defenses.

PubMed ID: 30694099

L. plantarum in young children increased faecal sIgA and TGF-β1, indicating enhanced mucosal immunity.

PubMed ID: 33671071

B. subtilis DE111 altered peripheral T‑cell subsets and increased detectable Bacillus DNA and fecal acetate—immune modulation evidence.

PubMed ID: 21566549

Nutraceutical including probiotics improved wart remission (immune‑related outcome), but many co‑ingredients confound attribution.

PubMed ID: 17700424

LGG shortened persistent diarrhea duration and hospitalization in children — strong clinical evidence of protection.

PubMed ID: 19690413

Milk with L. rhamnosus reduced dental caries and slightly fewer otitis media days — suggests augmentation of mucosal defenses in children.

PubMed ID: 18813028

LGG reduced duration/frequency of acute watery diarrhea and shortened hospital stay — supports enhanced host defense against GI infections.

PubMed ID: 37724527

Probiotic/prebiotic in septic AKI was associated with lower mortality and larger urea decreases (secondary signal).

PubMed ID: 12134110

RCT in liver transplant patients: enteral live L. plantarum+fiber markedly lowered postoperative infection rates.

PubMed ID: 12436353

Enteral live L. plantarum + fiber markedly reduced postoperative infections in large randomized trial.

PubMed ID: 12764986

Early enteral L. plantarum + oat fiber dramatically reduced infected pancreatic necrosis vs heat‑killed control.

PubMed ID: 15447816

Synbiotic lowered plasma endotoxin and some inflammatory markers after severe burns (small RCT).

PubMed ID: 15636620

Dramatic reduction in early post-transplant bacterial infections with probiotic/LAB regimen—strong immune/protective effect.

PubMed ID: 17592288

Synbiotic early enteral nutrition after pancreatoduodenectomy markedly reduced postoperative bacterial infections and antibiotic use.

PubMed ID: 17308252

Synbiotics in severely injured patients reduced infections (including pneumonia) and improved gut permeability — strong clinical immune benefit.

PubMed ID: 17523328

Synbiotics in severe pancreatitis reduced systemic inflammation and late organ dysfunction (fewer SIRS/MOF events).

PubMed ID: 24089227

Probiotic‑containing enteral nutrition increased cellular immune markers (CD4+, NK) and reduced GI symptoms in antibiotic‑treated patients.

PubMed ID: 27927601

Probiotics improved inflammatory markers (hsCRP) and oxidative stress in diabetic hemodialysis patients — supports enhanced host defenses.

PubMed ID: 29415828

Sporulated Bacillus shortened diarrhea resolution time in hospitalized patients on antibiotics/EN, supporting host defense.

PubMed ID: 35162195

Multi‑nutrient support including a short probiotic course was associated with markedly higher survival and less ventilation in hospitalized COVID‑19 — strong clinical immune signal though multi‑component.

PubMed ID: 36569851

Synbiotic produced small increases in immune recovery markers (CD4/CD8) and decreased microbial translocation marker sCD14.

PubMed ID: 40250086

Preoperative synbiotic preserved mucosal diversity and reduced histologic injury after radiotherapy.

PubMed ID: 22648843

Microbiota‑targeted enteral formula improved immune markers and shortened hospital stay in gut‑cancer patients — probiotics were a component of the immune benefit.

PubMed ID: 24795503

VSL#3 reduced hs‑CRP and improved metabolic markers; anti‑inflammatory effects support immune health.

PubMed ID: 25070447

Enteral formula containing probiotics reduced postoperative infections and improved immune cell counts — direct evidence of enhanced host defenses.

PubMed ID: 40008414

L. plantarum RCT upregulated immune‑related gene expression (NK/IL‑10 signatures) — direct immune enhancement evidence.

PubMed ID: 31426299

Probiotic maintained peripheral T‑cell subset stability in children at risk for celiac autoimmunity — immune modulation compatible with stronger defenses.

PubMed ID: 39271904

Preterm infant RCT lowered systemic inflammatory markers (TLR4, NF‑κB, IL‑1β) and feeding intolerance — clear immune/defense improvements.

PubMed ID: 19344357

Synbiotic increased TAS and improved glutathione redox ratio in H. pylori patients — enhanced systemic antioxidant defense.

PubMed ID: 22129852

Probiotic yogurt in T2D improved fasting glucose and antioxidant measures — supports metabolic and oxidative‑stress defenses.

PubMed ID: 23786900

Synbiotic in diabetics lowered hs‑CRP and raised glutathione, indicating reduced inflammation and enhanced systemic defense/antioxidant capacity.

PubMed ID: 23899653

Multispecies probiotic in diabetics prevented FPG rise and markedly reduced inflammation while increasing glutathione — supports immune/metabolic resilience.

PubMed ID: 28008750

Probiotic plus diet increased GPx activity relative to diet alone—supports antioxidant/defense improvement.

PubMed ID: 30057015

Probiotic + selenium reduced hs-CRP and improved metabolic markers in diabetics—reduced inflammation suggests stronger defenses (but confounded by selenium).

PubMed ID: 28786012

Synbiotic in GDM lowered inflammation and was associated with fewer cesareans and neonatal complications — clinical benefit linked to host defense.

PubMed ID: 30560426

Synbiotic in diabetic hemodialysis markedly reduced hs‑CRP and raised antioxidant capacity — supports better host defense/anti‑inflammatory state.

PubMed ID: 33409919

Probiotic + selenium increased total antioxidant capacity and lowered fasting glucose in schizophrenia—antioxidant/defense benefit (co-supplement confounder).

PubMed ID: 33878556

Attenuation of declines in antioxidant enzymes (GPx, GST) suggests preserved oxidative defenses.

PubMed ID: 35685534

Probiotic reduced hs-CRP and improved antioxidant markers in methadone-treated patients—evidence for reduced inflammation/strengthened defenses.

PubMed ID: 39223205

Synbiotic yogurt raised GPx and lowered total oxidative status in metabolic-syndrome adults—clear antioxidant/defense benefit.

PubMed ID: 16983476

Large RCT in critically ill trauma patients showed major reductions in infections, sepsis and mortality with synbiotic treatment — strong immune/defense signal.

PubMed ID: 20522788

ICU RCT: L. rhamnosus GG significantly reduced VAP and C. difficile rates and antibiotic days—strong immune/prophylactic effect.

PubMed ID: 24043284

Synbiotic in cyanotic infants sharply reduced nosocomial sepsis, NEC and mortality — strong evidence of enhanced host defenses/clinical protection.

PubMed ID: 25596096

B. lactis (± inulin) in VLBW infants greatly lowered NEC and nosocomial sepsis and improved survival—robust defensive effect.

PubMed ID: 29079990

Synbiotic lowered hs‑CRP and oxidative stress and increased NO — markers consistent with modulated host defense/inflammation.

PubMed ID: 34224785

Synbiotic formula reduced infant hospitalizations for infections — clinical evidence of improved resistance to infection.

PubMed ID: 35995418

Reduced LPS and hs-CRP in CKD imply reduced endotoxin burden and systemic inflammation, supporting defenses.

PubMed ID: 38662232

Perioperative synbiotics increased tumor-infiltrating CD8+ cells and IFN-γ and reduced inflammatory cytokines and complications—strong immune enhancement.

PubMed ID: 41126787

Probiotic in Parkinson's reduced systemic cytokines (TNF‑α, IL‑6) and altered microbiota — immunomodulatory effect.

PubMed ID: 18685511

Long‑term synbiotic intake reduced incidence, duration and severity of respiratory infections in adults.

PubMed ID: 19809023

bovine lactoferrin ± LGG produced very large, statistically significant reductions in late‑onset sepsis in VLBW neonates.

PubMed ID: 22184648

Same multicenter dataset showed marked reductions in invasive fungal infections and progression from colonization.

PubMed ID: 24709463

Large RCT showed strong reductions in NEC and death/NEC with bLF ± LGG — major neonatal immune/defense benefit.

PubMed ID: 30565745

Oral Lactobacillus blend+ lactoferrin as adjunct markedly reduced recurrent vulvovaginal candidiasis—improved mucosal defense.

PubMed ID: 31418411

Probiotics plus pentasa in IBD lowered inflammatory markers and altered microbiota—supports immune benefits.

PubMed ID: 38999876

L. plantarum combination reduced hs‑CRP/IL‑6 and increased SCFAs — supports enhanced anti‑inflammatory/defense profile.

PubMed ID: 16035374

Large RCT (multivitamin+probiotic) reduced fever days and increased T‑lymphocyte counts—robust immune signal.

PubMed ID: 24628464

L. GG reduced blood endotoxin and TNF‑α in cirrhosis, implying reduced systemic inflammation and improved barrier/defense.

PubMed ID: 24760382

Probiotic supplementation in HIV‑infected children was associated with higher CD4 counts — direct immune benefit signal.

PubMed ID: 35357105

L. casei reduced inflammatory cytokines in TB patients, demonstrating immune modulation.

PubMed ID: 40488914

L. reuteri reduced antibiotic‑associated diarrhea incidence — supports resilience after antibiotic insults.

PubMed ID: 15629974

L. reuteri formula markedly reduced febrile and diarrhoeal episodes and healthcare use in infants.

PubMed ID: 18595980

Large newborn RCT: synbiotic reduced respiratory infections and antibiotic prescriptions (meaningful immune/defense effect).

PubMed ID: 18996881

B‑GOS in elderly increased bifidobacteria and NK activity and reduced proinflammatory cytokines (immune enhancement).

PubMed ID: 18492839

Early prebiotic feeding reduced infections over two years (immune modulation supporting defenses).

PubMed ID: 19231042

Prebiotic infant formula lowered gastroenteritis episodes and antibiotic courses — supports stronger intestinal defenses in infants.

PubMed ID: 20730056

Large community RCT: prebiotic+B. lactis reduced dysentery, pneumonia/ALRI and antibiotic use — clear enhancement of resistance to infection.

PubMed ID: 20735782

Synbiotic reduced tissue inflammation and raised mucosal bifidobacteria in Crohn's — supports mucosal immune modulation.

PubMed ID: 20619394

Perioperative synbiotic greatly reduced postoperative infectious complications after liver transplant (strong clinical protection).

PubMed ID: 20729255

Three‑month synbiotic in children reduced incidence of common winter infections and school absence (reduced infections = stronger defenses).

PubMed ID: 22503510

Shorter SIRS duration and fewer abdominal complications post-esophagectomy with perioperative synbiotics — improved host response.

PubMed ID: 22576712

Marked reduction of pathogenic Gram-negative rods and increased beneficial bacteria in long-term tube-fed patients — supports host defense.

PubMed ID: 24131826

Large RCT in preterm infants showed markedly fewer viral RTIs (especially rhinovirus) with prebiotics and some probiotic benefit.

PubMed ID: 23788632

Randomized trial showed increased breastmilk IgA and TGF-β2 and fewer infant diarrhea cases—strong immune/protection evidence.

PubMed ID: 25331262

L. salivarius (±FOS) reduced inflammatory markers and increased beneficial gut bacteria in healthy adults—immune-supportive effects.

PubMed ID: 24402842

Perioperative synbiotics reduced bacterial translocation, bacteraemia and postoperative inflammation—clear protective effect around surgery.

PubMed ID: 25754214

Preterm infant trial halved NEC incidence—substantial enhancement of neonatal intestinal defense.

PubMed ID: 26153197

Synbiotics lowered systemic inflammatory markers (hs-CRP, IL-6, TNF-α) in T2D—indicates modulation of host immune/inflammatory state.

PubMed ID: 25803626

Double-blind RCT in surgical patients produced large reductions in postoperative infections, complications, antibiotic use and mortality—major immune/clinical defense benefit.

PubMed ID: 25575262

Perioperative synbiotics markedly reduced postoperative infections and antibiotic use after Frey's procedure (clinically meaningful immune/defense benefit).

PubMed ID: 26644166

Synbiotics during chemotherapy reduced febrile neutropenia and severe lymphopenia—reduced serious infectious complications.

PubMed ID: 29168358

Multistrain probiotic markedly lowered NEC, sepsis-related deaths and overall mortality in very preterm infants—strong protective effect.

PubMed ID: 28813414

Large RCT in rural newborns showed ~40% relative reduction in neonatal sepsis/death with synbiotic—strong evidence for enhanced defenses.

PubMed ID: 29155807

Synbiotic formula in infants with suspected CMA was associated with fewer systemic anti‑infective prescriptions (fewer infections treated).

PubMed ID: 29267553

Perioperative synbiotics produced large, statistically significant reductions in surgical‑site and postoperative infections—direct immune/defense benefit.

PubMed ID: 30261905

Substantial reductions in enteritis and ventilator‑associated pneumonia in sepsis patients—strong protection against infections.

PubMed ID: 30278428

Preoperative synbiotic reduced inflammatory markers and infectious complications and shortened hospital stay—supports stronger defenses.

PubMed ID: 31618905

Increased Tregs and dendritic‑cell activation markers indicate immunomodulation that could strengthen host defenses.

PubMed ID: 30617950

Hemodialysis patients had significant reductions in systemic inflammation (hs-CRP, IL-6) and endotoxin with synbiotic vs placebo.

PubMed ID: 33032474

Prevented and reduced severity of antibiotic-associated diarrhea—direct protective effect after antibiotic insult.

PubMed ID: 34462956

ICU trial reduced serum endotoxin and NLR, biomarkers of reduced systemic inflammatory burden/insult response.

PubMed ID: 33404812

Synbiotic reduced TNF-α and hs-CRP and increased adiponectin, indicating anti-inflammatory/immune modulation.

PubMed ID: 34775221

Large trial showed dramatic reductions in bacteremia and MLN bacterial translocation during chemo—strong immune/protective effect.

PubMed ID: 35947039

Modulated IL-17/IL-23 immune pathway in axial spondyloarthritis, showing immune effects though clinical disease activity unchanged.

PubMed ID: 37675747

In nephrotic syndrome adjuvant pre/probiotic increased T-regs and reduced relapses (immunologic and clinical benefit).

PubMed ID: 36409223

Increased regulatory T-cell proportion and Treg-related gene expression imply stronger immune regulation.

PubMed ID: 35583161

Perioperative synbiotic halved early postoperative infections, especially bloodstream infections—robust clinical immune protection.

PubMed ID: 35413573

Lower grade 4 neutropenia and less diarrhea during chemo vs prophylactic antibiotics (supports immune/clinical defense).

PubMed ID: 37614109

In healthy adults synbiotic increased fecal sIgA and lowered inflammatory markers (mucosal defense enhancement).

PubMed ID: 36602047

IL‑6 reduction and some lab improvements in hospitalized COVID‑19 patients (immunomodulatory effect).

PubMed ID: 36803508

Synbiotic formula reduced Klebsiella and resistome signals (reduced potential pathogens/resistance).

PubMed ID: 36904156

Reduced URTI incidence, increased salivary SIgA and improved recovery in athletes (direct immune benefit).

PubMed ID: 37037266

Zero severe aGVHD in synbiotic arm with increased Tregs in a pilot transplant trial (strong immune signal though small sample).

PubMed ID: 38462218

Lower LRTI incidence and higher fecal sIgA in infants fed synbiotic formula (reduced infections and mucosal immunity).

PubMed ID: 39287261

Large reduction in NEC and feeding intolerance in VLBW infants (major clinical defense benefit).

PubMed ID: 38794741

Large IBS symptomatic improvement likely reflects restoration/ resilience of gut ecosystem and defenses.

PubMed ID: 39705908

Probiotic shifted Th1→Th2, altered cytokines and increased clinical pregnancy rates—clear immune modulation.

PubMed ID: 39275204

Lowered NLR and improved lymphocyte counts indicate improved immune balance during chemo.

PubMed ID: 39437223

SLE trial reduced IL‑17A and lowered disease activity—meaningful immune modulation.

PubMed ID: 40783570

Vaginal L. crispatus colonization converted dysbiotic states and reduced pathogens—direct mucosal defense enhancement.

PubMed ID: 39915586

Infant formula increased beneficial bifidobacteria and restored Bacteroidota in C‑section infants—supports early immune development.

PubMed ID: 40389723

Mouthwash reduced oral mucositis severity during RT—improved local mucosal defense/resilience.

PubMed ID: 10967260

Strain-specific modulation of responses to oral typhoid vaccine (CR3/neutrophil changes)—evidence of immunomodulation.

PubMed ID: 10930365

VSL#3 increased fecal probiotic concentrations and prevented pouchitis relapses—supports mucosal defenses in that setting.

PubMed ID: 11114680

B. lactis increased neutrophil phagocytosis and NK activity in older adults—strong innate-immunity evidence.

PubMed ID: 11241043

Prophylactic LGG greatly reduced nosocomial diarrhea and rotavirus gastroenteritis in infants—strong preventive/defensive effect.

PubMed ID: 11722966

B. lactis HN019 raised several cellular immune markers and phagocytic/NK activities in elderly.

PubMed ID: 11387176

Probiotic milk slightly reduced days missed, respiratory complications and antibiotic use in daycare kids, suggesting modest immune support.

PubMed ID: 11349938

L. rhamnosus HN001 significantly increased PMN phagocytosis and NK cell activity in older adults—direct cellular immunity enhancement.

PubMed ID: 11799376

Maternal probiotics raised breast milk TGF-β2 and reduced infant eczema, indicating immune-modulating effects with protective outcomes.

PubMed ID: 12214543

Live lactobacilli in fermented milk reduced number and severity of respiratory infections in children, consistent with immune benefit.

PubMed ID: 11896937

E. coli Nissle colonization increased cellular proliferation and specific IgA/IgM in preterm infants — immunologic activation.

PubMed ID: 12236051

Enterococcus faecalis immunostimulant roughly halved acute sinusitis relapses and delayed first relapse — clear enhancement of host defenses.

PubMed ID: 12540416

Daily probiotic reduced nasal carriage of potentially pathogenic bacteria — could lower infection risk.

PubMed ID: 14505546

Bifidobacterium reduced UC relapses and lowered NF-kappaB activity — suggests anti-inflammatory/defensive modulation.

PubMed ID: 12679825

L. casei intake modestly shortened infection duration and reduced peak fevers in older adults — indicates enhanced host response to infection.

PubMed ID: 14749232

Infant probiotic formulas were associated with lower antibiotic use, implying fewer or milder infections.

PubMed ID: 15722985

Polybacterial lysate reduced diverticulitis symptoms and proposed IgA-mediated mucosal defense mechanism, indicating immune stimulation.

PubMed ID: 15578195

Probiotics around polio booster markedly increased neutralizing antibodies and specific IgG/IgA—clear immune enhancement.

PubMed ID: 15133865

BIFICO reduced relapse and decreased NF-kappaB activity—implies anti-inflammatory/host-defense modulation.

PubMed ID: 15316583

Fermented milk raised monocyte oxidative-burst capacity, indicating innate immune boosting.

PubMed ID: 15457926

L. casei fermented milk increased monocyte oxidative burst and NK activity—functional innate immune enhancement.

PubMed ID: 15815206

Probiotic-supplemented formula halved antibiotic-associated diarrhea in infants—protective effect.

PubMed ID: 15629973

NEC reduction in VLBW infants likely reflects improved host-microbe defense and resilience.

PubMed ID: 16054520

Large RCT showed shorter common cold duration and fewer fever days with probiotic tablets—clinical defense benefit.

PubMed ID: 15740542

S. boulardii strongly reduced antibiotic-associated diarrhea including C. difficile cases—prevention of pathogen-driven disease.

PubMed ID: 15829425

Probiotics limited antibiotic-driven facultative anaerobe overgrowth—supports microbial defenses.

PubMed ID: 16292090

S. boulardii lowered antibiotic‑associated diarrhea incidence, supporting protection of gut function during antibiotic stress.

PubMed ID: 16274475

Large RCT showed marked reductions in proportion reporting sick and sick‑days, consistent with improved host defense.

PubMed ID: 16080364

One-year E. faecium + selenium altered leukocyte adhesion molecules (immunomodulatory changes).

PubMed ID: 16925686

Perinatal probiotic exposure increased proportion of infants reaching protective Hib antibody levels at 6 months (enhanced vaccine response).

PubMed ID: 16844267

Large RCT: long-term probiotic intake shortened common cold duration and reduced symptom severity with T-cell increases.

PubMed ID: 16685066

Marked reductions in aflatoxin biomarkers suggest a protective effect against toxin-mediated harm to host defenses.

PubMed ID: 16697231

Oral lactobacilli given with metronidazole markedly improved bacterial vaginosis cure and restored protective lactobacilli (strong defense restoration).

PubMed ID: 16864708

Probiotic feeding increased antigen-specific IgA and sCD14 in infants — markers of immune maturation.

PubMed ID: 17014429

Infant cytokine changes (IL-5, TGF-beta, IL-10 shifts) reflect immunomodulatory effects.

PubMed ID: 16913215

Actimel reduced incidence/duration of some respiratory infections in children (clinical immunoprotective signal).

PubMed ID: 16705580

L. rhamnosus markedly reduced gut Candida colonization in VLBW infants (reduced fungal colonization = defense benefit).

PubMed ID: 16508257

Yogurt consumption boosted cellular immune markers in young women, though probiotic not superior to conventional yogurt.

PubMed ID: 16572062

S. boulardii prophylaxis reduced antibiotic‑associated diarrhoea — mitigates loss of colonization resistance during antibiotics.

PubMed ID: 16971641

Bb12 lowered enterobacteria/clostridia and increased bifidobacteria in preterm infants—reducing potential pathogen load supports host defenses.

PubMed ID: 17443852

Synbiotics reduced bacterial translocation during colectomy, suggesting preserved barrier function/defense.

PubMed ID: 18086218

Enhanced vaccine antibody responses and fewer antibiotic prescriptions suggest immune support in infants.

PubMed ID: 17878180

Modest increase in CD4 counts in HIV‑infected children suggests enhanced immune status.

PubMed ID: 17591036

Perioperative probiotic regimen substantially reduced postoperative infectious complications after major surgery.

PubMed ID: 17352961

Increased NK cells, antigen‑specific IgA and fewer influenza‑like illnesses after probiotic suggest immune boosting.

PubMed ID: 17360077

LGG reduced pulmonary exacerbations and hospital admissions in children with cystic fibrosis (clear clinical reduction in infectious complications).

PubMed ID: 17870185

B. cereus var. toyoi in pigs increased gut immune cell populations and reduced pathogenic E. coli presence (animal evidence of immune modulation).

PubMed ID: 18829790

Strong reduction in NEC or death in very low birth weight infants with probiotics — major defensive benefit.

PubMed ID: 18076918

Oral L. casei added to intravesical chemo reduced bladder cancer recurrence — may reflect immune‑mediated benefit (indirect).

PubMed ID: 18489775

ICU trial showed reduced/delayed P. aeruginosa respiratory colonization with oral L. rhamnosus — supports mucosal defense effects.

PubMed ID: 18990201

L. plantarum application in intubated patients reduced emergence of potentially pathogenic enteric species in the oropharynx — protective colonization effect.

PubMed ID: 18986600

Infant formula with probiotics reduced otitis media, antibiotic prescriptions and recurrent respiratory infections.

PubMed ID: 18631345

Perinatal probiotic supplementation increased newborn immune markers in cord blood and breast milk.

PubMed ID: 18422632

Certain probiotics accelerated antibody responses to oral cholera vaccine, indicating immune enhancement.

PubMed ID: 18854803

Oral probiotics after antibiotics helped restore protective vaginal lactobacilli and prevent relapses—supports mucosal defenses.

PubMed ID: 18552710

Increased fecal IgA and lower calprotectin in preterm infants indicate enhanced mucosal immunity.

PubMed ID: 18420983

Lactobacillus in chicks increased intestinal T‑lymphocyte infiltration (stimulated local immunity; animal data).

PubMed ID: 18423151

In severe hepatitis patients probiotics lowered TNF‑α/IL‑6 and raised IL‑2/IL‑10 with better clinical improvement (immune modulation).

PubMed ID: 19295645

Adjunctive vaginal probiotics with tinidazole greatly increased BV cure and restored normal flora (microbial defense restoration).

PubMed ID: 19651563

Large RCT in preschoolers showed major reductions in fever, cough, symptom duration and antibiotic use — robust immune/protective effect.

PubMed ID: 19896252

LGG lowered risk and duration of upper respiratory infections in day‑care children — clear immune benefit.

PubMed ID: 19820590

Synbiotic reduced bloodstream infections and VAP and lowered inflammatory markers in severely injured patients.

PubMed ID: 19747410

Large elderly RCT: fermented dairy with L. casei shortened respiratory/GI infection durations (functional immune benefit).

PubMed ID: 19187507

Adding probiotics to fluconazole improved yeast vaginitis cure rates (adjunctive host/microbial defense).

PubMed ID: 19685085

B. breve in chemo patients maintained healthier flora and was associated with fewer fevers and IV antibiotic use.

PubMed ID: 19615959

Fermented probiotic drink increased influenza vaccine antibody responses and seroconversion in elderly (strong evidence of immune enhancement).

PubMed ID: 19594864

Probiotic dairy reduced IgE and increased Tregs and mucosal IgA in allergic children — immune modulation.

PubMed ID: 20502866

Ventilated ICU patients had fewer catheter infections with probiotics despite no overall mortality benefit.

PubMed ID: 21504972

Large RCT in shift workers showed fewer common infections and increased leukocyte/NK cell counts and activity.

PubMed ID: 20135748

Probiotic mix shortened diarrhoea and promoted anti‑inflammatory cytokines; improved gut immune milieu.

PubMed ID: 20980486

Probiotics prevented NEC in VLBW infants — prevented a severe infection/inflammatory complication of the gut.

PubMed ID: 20557362

S. boulardii reduced side effects and modestly increased H. pylori eradication (supports therapy success and tolerability).

PubMed ID: 20487575

Two randomized studies showed increased NK cell activity and a substantial reduction in common cold risk in elderly subjects (immune enhancement with clinical benefit).

PubMed ID: 20670468

Modest reduction in acute diarrhoea incidence in children suggests some protective effect against GI infections.

PubMed ID: 21083585

Perioperative RCT improved gut barrier function and reduced postoperative infectious complications (reduced infection risk).

PubMed ID: 20455694

Oral lactobacilli reduced pathogenic milk bacterial counts and improved mastitis outcomes versus antibiotics—improved host defense against infection.

PubMed ID: 20410904

Preterm infant trial reduced Candida colonization and improved 1‑year neurological outcomes—indicates infection/colonization control and clinical resilience.

PubMed ID: 20485304

Daily L. casei drink modestly reduced overall and gastrointestinal infections in preschool children — clear immune-protective effect.

PubMed ID: 20659602

Vaginal lactobacilli capsules significantly lowered BV recurrence and Gardnerella detection — improved barrier/microbiome defense.

PubMed ID: 20350428

C. butyricum reduced pathogen colonization, diarrhea and sepsis in preterm infants — strong defense enhancement in a vulnerable group.

PubMed ID: 20517305

VSL#3 reduced UC activity and rectal bleeding, and may support mucosal defenses in colitis.

PubMed ID: 20658369

Probiotic bowel prep increased IgA expression and occludin expression (barrier/immune markers) after colorectal surgery.

PubMed ID: 20863419

BB‑12 in infants substantially reduced respiratory infections in an RCT — strong immune benefit.

PubMed ID: 20922415

S. boulardii effective clinically against Blastocystis and achieved high cure rates — supports host defense against GI pathogens.

PubMed ID: 20803023

Large RCT: probiotic mix reduced incidence, duration and symptom burden of common colds (enhanced host defense vs respiratory infections).

PubMed ID: 20403940

Lactobacillus GG significantly reduced hospital-acquired GI and respiratory infections in children (strong immune/protective effect).

PubMed ID: 20506712

Neonatal supplementation markedly lowered NEC and sepsis rates (substantial protection in vulnerable infants).

PubMed ID: 20099160

Preop Bifidobacterium increased stool SIgA and decreased postoperative septic complications (enhanced mucosal/systemic defense).

PubMed ID: 21285968

LGG increased seroprotection for H3N2 after LAIV in adults (strain-specific immune adjuvant effect).

PubMed ID: 21519752

Dose-dependent immune cell shifts and lower TGF-β1 in elderly, with trend to fewer infections (meaningful immunomodulation).

PubMed ID: 21899798

Large RCT: BB-12® and L. casei 431® increased systemic influenza-specific IgG subclasses and salivary sIgA — strong immune-boosting evidence.

PubMed ID: 22136422

Severe TBI pilot showed shift toward Th1, lower IL-6/CRP and fewer late infections with probiotics — significant immune effects.

PubMed ID: 21477383

Athlete trial showed dampened post-exercise cytokine spikes and reduced lower respiratory illness load (immunoprotective signal).

PubMed ID: 21266337

Infant probiotics during immunization trended toward fewer failed vaccine responses and fewer vaccine-related side effects (immune support signal).

PubMed ID: 21411836

L. casei Shirota reduced URTI episodes in athletes and preserved salivary IgA — clear enhancement of mucosal defenses.

PubMed ID: 22142891

LcS intake increased NK cell activity and CD16+ cell counts in smokers—direct immune‑function enhancement.

PubMed ID: 21814146

LGG markedly increased VRE clearance and raised Lactobacillus counts after antibiotic exposure—supporting colonization and pathogen displacement.

PubMed ID: 22507276

Schoolchildren trial showed fewer colds and less absenteeism with a two‑strain probiotic.

PubMed ID: 22197980

Perioperative probiotic markedly reduced postoperative infectious complications and improved immune markers.

PubMed ID: 22692023

L. rhamnosus GG was associated with fewer respiratory symptom days in subjects with confirmed fecal recovery—suggests enhanced resistance.

PubMed ID: 22237870

Bb12 raised fecal sIgA and vaccine-specific intestinal IgA in infants — supports mucosal immunity.

PubMed ID: 23071204

L. reuteri in very preterm infants trended to fewer pneumonias/NEC and other infection-related improvements in subgroups.

PubMed ID: 23020819

Probiotic blend shortened colds and reduced symptom severity in college students — clinical immune benefit.

PubMed ID: 23192454

B. longum BB536 raised fecal bifidobacteria and helped preserve NK activity in tube‑fed elderly — meaningful immune support.

PubMed ID: 22931620

Perioperative oral probiotics increased beneficial intestinal bacteria and raised serum immunoglobulins/IL‑2 — enhanced host defenses.

PubMed ID: 22645023

Elderly trial showed increased NK cells and hBD-2 with reduced IL-8 — robust immunomodulatory effects.

PubMed ID: 22738443

Neonatal trial reduced oropharyngeal pathogenic colonization and delayed VAP timing — clinically relevant protective effect.

PubMed ID: 22732975

L. plantarum increased influenza vaccine antibody responses in elderly volunteers — evidence of enhanced adaptive immunity.

PubMed ID: 22947249

Large RCT: heat-killed L. pentosus dose-dependently lowered common cold incidence and improved perceived general health.

PubMed ID: 22556209

In VLBW infants probiotics significantly reduced combined NEC-or-death — strong protective effect.

PubMed ID: 24246768

In cirrhosis, probiotics halved overt hepatic encephalopathy and reduced ammonia/SIBO — clinically meaningful immune/metabolic benefits.

PubMed ID: 23361033

Probiotic mix reduced GI Candida colonization and candiduria in critically ill children on broad-spectrum antibiotics (improved host defense).

PubMed ID: 24249817

Large multicenter RCT in very preterm infants found the probiotic mix significantly reduced NEC, indicating improved gut/host defenses.

PubMed ID: 24019207

Probiotic-containing yogurt altered immune gene expression (FOXP3, T-bet) in overweight/obese adults — immune-modulatory signals.

PubMed ID: 24268677

Large RCT showed B. animalis Bl-04 reduced risk of upper respiratory tract infections (~27% RRR) and delayed time to first illness.

PubMed ID: 24291194

Four-strain probiotic reduced antibiotic-associated diarrhea and C. difficile infections — enhanced resistance to infection after insult.

PubMed ID: 24309022

In VLBW infants L. reuteri lowered proven sepsis incidence — clear enhancement of host defenses in that population.

PubMed ID: 24028629

S. boulardii reduced clinical sepsis and feeding intolerance in VLBW infants—important defensive benefit in neonates.

PubMed ID: 24205115

Infant-derived strains were safe and increased fecal sIgA and anti-inflammatory cytokine ratios — measurable immune activity in humans.

PubMed ID: 23890374

LcS shortened URTI duration in elderly day‑care users (reduced illness burden).

PubMed ID: 24045086

Probiotics increased proportion of rugby players with no infection episodes and tended to shorten illness days (clinical immune benefit).

PubMed ID: 23660099

Marked reductions in proinflammatory cytokines and infections in severe pancreatitis suggest strengthened host response.

PubMed ID: 23307112

L. casei Shirota increased NK cell activity and shifted cytokine profile in older adults (direct immune enhancement).

PubMed ID: 23842110

B. infantis produced consistent, clinically meaningful reductions in systemic inflammatory markers across varied inflammatory disorders.

PubMed ID: 24311316

S. boulardii prevented antibiotic‑associated diarrhoea and improved recovery—supports host defence against gut‑related complications.

PubMed ID: 23794458

L. rhamnosus GG in children slightly reduced respiratory symptom-days, indicating modest defense effects.

PubMed ID: 24734423

Enterococcus faecium L3 given with antibiotics reduced C. difficile persistence and infectious complications in newborns.

PubMed ID: 24121143

L. reuteri markedly reduced respiratory exacerbations and URIs in cystic fibrosis—a clear immune/defense benefit.

PubMed ID: 25450083

VSL#3 reduced hospitalizations for HE and cirrhosis complications, implying improved clinical resilience to complications/infections.

PubMed ID: 24793963

L. rhamnosus + B. lactis showed a month-limited reduction in rhinovirus detections in one cohort—partial support for antiviral defense.

PubMed ID: 25205320

Lab4 probiotic + vitamin C reduced URTI days/incidence and preschool absences in children—a clear immune/defense benefit.

PubMed ID: 25099747

Perioperative symbiotic therapy raised NK‑cell levels and trended to fewer infections—immunologic support signal.

PubMed ID: 25183688

Raised fecal sIgA in toddlers indicates mucosal immune enhancement.

PubMed ID: 25516315

Critically ill neonates had significantly lower nosocomial pneumonia and MODS and higher IgA after probiotics.

PubMed ID: 25245226

In very low birthweight infants probiotic matched antifungal colonization prevention and reduced proven sepsis and feeding intolerance.

PubMed ID: 24927436

In preterm infants, probiotics reduced colonization by drug‑resistant bacteria in non‑breastfed subgroup (reduced pathogenic colonization = defense effect).

PubMed ID: 25460016

VSL#3 lowered mucosal inflammatory cytokines after Crohn's surgery (biologic impact on mucosal immunity though no clinical endpoint benefit).

PubMed ID: 24661511

S. boulardii reduced several antibiotic‑associated adverse events in children on H. pylori therapy (supports tolerability and defense against dysbiosis).

PubMed ID: 24750797

Probiotic during antibiotics preserved Bifidobacteria/Lactobacilli and prevented Enterobacteria overgrowth in children, supporting microbiota‑mediated defenses.

PubMed ID: 25623462

Probiotics + enteral nutrition reduced endotoxin and inflammatory cytokines and improved albumin—strengthened host status vs HE.

PubMed ID: 25609654

Oral multi‑strain probiotic reduced endotoxin and pro‑inflammatory cytokines and raised IL‑10 in peritoneal dialysis patients (clear immunomodulatory effect).

PubMed ID: 26635090

Probiotic given with antibiotics prolonged remission and restored vaginal Lactobacillus after BV (enhanced mucosal defense and resilience).

PubMed ID: 25469528

S. boulardii lowered LBP and IL‑6 in ART patients, indicating reduced microbial translocation and systemic immune activation.

PubMed ID: 25929897

Adding probiotic to H. pylori therapy increased eradication rates and reduced treatment‑related symptoms, supporting host defense during therapy.

PubMed ID: 26732025

Well‑powered RCT in children showed a marked reduction in common infections and increased fecal immune markers (sIgA, defensins, LL‑37).

PubMed ID: 26463725

In children, probiotic did not lower ARI incidence but did shorten duration and reduce severity—functional immune benefit.

PubMed ID: 26163609

Probiotic‑containing yogurt pretreatment improved H. pylori eradication rates when combined with therapy (supports treatment response/host defense).

PubMed ID: 26163028

Large VSL#3 trial in low birthweight infants showed significant reductions in PSBI incidence rate and benefit in smallest subgroup.

PubMed ID: 25909149

Preserved CD4% and large IL‑10 increase indicate immunomodulatory, defense‑supporting effects in older adults.

PubMed ID: 25708419

Marked reduction in ventilator‑associated pneumonia and shorter ICU/hospital stays imply improved host defenses.

PubMed ID: 25884192

Increased salivary antimicrobial peptides implies enhanced local mucosal defense.

PubMed ID: 26599038

L. casei Shirota reduced fever incidence and decreased C. difficile in elderly care residents, implying strengthened defenses against infection.

PubMed ID: 25724213

In very low birth weight infants probiotic supplementation reduced NEC incidence and severity (enhanced neonatal host defense).

PubMed ID: 26372517

BB-12 from 1 month lowered respiratory infection incidence in early childhood—direct immune protection evidence.

PubMed ID: 25846071

Infant BB536 increased bifidobacteria and enhanced Th1 responses — meaningful immunological maturation evidence.

PubMed ID: 26373743

Very low birthweight infants given probiotics had substantially fewer late‑onset sepsis events — very strong evidence for enhanced host defenses in this population.

PubMed ID: 26134988

B. breve lowered TNF‑α in children with celiac disease — evidence of anti‑inflammatory/immune modulation.

PubMed ID: 25814628

N. lactamica inoculation reduced meningococcal carriage, demonstrating enhanced colonization resistance.

PubMed ID: 26419583

L. casei Shirota substantially reduced URTI incidence and preserved NK cell activity in adults.

PubMed ID: 25604727

B. bifidum increased healthy days and reduced cold/flu reporting in stressed students.

PubMed ID: 26978751

S. salivarius K12 reduced adenoiditis exacerbations and some infection complications in children.

PubMed ID: 25653151

S. boulardii significantly shortened diarrhoea duration and reduced hospital/ECU stays in children—improved resistance to enteric disease progression.

PubMed ID: 26385346

Intranasal S. salivarius lowered acute otitis media incidence among colonized children.

PubMed ID: 26611780

Well-powered RCT: L. salivarius PS2 significantly lowered postpartum infectious mastitis (fewer infections).

PubMed ID: 26234407

Large randomized trial: L. lactis JCM5805 reduced cough/feverish days in winter and increased antiviral ISG15.

PubMed ID: 27590374

Oral L. rhamnosus + L. reuteri reduced Group B Streptococcus carriage in pregnant women.

PubMed ID: 27043237

Multicenter RCT in ventilated patients reduced microbiologically confirmed VAP and gastric pathogen colonization.

PubMed ID: 27294502

L. casei Shirota reduced CMV/EBV antibody titres suggesting immune modulation.

PubMed ID: 27973989

S. boulardii reduced antibiotic‑associated diarrhea and blunted Escherichia overgrowth (immune/gut defense effect).

PubMed ID: 26821116

BB‑12 increased IL‑2, NK cytotoxicity and reduced URTI days in humans—direct evidence of enhanced innate/antiviral defenses.

PubMed ID: 29328644

Adjunct probiotic improved H. pylori eradication rates and tended to reduce antibiotic adverse effects.

PubMed ID: 27168455

Daily fermented milk modestly reduced rhinopharyngitis incidence in daycare children.

PubMed ID: 27649676

BIFICO reduced neonatal nosocomial enteric infection incidence.

PubMed ID: 27363733

L. helveticus shortened URTI duration and reduced symptoms in athletes—enhanced host defense against respiratory infection.

PubMed ID: 27464469

Lactobacillus GG + micronutrients lowered nosocomial infections and diarrhoea in hospitalized children (combination product).

PubMed ID: 28007678

B. animalis subsp. lactis added to H. pylori therapy increased eradication rates and reduced diarrhea‑related dropouts—clinically meaningful adjuvant immune/therapeutic support.

PubMed ID: 27593544

Multispecies probiotic increased some innate immune markers in cirrhosis patients (modest immune activation signals).

PubMed ID: 27206514

Oral probiotic after fluconazole markedly lowered 6‑month vulvovaginal candidiasis recurrence—supports mucosal defense/colonization resistance.

PubMed ID: 28874323

Probiotic modestly increased rotavirus vaccine seroconversion in Indian infants, especially when combined with zinc.

PubMed ID: 29124387

L. coryniformis K8 given around influenza vaccination substantially increased seroconversion and reduced respiratory symptoms and analgesic use in elderly.

PubMed ID: 27100317

L. helveticus prevented declines in mucosal and serum IgA in elite athletes — indicates preservation of immune defenses.

PubMed ID: 28654019

Fermented milk with L. paracasei CBA L74 significantly reduced common infectious diseases in children and increased innate/adaptive immune markers.

PubMed ID: 28935921

L. casei Shirota reduced bacterial translocation into blood in T2D patients, suggesting improved gut barrier and systemic defense.

PubMed ID: 28848330

Daily L. paracasei N1115 yogurt reduced incidence of acute URTI in middle‑aged/elderly adults and increased T‑cell markers modestly.

PubMed ID: 28922099

Multi-strain probiotic downregulated inflammatory gene expression (IL-8, TNF-α) in MS patients — evidence of immune modulation.

PubMed ID: 29024599

Probiotic intake increased anti-inflammatory IL-10 in young men — immunoregulatory effect.

PubMed ID: 28858247

In preterms, L. reuteri increased fecal IL-10 and reduced inflammatory markers and antibiotic days — immune benefit.

PubMed ID: 28343401

B. lactis reduced nasal CXCL8 and viral shedding in an experimental rhinovirus challenge — enhanced innate mucosal responses.

PubMed ID: 29196153

Vaginal L. crispatus after antibiotics halved BV recurrence and prolonged recurrence-free interval — mucosal defense enhancement.

PubMed ID: 28561762

Large RCT in older adults showed increased NK-cell activity and increases in IFN-γ, IL-12 and IgG1 with probiotic yogurt—strong immunostimulatory evidence.

PubMed ID: 28388647

S. boulardii shifted gut bacteria away from pro‑inflammatory clostridial taxa and associated with lower translocation/inflammation markers in treated HIV patients.

PubMed ID: 29065707

Large RCT in preschoolers: BB536 reduced sore throat duration by ~46% and marginally reduced other URTI symptoms; immune‑relevant microbiota changes observed.

PubMed ID: 30521105

Probiotic combo in nasopharyngeal cancer patients greatly reduced severe oral mucositis and preserved immune cell counts during chemoradiotherapy.

PubMed ID: 30536353

Pilot showed fewer oral/respiratory infections in children after probiotic supplementation.

PubMed ID: 29957709

In children with severe sepsis probiotics markedly lowered pro‑inflammatory cytokines, raised anti‑inflammatory cytokines and reduced SOFA scores — strong immunomodulatory and clinical signal.

PubMed ID: 30424728

Three‑strain probiotic in very preterm infants significantly increased Bifidobacterium abundance during supplementation — supports mucosal colonization/defense.

PubMed ID: 29540160

HN001 colonized gut and substantially reduced stool S. aureus carriage, implying protective microbiome effects.

PubMed ID: 30630805

Probiotic adjunct in UC reduced inflammatory markers and adverse reactions, indicating immunomodulatory benefit.

PubMed ID: 29304768

Long‑term vaginal L. rhamnosus improved HPV clearance and resolution of PAP abnormalities, indicating mucosal defense enhancement.

PubMed ID: 29453431

Early LGG supplementation induced T‑reg cells and anti‑inflammatory metabolites, supporting immune tolerance/defense.

PubMed ID: 29364495

Oral L. plantarum increased vaginal lactobacilli colonization and improved signs in recurrent vulvovaginal candidiasis—enhanced local defenses.

PubMed ID: 29725956

Large intervention with S. boulardii in antibiotic‑treated inpatients produced a large, statistically robust drop in C. difficile infections.

PubMed ID: 31340751

Post‑colorectal surgery probiotic reduced circulating inflammatory cytokines, indicating immune modulation.

PubMed ID: 30882242

Vaginal L. crispatus lowered Nugent score and Gardnerella counts, reflecting strengthened local defenses.

PubMed ID: 31056685

Systemic sclerosis trial showed decreased Th17 cells with probiotics — measurable immune modulation though clinical defense endpoints not improved.

PubMed ID: 31177581

Addition of S. salivarius K12 improved mycological cure rates for oral candidiasis — improved host defense in the oral niche.

PubMed ID: 30898471

VLBW infant trial increased fecal sIgA, indicating enhanced mucosal immune defense.

PubMed ID: 31210557

Reduction in proinflammatory cytokine responses indicates immunomodulation rather than stronger antibody responses.

PubMed ID: 31705339

Vaginal probiotic markedly increased cure rates for TV/BV when added to metronidazole, improving local defenses.